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The aetiology and pathogenesis of primary open angle glaucoma (POAG), the second most
common cause of irreversible visual loss in the United Kingdom, remains a conundrum for
contemporary ophthalmology. Evidence suggests that glaucoma is a complex disorder,
where multiple genes interact with each other and with factors in the environment. However,
the aetiological heterogeneity of glaucoma coupled with its varied clinical presentation and
course has made the study of glaucoma genes problematic. We established the Orcades Eye
Study, a cross sectional family based genetic study, to explore the inheritance of primary
open angle glaucoma (POAG). As POAG is a disease of late onset and low prevalence,
rather than study disease per se we chose to study quantitative traits (QTs) related to POAG,
in an isolated population in the northern Scottish archipelago of Orkney. A number of factors
in this population, including reduced genetic heterogeneity and more homogenous
environmental effects, confer certain advantages over more admixed urban populations in
complex disease gene mapping. Preliminary analysis of the procured quantitative trait data
(n=256) has demonstrated that the values obtained for the POAG related QTs of intraocular
pressure (IOP), central corneal thickness and a number of optic disc parameters including
optic cup area, disc area, retinal nerve fiber thickness, vertical cup to disc ratio and
peripapillary atrophy are not dissimilar to other published White Caucasian populations. We
also found that intraocular pressure shows an increase with age and is influenced by central
corneal thickness but found no relationship between IOP and gender or IOP and other ocular
biometric variables including optic nerve head parameters and refractive components.
Neither central corneal thickness nor optic nerve head parameters had a statistically
significant relationship to age, gender or other tested ocular biometric parameters. These
findings are clinically important as these factors should be taken into consideration when
evaluating intraocular pressure and other ocular biometric traits in the investigation of
glaucoma and other ocular diseases in the population of Orkney. Data collection is ongoing,
and with time, an increased sample size and a meaningful genetic analysis, the Orcades Eye
Study will hopefully identify genes and regions of the genome associated with primary open
angle glaucoma susceptibility in the Scottish Population Isolate of Orkney. To our
knowledge, the only other population based study which has investigated as large a number
of glaucoma related QTs is the Beijing Eye Study.
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CHAPTER 1
PRIMARY OPEN ANGLE GLAUCOMA
1.1 AN INTRODUCTION TO PRIMARY OPEN ANGLE GLAUCOMA
The solitary term “glaucoma” describes a heterogeneous group of progressive optic
neuropathies that have in common, a slow progressive degeneration of retinal
ganglion cells and their axons, resulting in a characteristic structural damage to the
optic disc and a concomitant pattern of visual field loss if untreated (Weinreb and
Khaw, 2004, Burr et al., 2007). This term is also used to describe ocular diseases
which have already acquired the characteristic ocular neuropathy such as in primary
open angle glaucoma (POAG), as well as other conditions in which intra ocular
pressure (IOP) is elevated but no irreversible optic nerve injury has yet occurred such
as in primary congenital glaucoma and acute angle closure glaucoma. It is a common
disease and the primary cause of irreversible visual impairment in the world
(Resnikoff et al., 2004).
There is some controversy over the true etymology of the term “glaucoma.” Its
origins can be traced back to ancient Greece and the works of Hippocrates of Kos.
The term “glaucosis” was used to described a blinding disease which occurred most
commonly in the elderly population (Fronimopoulos and Lascaratos, 1991, Tsatsos
and Broadway, 2007, Lascaratos and Marketos, 1988a, Nathan, 2000). The word
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“glaucoma” itself is derived from the ancient Greek word “glaukos”, which can be
used as a noun, an adjective or a verb and is believed to originate from the Greek
verb “glausso” which means to “to glow” or to “shine”. This description may
perhaps relate to the inflamed eye associated with acute forms of glaucoma. The
Greek word “glaukos” also means “owl” – so named because of the bird’s striking,
glowing eyes. Used as a noun, it can mean “blue-white” or “ blue-green”, which,
from an ocular perspective, may refer to the blue-green hue sometimes associated
with corneal oedema or cataract.
Whatever its true etymology, the term “glaucosis” of antiquity is unlikely to have
represented the group of diseases that is described today under the term of
“glaucoma”. There is evidence to suggest the original term was used to described
cataracts rather than a disease associated with raised ocular pressure (Fronimopoulos
and Lascaratos, 1991, Tsatsos and Broadway, 2007). At the time of Hippocrates of
Kos (460-377 BC), there was little differentiation between the two conditions, all
afflictions of the eye being attributable to “disturbed or ill humours” (Cohen, 2001).
The initial differentiation between these two entities is credited to the Romans,
initially Celsus (25 BC– 50AD) and subsequently Galen (131-210AD) who
described cataract as potentially amenable to remedy and glaucoma as incurable
(Cohen, 2001).
Early medical records of glaucoma consisted of isolated observations by a number of
medical practitioners, with references being made to what would now be considered
advanced angle closure glaucoma. The Arabian surgeon Al-Tabari in the 10th century
3
is the first known individual to describe an association between raised intra-ocular
pressure (IOP) and glaucoma (Cohen, 2001). Four centuries later Sams-ad-Din of
Cairo described a certain ocular malady as “ migraine of the eye……pain in the
eye…dilation of the pupil and cataract. If chronic …blindness intervenes.” Following
the post-mortem examination of eyes, Brisseau was the first to propose glaucoma
was not associated with a lens disorder. He suggested that the term cataract should
be reserved for opacities of the lens and that glaucoma was secondary to an
abnormality of the vitreous (Nathan, 2000, Drews, 2006). About a century later , the
British surgeon James Guthrie, coined the term “glaucoma” to describe an ocular
disease associated with rigidity of the globe. Table 1.1 summarizes some of the
milestones in the history of glaucoma.
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Hippocrates Uses the term “glaucosis” to describe a blinding eye condition.
c.330-
260/255BC





Initial differentiation between glaucoma and cataract.
“Psychic pneuma” circulated via central and peripheral nervous
systems to provide body with sensation (Galen). Lens believed to
be responsible for vision and nourished by retinal blood supply.
Described channels in optic nerve – “poroi optika.”Optic nerves
believed to join at chiasma to produce single vision.
~10th century Al-Tabari Relationship between raised eye pressure and glaucoma described
c.1514-
1600
Versalius, Fallopia, Coiter Finds little evidence to support Galen’s theory of optic nerve
channels (Versalius). Organization of nerves reported in the term of
“fibres” (Fallopia and Coiter), but nerve remains structure through
which substances flowed, hence nerve fibers still considered hollow.
1573 Varolio Credited with first detailed recorded dissection showing the
structure of the optic nerve and its relationship to the central
nervous system.
1626 Bannister Digital tonometry to identify elevated IOP
1664 Descartes Develops working model of optic nerve further. Describes nerve as
a cylindrical structure enfolding bundles of smaller cylinders which
contains slender filaments which appear to arise from the brain.
1668 Mariotte Reports on the presence of a blind spot in the visual field
corresponding to the position of the optic nerve head.
1707 Brisseau Further differentiation between glaucoma and cataract. Lens
identified as site of cataract formation
1717 Van Leeuwenhoek Microscopic examination of the optic nerve provides further
evidence for Descartes’ description of optic nerve structure. Also
unable to find evidence for Galen’s poroi optika. Suggests once the







Several texts published concurrently regarding the importance of
“the hardness of the eye” as a symptom
Guthrie credited with coining the term “glaucoma”
1741 St.Yves Periods of blurred vision may occur prior to signs of advanced
glaucoma
1 Information summarized from the following references: LASCARATOS, J. & MARKETOS, S. (1988b)
Ophthalmological lore in the Corpus Hippocraticum. Doc Ophthalmol, 68, 35-45, FRONIMOPOULOS, J. &
LASCARATOS, J. (1991) The terms glaucoma and cataract in the ancient Greek and Byzantine writers. Doc
Ophthalmol, 77, 369-75, NATHAN, J. (2000) Hippocrates to Duke-Elder: an overview of the history of
glaucoma. Clin Exp Optom, 83, 116-118, COHEN, H. C. (2001) The History of Filtering Surgery
IN MERMOUD, A. & SHAARAWY, T. (Eds.) Non-Penetrating Filtering Glaucoma Surgery
London, Martin Dunitz Ltd, DREWS, R. C. (2006) Green cataract. Arch Ophthalmol, 124, 579-86, TSATSOS,
M. & BROADWAY, D. (2007) Controversies in the history of glaucoma: is it all a load of old Greek? Br J
Ophthalmol, 91, 1561-2. KRONFELD, P. C. & (2009) The History of Glaucoma. IN TASMAN, W. & JAEGER,
E. A. (Eds.) Duane's Ophthalmology. 530 Walnut Street, Philadelphia, Pennsylvania 19106-3621
Lippincott Williams & Wilkins.
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1791 Galvani Proposes “electric fluid” rather than previously postulated spirits
and fluids important in the function of the nervous system
1801-1896 Longet, Muller, Bois-
Reymond
Further work into the electric nature of nerve conduction.
Electricity believed to produce a “nerve principle”. Presence of
electric currents within nerves proven (Bois-Reymond, 1843).
1830-1854 Mackenzie Makes distinction between acute and chronic forms of glaucoma.
Describes different stages of chronic glaucoma.
Suggests scleral puncture as a method of treatment.
1851 Helmoltz Introduces the ophthalmoscope into clinical practice.
1854 Von Jaeger
Von Graefe
Optic disc evaluated with ophthalmoscope
Initially disc described as a swelling as opposed to cupping
1855 Weber Clarifies optic disc depressed rather than swollen
1856 Von Graefe Credited as being the first to chart paracentral visual field defects
associated with chronic glaucoma, and use these to appraise the
success of surgical interventions.
1857 Kirsch, Von Graefe Importance of evaluating optic nerve head recognized.
Von Graefe’s iridectomy gains popularity as operation of choice for
treating glaucoma
1857 Muller Anatomic observation of disc cupping thought to be secondary to
raised vitreous pressure on lamina
1857 Forster First formal perimeter introduced. Initial targets of considerable size
1860s Donders, Von Graefe, Argyll
Robertson
Further classification of glaucoma. Primary and secondary forms,
“glaucoma simplex”, “glaucoma with ophthalmia”
Elevated pressure believed to be secondary to “hypersecretion” of
intraocular liquor (Donders)
Inflammation also considered important in the aetiology of raised
pressure (von Graefe)
Preliminary efforts at developing a mechanical tonometer (von
Graefe, 1862)
Describes effect of calabar bean on miosis and accommodation
(von Graefe, Robertson). Miotic effect utilized in iridectomy.
Experimental tonometer developed to be used on closed eyelids
(1862)
First mechanical tonometers trialled on human eyes (Donders 1863-
68)
1862 Bowman Suggests a 9 stage classification system (-T3 to +T3, exceptionally
low to extremely high) of ocular pressure or tension based on
digital palpation
1867 Weber First applanation tonometer
1870 Knapp Extension of blind spot described in patients with “choked discs”
1870 Stricker and others Advancements in histology and microscopy lead to the
understanding that the numbers of optic nerve fibres are reduced in
diseases like glaucoma.
1870 Schwalbe Systematically investigates aqueous flow. Believes anterior
chamber communicates directly with anterior ciliary veins and is
part of the lymphatic system.
1873 Leber Disputes Schwalbe’s hypothesis. Anatomic/cannulation studies
gives rise to “filtration theory of aqueous formation”. In order to
maintain a steady IOP in vivo, believed that fluid outflow was
accompanied by a comparable amount of fluid formation. Outflow
of fluid occurred via trabecular meshwork to anterior ciliary and
vortex veins.
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1876-7 Laquer Reduction of IOP noted following the use of physiostigmine in
certain cases of glaucoma. Subsequently describes ability of
physiostigmine to abrogate acute attacks and thwart recurrent
attacks of acute glaucoma.
1877 Weber Pilocarpine introduced as a topical hypotensive.
1879 Priestly-Smith Believes there are vascular and nutritional as well as pressure
related components to glaucomatous optic neuropathy.
1882 De Wecker Suggests certain forms of corneo-scleral incisions would mend in a
way which would allow aqueous to drain through healed tissue into
subconjunctival space in the presence of a pressure gradient.
1885-88 Imbert and Fick Investigates theory of applanation further – Imbert-Fick Law.
Develops basic mechanical fixed area tonometer based on this
principle. Never used on human eyes though tested on other
mammals.
1885 Malakoff Explores applanation tonometry further First known practical
applanation tonometer developed. Tonometer of 1892 gains
popularity
1889 Bjerrum Further development of perimetry. 2 meter test distance introduced
and smaller targets. The blind spot, the presence of relative and
absolute scotomas, described. Initial seeds of the nerve fibre theory
of glaucoma sown.
1889 Drance and Begg Optic disc haemorrhage associated with glaucoma
1895 Leber Notes increased resistance to aqueous outflow in enucleated human
globes with advanced glaucoma. Development of Leber-Knies
Theory describes glaucoma as a malady of abnormal aqueous
outflow.
1897 Czermak Shallow anterior chamber associated with acute inflammatory
forms of glaucoma.
1899 Elschnig Normal discs noted to be variable
Early
1900s
Trantras Credited with being the first to examine angle of anterior chamber.
Coins the word “gonioscopy”.
1902 Darier Use of adrenaline alone or together with physiostigmine as a ocular
hypotensive described.
1903 Herbert Describes a number of operations establishing subconjunctival
fistula. First report of effect of aqueous outflow on peribulbar
tissues.
1905 Schnabel Describes the development of cavities and destruction of nerve
fibres. Believes mechanism of glaucomatous optic neuropathy
secondary to adsorption of noxious fluid by optic nerve fibres
1905 Schiotz Introduces indentation tonometer. Subsequently replaces Malakoff.
1906 Lagrange Describes iridosclerotomy
1909 Freeland, Elliot Trephine exchanged for Lagrange’s scissors
1913 Salzman Credited as being the second pioneer of gonioscopy
1913 First international review of
glaucoma surgery
Operation of choice changes from iridectomy to “filtering cicatrix”
linked to the anterior chamber for chronic glaucoma. Iridectomy
remains in favour for more acute cases of glaucoma.
1919-20 Koeppe Describes method of direct gonioscopy with Koeppe lens
1920s Seidel Expands on Leber’s works. Describes aqueous formation in more
detail, transconjunctival movement of aqueous following
trephination.
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1920 Curran, Seidel Describes mechanism of acute pupillary block
1921 Pickard Drawings of optic nerve head standardized
1922 Elliot Optic cup enlargement and pallor associated with glaucoma
1923 Hamburger New preparations of adrenaline introduced.
1927 Peter Association of paracentral scotomas and chronic glaucoma
described
1925-47 Tronsco Further work on angle anatomy. Credited with clarifying the
structural organization and nomenclature of the angle
1938 Barkan Used gonioscopy routinely in clinical practice. Differentiated
between “open angle” and “narrow angle” glaucoma. Suggested
IOP increase in former secondary to sclerosis of trabecular
meshwork. Introduced the “internal trabeculotomy” for open angle
glaucoma, suggested peripheral iridectomy for narrow angle
glaucoma and goniotomy for congenital glaucoma.
1954 Many Seeds sown for the current classification of glaucoma at the
International Symposium on Glaucoma
1959 Mackay, Marg Introduces combined applanation-indentation tonometer.
Forerunner of the currently widely used Tonopen.
~1960 Goldman, Schmidt Further development of Fick’s concept of a fixed area tonometer
into the now widely used Goldman Applanation tonometer
1960 Anderson, Kirsch Cupping of the optic disc occurs before the loss of visual field
1965 Posner Introduces Posner Applanometer, a fixed force tonometer, into
clinical use.
1965-67 Draeger, Perkins Introduce portable applanation tonometer based on the Goldman
principle.
1973 Asseff, Bjerrum, Phelps,
Wesimen
Vertical optic disc cupping important
1970s Many Well designed large scale epidemiological studies provide evidence
about the risk factors for glaucoma
1.2 DEFINITION AND CLASSIFICATION OF GLAUCOMA
With increased observation and contemplation, it was gradually recognized that
glaucoma was not a single disease entity but that several forms existed. Without
appropriate instruments to examine the interior of the eye, glaucoma were initially
classified on the basis of external appearance. The first elementary classification of
glaucoma, congestive versus non-congestive, was based on the presence or absence
of inflammatory changes on the surface of the globe. Classification systems that
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followed co-evolved with advancement in technology and subsequent knowledge.
Current methods of classification are loosely based on a system proposed in 1954 at
the International Symposium on Glaucoma (table 1.2)(Consoli et al., 2005). Even
today, there is no universally accepted definition or classification system for
glaucoma (Kroese and Burton, 2003, Foster et al., 2002). For the purpose of this
thesis, the terminology proposed by the European Glaucoma Society has been
adopted. (European_Glaucoma_Society, 2003). The open angle glaucomas (OAG),
as defined by the European Glaucoma Society , are group of chronic, progressive
optic neuropathies, that have in common characteristic changes at the optic nerve
head, retinal nerve fibre layer and are accompanied by an open anterior chamber
angle. Primary open angle glaucoma (POAG) is not associated with any other ocular
disease or congenital anomaly. Table 1.2 summarizes some of the different
classification systems currently in use – the WHO classification of glaucoma,
according to ICD-10, the American Association of Ophthalmology and the European
Glaucoma Association, as well as the system proposed in 1954.
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TABLE 1.2: SYSTEMS USED IN THE CLASSIFICATION OF GLAUCOMA
SYSTEM OF CLASSIFICATION DESCRIPTION
INTERNATIONAL SYMPOSIUM
ON GLAUCOMA 1954
(CONSOLI ET AL., 2005)
1. Primary Glaucoma with two sub classes
(i). Simple Glaucoma






2. Secondary Glaucoma: due to pre-existing disease. This may be either
(i). Open angle
(ii). Closed angle





Diseases of the Eye and Adnexa (H00-H59)
Glaucoma (H40-H42)
H40 Glaucoma - Excludes
 absolute glaucoma ( H44.5 )
 congenital glaucoma ( Q15.0 )
 traumatic glaucoma due to birth injury ( P15.3 )
H40.0 Glaucoma Suspect
Ocular Hypertension
H40.1 Primary open-angle glaucoma
Glaucoma (primary)(residual stage):




H40.2 Primary angle closure glaucoma




H40.3 Glaucoma secondary to eye trauma
H40.4 Glaucoma secondary to eye inflammation.
H40.5 Glaucoma secondary to other eye disorders
H40.6 Glaucoma secondary to drugs
H40.8 Other glaucoma
H40.9 Glaucoma, unspecified.







 Primary Congenital Glaucoma
 Primary Infantile Glaucoma
 Glaucoma Associated with Congenital Anomalies (e.g. aniridia,
Sturge Weber, Marfan’s syndrome)
Primary Open Angle Glaucomas
 Primary Juvenile Glaucoma
 Primary Juvenile Glaucoma Suspect
 Primary Open Angle Glaucoma (POAG)/High Pressure
Glaucoma(HPG)
 Primary Open Angle Glaucoma Suspect (POAG/HPG Suspect)
 Primary Open Angle Glaucoma/Normal Pressure Glaucoma
(POAG/NPG)
 Primary Open Angle Glauomca/Normal Pressure Glaucoma
Suspect (POAG/NPG-suspect)
Secondary Open Angle Glaucomas
 Secondary Open Angle Glaucomas Caused By Ophthalmic
Conditions
o Pseudoexfoliative Glaucoma (PEX)
o Pigmentary Glaucoma
o Lens-induced Secondary Open Angle Glaucoma
o Glaucoma Associated with intraocular haemorrhage
o Uveitic Glaucoma
o Glaucoma Associated with Retinal Detachment
o Open Angle Glaucoma Due to Ocular Trauma
 Iatrogenic Secondary Open Angle Glaucoma
o Glaucoma due to corticosteroid treatment
o Secondary Open Angle Glaucoma due to ocular
surgery and laser
 Secondary Open Angle Glaucomas Caused by Extra-ocular
Conditions - glaucoma caused by increased episcleral pressure
e.g. due to orbital or retrobulblar tumours
Primary Angle Closure Glaucoma
 Acute Angle Closure Glaucoma
 Chronic Angle Glaucoma
AMERICAN ACADEMY OF OPHTHALMOLOGY
(American_Academy_of_Ophthalmology, 2008)
I. Open Angle Glaucomas
1. Primary open angle glaucoma
2. Normal tension glaucoma
3. Juvenile open angle glaucoma
4. Glaucoma suspect
5. Secondary open angle glaucoma
II. Angle Closure Glaucomas
1. Primary angle closure glaucoma with relative papillary block
2. Acute angle closure
3. Subacute angle closure (intermittent angle closure)
4. Chronic angle closure
5. Secondary angle closure with papillary block
6. Secondary angle closure without papillary block
7. Plateu iris syndrome
Childhood Glaucomas
1. Primary congenital glaucoma
2. Glaucoma associated with congenital anomalies
Secondary glaucoma in infants and children
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1.3 EPIDEMIOLOGY OF PRIMARY OPEN ANGLE GLAUCOMA
Recent estimates of visual impairment by the World Health Organization states that
over 161 million people were visually impaired in 2002 (Resnikoff et al., 2004). Of
these, 124 million people had low vision* and 37 million were blind. Glaucoma was the
primary cause of irreversible visual impairment, second only to cataract in all causes.
Quigley and Broman (2006) have estimated that by 2020, there will be approximately 80
million individuals with glaucoma - 59 million of these will have open angle glaucoma
(Quigley and Broman, 2006). Primary open angle glaucoma is the second most
common cause of blind registration after macular degeneration in the United Kingdom
(Bamashmus et al., 2004) and is calculated to cost approximately £380 per patient per
annum (Traverso 2005) with an estimated £300 million spent in the UK in 2002
(Rouland 2005). The epidemiology of open angle glaucoma has been the subject of
many comprehensive reviews elsewhere (Leske, 2007, Leske, 1983, Leske and
Rosenthal, 1979, Rudnicka et al., 2006, Pascolini et al., 2004) and will only be
summarized here.
* As defined in the International Classification of Diseases and Health Related Problems, 10th Revision,
Second Edition. World Health Organization, Geneva http://www3.who.int/icd/currentversion/fr-icd.htm
12
1.3.1 PREVALENCE OF PRIMARY OPEN ANGLE GLAUCOMA
Since as far back as the 1920s, glaucoma research has gained from a multitude of
epidemiological studies, conducted across continents investigating the prevalence of
open angle glaucoma. In many earlier studies, glaucoma and ocular hypertension were
synonymous and failed to meet certain methodological standards such as clearly
describing the criteria used to define the disease (Leske and Rosenthal, 1979, Leske,
1983). One of the first studies to be well received as being adequately designed and
conducted was the Welsh Glaucoma Survey in the Rhondda Valley (Leske, 1983,
Hollows and Graham, 1966). 92% of the town’s eligible population were examined but
only people between the ages of 40 and 75 were included in the study. The diagnostic
criteria used were an IOP above 20 mmHg, cupping of the optic disc and visual field
defects. The prevalence of chronic simple glaucoma was found to be 0.28% in the
examined population. Since then over 50 population based studies have been conducted
in different populations. These populations have been either entire towns or defined
regions or by recruiting volunteers using clearly defined selection strategies such
random or clustered sampling procedures. These include the Rotterdam Eye Study
(Dielemans et al., 1994), Roscommon Eye Study (Coffey et al., 1993) and the Reykjavik
Eye Study (Jonasson et al., 2003) from Europe, The Blue Mountains Eye Study
(Mitchell et al., 1996) and Melbourne Visual Impairment Study (Wensor et al., 1998)
from Australia. Studies from the United States include the Beaver Dam Eye Study
(Dielemans et al., 1994), Baltimore Eye Survey (Tielsch et al., 1991), Salisbury Eye
Evaluation Project, Proyecto VER (Quigley et al., 2001) and the Los Angeles Latino
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Eye Study. Studies from the Caribbean include the Barbados Eye Study (Leske et al.,
1994). Studies are now emerging from India (the Andhra Pradesh Eye Study (Dandona
et al., 2000), the Aravind Comprehensive Eye Study (Ramakrishnan et al., 2003),
Chennai Glaucoma Study (Vijaya et al., 2005), Dhaka Eye Study (Rahman et al., 2004)),
Singapore (Tanjong Pagar Survey) (Foster et al., 2000)and Singapore Malays Eye Study
(Foong et al., 2007) and China (Beijing Eye Study(Jonas et al., 2006), Liwan Eye Study
(He et al., 2006) ).
These studies show that the prevalence of POAG varies world wide and shows inter-
population variation. Figure 1.1 is a summary of world-wide data, table 1.3 summarizes
some of the main studies investigating the prevalence of open angle glaucoma.
FIGURE 1.1: GLOBAL PREVALENCE ESTIMATES FOR OPEN ANGLE GLAUCOMA
(SOURCE:(LESKE, 2007)
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TABLE 1.3: POPULATION BASED STUDIES INVESTIGATING THE PREVALENCE OF OPEN ANGLE GLAUCOMA 1966-2007












 “Chronic simple glaucoma” : defined by the presence of 4
criteria:
1. Glaucomatous cupping of the optic disc
2. Visual field defects of a defined type
3. IOP equal or known to have been 21mm Hg
4. AC angle free of abnormal mesoderm and
unobstructed by root of iris.
 “Suspected low tension glaucoma (LTG) ”: As above but IOP
< 21mm Hg
 “LTG – confirmed” : as in suspected LTG but also
subsequent IOP readings < 21 mmHg.
 “LTG-unconfirmed”; as in suspected LTG but subsequent













1. Repeatable visual field defect consistent with
glaucoma but unexplained by other ocular
pathology
2. Glaucomatous optic cupping of the optic disc
3. Normal anterior segments
56-71 0.86%
St.Lucia, West Indies
(Mason et al., 1989)
1989 African Caribbean  “Primary”/ “Conservative” definition of glaucoma: The
presence of glaucomatous visual fields found to be abnormal,








 “Secondary” definition of glaucoma:
1. Individuals with visual fields meeting all other criteria for the
definition of glaucoma but deemed unreliable by definition.
2. In the absence of visual field testing, glaucoma diagnosed if;
a. IOP  30mmHg AND CDR  0.7 in either eye
b. OR CD asymmetry  0.2 AND no













(Tielsch et al., 1991)
1991 Black Americans
White Caucasians
 Primary open angle glaucoma defined on:
1. The presence of glaucomatous optic nerve damage most
frequently defined by characteristic visual field defects.
In the absence of visual field data, glaucomatous optic
neuropathy could be defined:
(i) By the presence of complete cupping of the
ONH AND a visual acuity 20/200;
(ii) OR the presence of CDR asymmetry  0.4
(iii) OR in the presence of “significant” and
compatible disc and nerve fibre layer
abnormalities.
2. Open irido-corneal angles









The Beaver Dam Eye
Study
(Klein et al., 1992b)
1992 White Caucasian
n = 4926
 “ Definite” open angle glaucoma: any two or all three of the
criteria, below. Prevalences shown are of cases of definite
open angle glaucoma.
1. IOP  22 mmHg in involved eye
2. Visual field defect compatible with glaucoma









 “Probable open angle glaucoma”: Individuals who did not
meet the criteria for “definite” glaucoma but had a history of
filtering surgery OR were on treatment for glaucoma.
Roscommon
West of Ireland
(Coffey et al., 1993)
1993 White Caucasian
n = 2186
Criteria used to define primary open angle glaucoma not stated
explicitly but table 3 from reference lists features of glaucoma cases in
the Roscommon survey:
1. Definite” glaucomatous field defect as defined in study protocol
with CDR > 0.5 AND IOP  21 mmHg.
2. “ Definite” glaucomatous field defect with CDR > 0.5 AND
IOP > 21 mmHg
3. Visual acuity  6/60, CDR >0.8 AND IOP >30 mmHg
4. “Probable visual field defects” as described in study protocol
with IOP > 30 mmHg AND CDR > 0.
5. Repeatable probable defects with CDR > 0.8
6. CDR < 0.5 with definite defect and IOP > 30mmHg













(Salmon et al., 1993)
1993 Admixed population
(“Cape Coloureds” – strong






Open angle glaucoma defined in the presence of:
1. Glaucomatous visual field loss consistent with appearance of
optic nerve head












Unclear if the age specific prevalence stated is for POAG or includes all types of glaucoma. POAG n=41, angle closure glaucoma n=2, secondary glaucoma n=9, ocular





(Wormald et al., 1994)
1994 African-Caribbean “ Chronic glaucoma” defined in:
1. The presence of repeatable glaucomatous visual field defects
in one or both eyes
2. OR in the presence of advanced visual loss which precludes






1994 White Caucasian Primary open angle glaucoma defined:
1. In the presence of a glaucomatous visual field defect
2. Accompanied by open and normal anterior chamber angles
3. AND with either
(i). VCDR  0.5
(ii). OR CDR asymmetry  0.2













Open angle glaucoma defined in the presence of:
1. Optic disc changes as defined in study protocol
(at least two signs of glaucomatous optic neuropathy
including
(i). A vertical or horizontal CDR  0.7
(ii). CDR asymmetry >0.2
(iii). notching of the neuro-retinal rim
(iv). Most narrow area of the rim  0.1 disc diameters
(v). The presence of optic nerve head haemorrhages.
(vi). OR the signs of glaucomatous optic neuropathy
documented in other notes accepted in the absence of







2. AND defined visual field changes (in the absence of reliable
visual field evidence, other evidence of glaucomatous field
loss such as severe impairment of vision or blindness was
accepted).
3. And in the absence of other extraocular disease which may





1996 White Caucasian Open angle glaucoma (incuded “chronic simple glaucoma” and
“capsular” glaucoma) defined on the basis of
1. A defined reproducible visual field consistent with glaucoma
2. Which could not explained by other ocular pathology or
artefact.




(Mitchell et al., 1996)
1996 White Caucasian
n = 4297
 Open angle glaucoma diagnosed in the presence of a visual
field defect characteristic of glaucoma combined with either:
1. Compatible narrowing of the optic disc and CDR > 0.7
2. OR CDR asymmetry  0.3
3. AND in the absence of other ocular pathology such as
rubeosis and secondary causes of glaucoma excluding
pseudoexfoliation.
 Low pressure glaucoma defined OAG accompanied by
1. An IOP 21 mmHg in both eyes,
2. In subjects without a history of glaucoma surgery
3. AND not on ocular hypotensive medication.







(Bonomi et al., 1998)
1998 White Caucasian  POAG (including patients with PEX) defined if two of the
following criteria detected on second or third examination, in
the presence of an open anterior chamber angle, in the
absence of peripheral anterior synechie
1. IOP 22 mmHg
2. The presence of defined visual field defects
3. Optic nerve head findings:
(i). Concentric excavation of a CDR  0.7
(ii) OR oval excavation with a difference of 0.2
between vertical and horizontal;
(iii). OR Notching of the NRR;
(iv). OR excavation reaching the disc margin;
(v). OR disc haemorrhage
(vi). Asymmetrical disc excavation with a difference in
CDR>0.2 between the two eye;
 Normal tension glaucoma (NTG) defined as above but with




(Foster et al., 1996)
1996 Chinese Open angle glaucoma defined in the presence of :
1. A definite or probable glaucomatous visual field defect as
defined in study protocol
2. AND a compatible optic nerve head changes






(Cedrone et al., 1997)
1997 Italian Primary open angle glaucoma defined:
1. In the presence of visual field defects characteristic of
glaucoma and considered reliable as defined in the study
protocol
















3. AND in the presence of an open anterior chamber angle
4. AND accompanied by at least one of the criteria below:
(i) . IOP > 20mmHg
(ii). OR CDR  0.5




(Wensor et al., 1998)
1998 Mainly White Caucasian
n = 3271
No specific diagnostic criteria used to define POAG. Final
classification for each individual based on using all available data for
each volunteer by each expert using his or her clinical judgement to
classify each case into either possible, probable or definite cases. Cases
that had significant discrepancies as defined, were resolved in open
discussion.
Criteria for the consideration of Glaucoma Consensus Meeting
1. Past history of glaucoma
2. IOP > 21 mmHg in either eye
3. Visual field defects defined in study protocol









2000 East African Three different definitions of POAG used to allow comparison of
POAG prevalence with other published studies. POAG defined in the
absence of an occludable angle and possible secondary causes of
glaucoma
.
 Definition 1: POAG diagnosed if -
1. If CDR  0.9
2. OR CDR  0.7 accompanied by one of the following
features:
(i). “Definitely abnormal” nerve fibre layer















(iii). OR CDR asymmetry  0.3 in eyes if eyes had less
than a 0.2 unit difference in disc diameter
 Definition 2: Includes all volunteers described in definition 1
but also includes the individuals with the criteria below:
1. At least one eye with a reliable visual field defect as
defined in the study protocol.
2. AND CDR  0.7
3. OR a CDR asymmetry  0.2 if asymmetry is not
explained by a disc diameter difference of 0.2 units
using a Haag-streit micrometer.
 Definition 3: Includes all volunteers described in definition 1
and 2 but also includes the individuals with at least one eye
with:
1. A CDR 0.5





(Foster et al., 2000)
2000 Singaporean Chinese In the presence of a normal drainage angle and the absence of
secondary causes, POAG defined according to 3 categories:
 Category 1: In the presence of a visual field consistent with
glaucoma, POAG defined if one of the following criteria
present:
1. Eyes with CDR or CDR asymmetry  97.5th percentile for
the normal population
2. OR a NRR width  0.1 CDR (between 5 and 7 o’clock or
between 11 and 1 o’clock)
40 – 79 1.2%
CONTINUED
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 Category 2 (advanced structural damage where reliable field
testing is not possible), POAG defined in:
1. Eyes with a CDR  99.5th percentile
2. OR CDR asymmetry  99.5th percentile for the normal
population
 Category 3 (optic disc not visualized, visual field not
possible), POAG defined if:
1. The visual acuity was PL or worse AND the IOP > 21mmHg
2. OR eye was defined as being blind with evidence of
glaucoma filtering surgery
3. OR previous medical records confirmed previous glaucoma.
Andhra Pradesh Eye
Disease Study
(Dandona et al., 2000)
2000 Indian
n = 5150
 Primary open angle glaucoma defined:
1. In the presence of glaucomatous optic neuropathy defined as:
(i). A VCDR > 0.8
(ii). OR a narrowest neuroretinal rim width < 0.2
(including classic notching)
(iii). OR CDR asymmetry >0.2 between eyes
2. Coupled with a visual field defect in a location compatible
with the observe optic nerve head changes.
3. In the presence of normal anterior chamber angles
 In the absence of visual field information, glaucoma was defined
in the presence of a normal anterior chamber angles if one of
the following criteria was met:
1. The presence of “significant” optic disc excavation
compatible with glaucoma;
2. OR end-stage glaucoma with severe central vision loss
was present










(Quigley et al., 2001)
2001 “Hispanic” Open angle glaucoma defined in the absence of an alternative
explanation for disc and visual field findings, and in the presence of
an open angle by gonioscopy by the:
1. The presence of a glaucomatous visual field defect as
defined in the study protocol, accompanied by one of
the following criteria:
(i). A VCDR or asymmetry  97.5th percentile of the
normal population.
(ii). OR if narrowest rim width less than 0.1 by ratio to
the disc diameter in a position matching the visual
field defect
2. OR in the absence of a reliable visual field , the
presence of a CDR 99.5th percentile of the
normal population
3. OR in the absence of a reliable visual field AND the
optic disc not visualized, glaucoma was diagnosed if
(i). Visual acuity sufficiently low for the individual
to be considered “legally blind”












2002 West African “Chronic open angle glaucoma” defined in the presence of a minimum
of 2 of the following criteria in one or both eyes:
1. A VCDR  0.5 OR CDR asymmetry  0.2
2. IOP  22mm Hg










“ Definite open angle glaucoma” defined in the absence of an
alternative explanation for disc and visual field findings and in the
presence of an open angle by gonioscopy:
1. A glaucomatous visual field defect as defined in the
study protocol accompanied by either:
(i). VCDR  97.5th percentile of the normal population.
(ii). OR VCDR asymmetry  97.5th percentile of the
normal population.
2. OR in the absence of of a reliable visual field, a CDR
 99.5th percentile of the normal population.
3. OR in the absence of a reliable visual field AND the optic
disc not visualized, glaucoma was diagnosed if the visual















(Bourne et al., 2003)
2003 Thai
n=701
Glaucoma defined , according to 3 categories , n the absence of
secondary causes and the lack of alternative explanations visual defects
in categories 1 and 2:
 Category 1: Glaucoma defined in eyes in the presence of a
visual field consistent with glaucoma if one of the following
criteria present:
1. With CDR  97.5th percentile for the normal population
2. OR CDR asymmetry  97.5th percentile for the normal
population
 Category 2: Advanced structural damage where reliable field
testing is not possible, glaucoma defined in eyes with:
1. CDR  99.5th percentile for the normal population





 Category 3: Optic disc not seen because of media opacities
and visual fields not possible, glaucoma defined if:
1. VA < 3/60 AND the IOP > than 99.5th percentile
2. OR VA < 3/60 AND the eye shows evidence of
glaucoma filtering surgery.




(Jonasson et al., 2003)
CONTINUED
2003 White Caucasian Diagnostic criteria for open-angle, one for the following:
 Category 1: Two out of 3 of the following criteria, in the
presence of a glaucomatous visual field defect,
1. VCDR 97.5th percentile (0.7)
2. Defined glaucomatous changes to ONH such as notching
of the neuro-retinal rim
3. CDR asymmetry  97.5th percentile (0.2)
 Category 2: Two out of 3 of the following criteria, in the
absence of a glaucomatous visual field defect,
1. VCDR 99.5th percentile (0.8)
2. Defined glaucomatous changes to ONH such as notching
of the neuro-retinal rim
3. CDR asymmetry  99.5th percentile (0.3)




* OAG- open angle glaucoma; PEX- pseudoexfoliative glaucoma,
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 Category 3: In the absence of a visual field test and when the
optic disc can not be visualized, a subject is considered to have
glaucoma is if one of the following criteria is met:
1. VA<3/60 and IOP >99.5th percentile
2. VA<3/60 and IOP >99.5th percentile and the eye show






2003 Indian Primary open angle glaucoma defined according to 2 categories:
 Category 1: In the presence of a reliable visual field defect
compatible with one of the changes found below:
1. VCDR > 0.8
2. OR a narrowest NRR width < 0.2
3. OR CDR asymmetry > 0.2 accompanied compatible
visual field defect.
 Category 2: In the absence of reliable visual field data,
presence of one of the following was considered sufficient for
the diagnosis of glaucoma:
1. “Significant” optic disc excavation in keeping with
glaucomatous optic neuropathy
2. OR end stage glaucoma with severe central vision loss











2003 Black South African In the absence of an alternative explanation for disc and visual field
findings, in the presence of an open angle by gonioscopy, open angle










 Category 1: One of the following criteria in the presence of a
glaucomatous visual field defect as defined by study protocol:
1. VCDR  97.5th percentile of the normal population
2. OR CDR asymmetry  97.5th percentile of the normal
population.
 Category 2: In the absence of a reliable visual field and the
presence of one of the following criteria:
1. A CDR  99.5th percentile of the normal population.
2. OR CDR asymmetry of  0.3
 Category 3: If the the optic disc not visualized, the presence
of all three of the following criteria:
1. Visual acuity  PL
2. AND the IOP > 30mmHg.
3. AND the presence of of an afferent pupillary defect if
the pupil was visible.
Tajimi, Japan
(Iwase et al., 2004)
2004 Japanese
n = 3021
In the absence of a history or findings of irido-cyclitis, or other ocular
findings which were likely to cause glaucomatous optic neuropathy,
POAG was diagnosed on the basis of the following:
 Category 1:POAG was define in the presence of a visual
field abnormality compatible with associated optic disc
changes and the presence of one of the following criteria:
1. VCDR  0.7
2. OR the rim width 11 to 1 o’clock or 5 to 7 o’clock is 
0.1 of the disc diameter;
3. OR the differences of the VCDR  0.2 between both eyes















 Category 2: In the absence of a reliable visual field, POAG
diagnosed if:
1. CDR > 0.9 or more ;
2. OR the rim width 11 to 1 o’clock or 5 to 7 o’clock is 
0.05 of the disc diameter;





2004 West African Primary open angle glaucoma diagnosed if:
 Subject already on treatment for POAG
OR
 New diagnosis made by the presence of the following criteria:
1. CDR > 0.5 ± notching with associated visual field changes.
2. OR by the presence of visual field defects either in the

















(Rahman et al., 2004)
2004 Indian
n = 2347
POAG defined in the presence of an open angle by one of the three
categories:
 Category 1: In the presence of a visual field defect consistent
with glaucoma, and the following criteria
1. A CDR  97.5th percentile for the normal population
2. OR CDR asymmetry  97.5th percentile for the normal
population with glaucoma.








 Category 2: In the presence of advanced structural damage
where reliable field testing is not possible glaucoma was
defined in the presence of:
1. A CDR asymmetry  99.5th percentile for the normal
population
2. OR CDR asymmetry  99.5th percentile for the normal
population
3. In the absence of an alternate explanation for disc and
field findings
 Category 3: When optic disc visualized because of media
opacities, glaucoma defined if :
1. VA < 6/60 AND IOP > than 99.5th percentile









 Primary open angle glaucoma defined in the presence of:
1. An IOP > 21 mmHg
2. AND an anterior chamber angle that can not be
occluded, and is absent of vascular abnormalities and
goniosynechie
3. AND the following disc abnormalities (unclear if only
one abnormally is required or a number of
abnormalities, and only if abnormalities on
ophthalmoscopy only or includes




(i). Rim/disc ratio <0.1 anywhere
(ii). Rim/disc ratio0.1 and <0.4 for
more than 90 degrees of disc;
(iv) Oval appearance of the cup with a
(v) difference
in vertical to horizontal cup/disc ratio (C/D)
 0.2;
(iv) CDR asymmetry > 0.2 between the two
eyes;
(v). Presence of disc haemorrhage crossing the
rim
(vi). GDx discriminant analysis formula of
Weinreb >0.501 or the number value >25
(vii). HRT discriminant analysis formula of
Mikelbert > 0.5
4. OR in the presence of defined visual field defect
compatible with optic disc findings in the absence of
other ocular or neurological pathology to explain
these findings.
 “Normal pressure glaucoma” was defined with the criteria as




(Vijaya et al., 2005)
2005 Indian
N = 3850
Primary open angle glaucoma defined in the presence of an open
drainage angle and the criteria in one of the three categories:
 Category 1: In the presence of a defined “definite” visual










1. CDR  97.5the percentile for the normal population
2. OR CDR asymmetry  97.5the percentile for the
normal population
3. OR neuro-retinal rim reduced to  0.1 CDR between 11
and 1 o’clock or between 5 and 7 o’clock
 Category 2: Advanced structural damage with unproved
visual loss, including subjects without reliable visual fields
diagnosed with glaucoma in the presence of
1. CDR 99.5th percentile for the normal population
2. OR CDR asymmetry  99.5th percentile for the normal
population.
 Category 3: Subjects whose optic discs could not be
examined e.g. due to media opacities, glaucoma diagnosed if





2005 Indian Primary open angle glaucoma defined according to 3 categories:
Category 1: POAG defined
1. In the presence of an open anterior chamber angle
2. In the absence of other ocular pathology to explain the
findings below
3. AND in the absence of secondary causes for glaucoma
4. AND the presence of a VCDR  0.7 OR
5. OR VCDR asymmetry of  0.2










Category 2: In the absence of a reliable visual field, POAG defined
1. In the presence of an open anterior chamber angle
2. In the absence of other ocular pathology to explain the
findings below
3. AND in the absence of secondary causes for glaucoma
4. In the presence of a VCDR  0.9 in either eye
5. OR disc asymmetry  0.3
 Category 3: If the optic disc could not be examined in the
presence of a media opacity, POAG was defined:
1. In the presence of an open anterior chamber angle
2. In the absence of other ocular pathology to explain the
findings below
3. AND in the absence of secondary causes for glaucoma
4. AND an IOP > 26mmHg
5. AND visual acuity < 3/60
6. OR evidence of previous glaucoma surgery.
Liwan, Guangzhou
(He et al., 2006)
2006 Chinese Primary open angle glaucoma defined according to three categories:
 Category 1: In the presence of a visual field defect consistent
with glaucoma and the absence of a narrow drainage angle,
POAG diagnosed:
1. In the presence of a VCDR  97.5the percentile for the
normal population





 Category 2: In the presence of advanced structural damage
with unproved visual loss, in the absence of reliable visual
fields, and in the absence of a narrow drainage angle, POAG
defined in the presence of:
1. CDR  99.5th percentile for the normal population
2. OR CDR asymmetry  99.5th percentile for the normal
population.
 Category 3: Subjects whose optic discs could not be
examined, e.g. due to media opacities had POAG defined, in
the absence of a narrow drainage angle if:
1. If IOP  99.5th percentile for the normal population





(Friedman et al., 2006)
2006 White Caucasians
Black Americans
Subject classified as having open angle glaucoma if diagnosed as
having either “definite” or probable OAG as defined below.
 “Definite open angle glaucoma” defined in eyes
1. With optic discs considered to have “glaucomatous
appearing” optic discs
2. Accompanied with a visual field defect
3. OR the presence of total cupping.
4. In the presence of a trabecular meshwork visible for
>90
5. And the absence of peripheral anterior synechie
6. OR the presence of peripheral anterior synechie but












1. “Poorer documentation” of glaucomatous visual field
loss
2. But ONH had classical features of glauomca such as
excavation, thin NRR, large VCDR and vertical cup
disc asymmetry.
3. In the presence of a trabecular meshwork visible for >90
4. And the absence of peripheral anterior synechie
5. OR the presence of peripheral anterior synechie but with








Primary open angle glaucoma defined in 3 categories:
 Category 1: In the presence of a visual field compatible with
glaucoma, an open anterior chamber angle, and in the absence
of secondary causes for glaucoma, POAG defined in the
presence of:
1. A VCDR  97.5the percentile for the normal
population
2. OR a VCDR asymmetry  97.5the percentile for the
normal population
 Category 2: In subjects with advanced structural damage with
unproved visual loss, in the absence of reliable visual field,
secondary causes for glaucoma and the presence of an open
angle, POAG defined in the presence of:
1. A CDR  99.5th percentile for the normal
population.




















 Category 3: Subjects whose optic discs could not be
examined , e.g. due to media opacities, in the absence of
secondary causes for glaucoma and in the presence of an open
angle, considered to have POAG if:
1. The visual acuity was < 20/400 AND IOP >
99.5th percentile for the normal population.




2007, Astrom et al.,
2007)
2007 White Caucasian The definition of open angle glaucoma (which included normal tension
glaucoma and PEX) based on
1. The presence of visual defects consistent with glaucomatous
optic neuropathy
2. In the absence of any other explanation for such defects.
Though the evaluation of the disc described, it is not stated explicity
that the visual field defect was required to be consistent with the











The numbers of studies investigating the incidence of POAG compared to the relative
plethora of data on its prevalence are limited. The measurement of incidence requires a
lengthy temporal follow up, and as the frequency of glaucoma in the population is
relatively low, a sizeable cohort must be followed over time. The low frequency of OAG
also leads to small numbers of incident cases, and hence imprecise estimates.
The first longitudinal study investigating the incidence of glaucoma using visual field
testing was carried in Dalby, Sweden by Bengsston et al. who investigated the incidence
of open angle glaucoma found in this population. Table 1.4 summarizes some of the
population based cohort studies which have published incidence figures on open angle
glaucoma. The inter-population differences in glaucoma are in keeping with the
published differences in prevalence.
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TABLE 1.4: POPULATION BASED STUDIES INVESTIGATING THE INCIDENCE OF PRIMARY
OPEN ANGLE GLAUCOMA 1989-2007*





















Follow up ~10 years
1989 White Caucasians 55-85 0.24%
Melbourne, Australia
(Mukesh et al., 2002)
Follow Up ~5 years













(de Voogd et al., 2005)
Follow Up ~5 years















(Leske et al., 2007b)











* All studies are prospective population based unless otherwise stated.
† Incidence of open angle glaucoma estimated from Framingham data.
‡ Incidence of “definite” open angle glaucoma
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Skelleftea, Sweden
(Astrom and Linden, 2007)









1.3.3 RISK FACTORS FOR PRIMARY OPEN ANGLE GLAUCOMA
The term “ risk factor” describes variables that may be causal in disease as they are
statistically associated with the disease, and were (or could have been) present before
it’s occurrence (Boland and Quigley, 2007). Risk factors for OAG have been identified
from a variety of studies, from observational to experimental, and have been separated
here into demographic, systemic, ocular, environmental and genetic. Table 1.5
summarizes the main risk factors with associated risk statistics.
* Mean age rather than range quoted.
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TABLE 1.5: RISK FACTORS ASSOCIATED WITH OPEN ANGLE GLAUCOMA





(EFFECT PER DECADE INCEASE IN AGE STRATIFIED BY POPULATION, ADJUSTED ODDS RATIO,
FROM RUDNICKA ET AL., 2006)
African-Caribbean 1.61 (1.53 -1.70)
White Caucasian 2.05 (1.91- 2.18)
Asian 1.57 (1.46 - 1.68)
ANCESTRY
(META-ANLYSIS OF PREVALANCE OF OAG STRATIFIED BY POPULATION, FROM RUDNICKA ET
AL., 2006).
African-Caribbean 4.23 (3.07-5.83)
White Caucasian 2.09 (1.61-2.70)
Asian 1.41 (1.00-2.00)
GENDER (MEN COMPARED TO WOMEN, ADJUSTED ODDS RATIO UNLESS OTHERWISE STATED,
FROM RUDNICKA ET AL., 2006)
Overall, as a prevalence adjusted for age and population 1.37 (1.22-1.53)
African-Caribbean 1.27 (1.05-1.55)












(HAZARDS RATIO PER 40µM DECREASE , FROM GORDON ET AL., 2002)
1.7
MYOPIA
(POOLED RELATIVE RISK OF MYOPES COMPARED TO NON-MYOPES, INCLUDING MYOPIA OF ALL
DEFINITIONS, FROM BURR ET AL., 2007)
1.88 (1.53-2.31)
OTHER RISK FACTORS
FAMILY HISTORY (POOLED RELATIVE RISK ESTIMATE ADJUSTED FOR AGE, FROM BURR ET AL.,
2007)
3.14 (2.32-4.25)
DIABETES (POOLED RELATIVE RISK ESTIMATED, FROM BURR ET AL., 2007) 1.93 (1.38-2.69)
* From Rudnicka et al. Odds ratio from Bayesian meta-regression model. Effect per decade increase in age
by population.
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1.3.3.1 DEMOGRAPHIC RISK FACTORS
1.3.3.1.1 AGE
The main demographic factor associated with increased glaucoma risk is age. Increasing
age has been associated consistently with increasing risk across studies, not merely
observational studies but in large multi-centre randomized controlled trials such as the
Ocular Hypertension Treatment Study (Gordon et al., 2002) and the European Glaucoma
Prevention Study (Miglior et al., 2005, Miglior et al., 2007a). The magnitude of risk also
consistently multiplies with increasing age, increasing several fold from the 40-50 year
age group to the over 80 age group. (Rudnicka et al., 2006, Tuck and Crick, 1998).
Other than ancestry, discussed below, no other demographic factor has been consistently
associated with such increased risk. Table 1.6 summarizes the relationship between
POAG prevalence, age and ancestry.
TABLE 1.6: ESTIMATED PREVALENCE OF OPEN ANGLE GLAUCOMA ACCORDING TO AGE AND ANCESTRY
(SOURCE: FROM (RUDNICKA ET AL., 2006)
Age Range
(Years)
Predicted Prevalence of Open Angle Glaucoma
(95% confidence intervals)
White Black Asian
30-39 - 1.8 (1.2-2.7) 0.4 (0.3-0.6)
40-49 0.4 (0.3-0.6) 2.9 (1.9-4.4) 0.6 (0.4-1.0)
50-59 0.8 ( 0.5–1.2) 4.6 (3.1-6.8) 1.0 (0.6-1.6)
60-69 1.6 (1.1.-2.5) 7.2 (4.9-10.6) 1.6 (1.0-2.4)
70-79 3.3 (2.2-4.9) 11.2 (7.6-16.1) 2.5 (1.6-3.8)
80-89 6.6 (4.4-9.7) 16.9(11.7-23.8) 3.8 (2.3-5.9)
90-95 10.8 (7.2-15.8) 22.5(15.7-31.2) -
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Increasing age is associated with a multitude of changes to the eye and its associated
blood supply – changes which may promote the pathogenesis of glaucoma. The
trabecular meshwork is the key route of aqueous egress in the eye (Hart, 1992). Aqueous
formed in the ciliary body, courses through the posterior to the anterior chamber, then
drains through the trabecular meshwork and the uveoscleral pathways. Both pathways
show a decrease in outflow with age (Gabelt and Kaufman, 2005). Trabecular meshwork
cells are lost and the accrual of extracellular substances within the meshwork have been
noted with increasing age. These changes may contribute to the observed age related
increase in intraocular pressure observed in a number of population based studies (Klein
et al., 1992a, Wu and Leske, 1997, Bonomi et al., 1998, Hashemi et al., 2005).
Glial cells of the retina and optic nerve play a multitude of roles and contribute towards
many aspects of retinal ganglion cell function(Zhong et al., 2007). This includes
structural and functional support for retinal ganglion cells including the provision of
basic metabolic support, regulation of the extracellular environment and the production
of neurotrophins. Microglia provide immune regulatory functions and assist in
maintaining the perivascular barriers and attempt to protect neurones from destructive
inflammatory cytokines. Aging has an unfavorable effect on the viability and
regenerative capacity of microglial cells of the central nervous system (Streit, 2006).
Similar age dependent attrition may be seen in glial cells of the retina and optic nerve
and it possible that these changes may adversely effect their neuro-supportive and neuro-
protective functions.
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The retina and optic nerve of donor eyes have been demonstrated to show an increased
accrual of advanced glycation end (AGE) products (Tezel et al., 2007). Though
commonly associated with diabetes, AGE products are not limited to this disease.
Glycation occurs concurrently with oxidation and though without abnormal glucose
levels its associated changes are less marked, AGE products can be noted in relation
with aging in a number of tissues. AGE related changes may contribute to
biomechanical changes of the lamina cribrosa and may promote intracellular changes in
retinal ganglion cells and glial cells that encourage impaired function and apoptosis.
The control of ocular blood flow is complex and involves multiple systems (Grieshaber
et al., 2007). At a local level, auto-regulation attempts to meet local demands by
responding to changes in perfusion pressure through a variety of mechanisms. Of
particular importance are endothelial cells which not only serve an important barrier
function, but also have a role in controlling vascular resistance by functioning as a
central hub for the collection, integration and subsequent response to a variety of
physical and biochemical stimuli such as mechanical stress and oxygen tension. The
appropriate endothelium derived vasoactive factors (EDVFs) are released in response to
various stimuli and these collaborate with other systems such as the autonomic nervous
system to produce a suitable response. The key components are nitric oxide, which
causes vasodilation by stimulating the relaxation of pericytes and smooth muscle cells
via cyclic guanine monophosphate, and endothelin-1, which has the converse effect on
vascular tone via endothelin receptors which increase intracellular calcium levels.
Excessive concentrations of ET-1 have been demonstrated to cause vasospasm. Aging is
associated with a number of changes to the vascular system including thickening of the
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intima and media and increased rigidity of the vascular wall, an increased response to
vasoconstrictors and deterioration in endothelial function. (Yildiz, 2007). With age,
endothelial cells demonstrate increasing levels of apoptosis and a reduced ability to
regenerate. The dynamic equilibrium between vasoconstriction and dilatation, and
between the pro- and anti-atherogenic systems, shifts to favour the former in both cases,
with altered nitric synthase activity and a rise in the production of reactive oxygen
species. These changes have obvious derogatory effects on autoregulation. Optic nerve
head blood flow also declines with age (Boehm et al., 2005). All these factors may
contribute to the pathogenesis of glaucomatous optic neuropathy as discussed in the
sections that follow.
1.3.3.1.2 GENDER
The relationship between gender and primary open angle glaucoma is inconsistent across
studies, with some prevalence studies reporting an increased frequency in men, others in
women and others demonstrating little difference between studies. For example, the
Baltimore and Beaver Dam studies found no significant difference in glaucoma risk
between males and females (Tielsch et al., 1991, Klein et al., 1992b), Rotterdam and
Barbados Eye studies found an increased risk in males(Dielemans et al., 1994, Leske et
al., 1994) whilst the Blue Mountains Eye Study found an increased prevalence of POAG
amongst women (Mitchell et al., 1996). Similar inconsistencies can be observed
amongst incidence studies. For example, the Rotterdam and Skelleftea studies found no
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significant difference between males and females in the incidence of glaucoma (de
Voogd et al., 2005, Astrom et al., 2007) However, the Dalby study found a higher
incidence amongst women (Bengtsson, 1989). Hence, there appears to be some evidence
for a higher risk of POAG in some populations in males and in others in females.
The reasons for these for these inconsistencies are not clear. It may reflect the influence
of gender in the pathogenesis of glaucoma in different populations. Gender, like
ancestry, in addition to a genetic component, also has and socio-cultural implications,
and it is possible that some of the differences described might be reflective of these
predilections. A meta-analysis of 46 studies by Rudnicka et al. demonstrated a higher
risk of POAG amongst men compared to women (Rudnicka et al., 2006). However, in
certain subgroups of POAG, such as normal tension glaucoma, the prevalence is more
consistently higher in women (Drance et al., 2001). There is evidence to suggest that
female sex hormones may be protective against raised intraocular pressure (Altintas et
al., 2004, Sator et al., 1997). Oestrogen receptors can be found in the ciliary body and
outflow tract and it is possible it could influence glaucoma via aqueous formation and
egress as well as vascular factors (Ogueta et al., 1999, Lee et al., 2003). Evidence from
population based studies however, are inconsistent (Hulsman et al., 2001, Lee et al.,
2003, Nirmalan et al., 2004).
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1.3.3.1.3 ANCESTRY (POPULATION/ETHNICITY/RACE)
The third demographic risk which has been relatively consistently associated with
glaucoma is ancestry. A meta-analysis of variations in the prevalence of POAG by age,
gender and ancestry by Rudnicka et al (Rudnicka et al., 2006) showed that prevalence of
POAG is highest amongst populations of African-Caribbean (“black”) ancestry at all
ages, (compared to White-Caucasian and Asian) – an estimated overall prevalence of
16% in those over the age of 70 amongst blacks compared to 6% and 3% respectively in
Caucasians and Asians (Rudnicka et al., 2006). Table 1.5 summarizes the estimated
prevalence of open angle glaucoma according to age and ancestry by Rudnicka et al. Not
only are individuals of African ancestry at a greater risk for developing POAG, the
course of the disease tends to be more aggressive and blindness is more likely to ensue
in these individuals. Inter-population differences in optic nerve structure, central corneal
thickness, IOP levels and the prevalence of other putative glaucoma associated risk
factors such as refractive error, blood pressure, diabetes, as well as differences in
response to medication, uptake of treatment have been cited as possible explanations for
this differential, but these findings have not been consistent across studies (Racette et al.,
2003). It’s worth noting at this juncture that the classification of population diversity
remains a challenging, complex and sensitive issue, with much debate over what terms
such as “ethnicity” and “race” represent (Keita et al., 2004). Hence these overall figures
should be interpreted with caution as using umbrella descriptions such as “Black”,
“White” or “Asian” oversimplifies human diversity (Tishkoff and Kidd, 2004).
Individuals of African descent for example, belong to one of the most genetically varied
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populations in the world. If the prevalence of POAG in populations deemed to be of “the
same race” is analyzed in greater detail, there can be significant variations in POAG
prevalence between populations (Kosoko-Lasaki et al., 2006). POAG prevalence is
significantly lower (p<0.001) in South Africa, Nigeria, Tanzania and Baltimore
compared to Ghana, St. Lucia or Barbados, ranging from as low as 2.9% in South
Africa and rural Nigeria, to as high as 8.3% in Ghana, amongst individuals of African
ancestry. Amongst “white” populations the prevalence of POAG is significantly higher
in white Australians than in the Dutch (p<0.001).
1.3.3.2 SYSTEMIC DISEASES ASSOCIATED WITH PRIMARY OPEN ANGLE GLAUCOMA
A number of systemic diseases have been associated with primary open angle glaucoma
including diabetes (Klein et al., 1994), (Dielemans et al., 1996, Mitchell et al., 1997,
Bonovas et al., 2004), blood pressure (Dielemans et al., 1995, Tielsch et al., 1995b,
Bonomi et al., 2000b, Mitchell et al., 2004, Leskea et al., 2004, Leske et al., 2007a),
cardiovascular disease (Lee et al., 2006), thyroid disease (Lee et al., 2004a) and
migraine, (Corbett et al., 1985, Phelps and Corbett, 1985, Wang et al., 1997, Drance et
al., 2001). However these findings have not always been consistent across large cross-
sectional population based studies as well as longitudinal trials – studies which also
suggest the effects of these factors are potentially modified by the presence of other risk
factors (Kahn et al., 1977b, Leibowitz et al., 1980, Klein et al., 1993, Ponte et al., 1994,
Leske et al., 1995, Tielsch et al., 1995b, Tielsch et al., 1995c, Wang et al., 1997, Ellis et
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al., 2000, Drance et al., 2001, Gordon et al., 2002, Geyer et al., 2003, Leske et al., 2003,
Pache and Flammer, 2006, Leske et al., 2007a). These as well as a multitude of other
factors – autoimmune, neurodegenerative, endocrine, vascular - are reviewed in detail by
Pache and Flammer (Pache and Flammer, 2006), Flammer (Flammer and Mozaffarieh,
2007) and Grieshaber (Grieshaber et al., 2007, Grieshaber and Flammer, 2007), and
more recently by Coleman and Caprioli (Coleman and Miglior, 2008, Caprioli and
Coleman, Caprioli and Zeyen, 2009) and Leske (Leske, 2009). Their possible roles in
the pathogenesis of glaucomatous optic neuropathy, are discussed bellow.
1.3.3.3 OCULAR RISK FACTORS ASSOCIATED WITH PRIMARY OPEN ANGLE
GLAUCOMA
1.3.3.3.1 INTRA-OCULAR PRESSURE
1.3.3.3.1.1 GENERATION OF INTRA-OCULAR PRESSURE
Since the 10th century and the work of the Arabian surgeon Al-Tabari, intraocular
pressure has been associated with the pathogenesis of glaucoma. (Cohen, 2001). The
intraocular pressure of the eye is mainly due to the formation and outflow of aqueous
humour produced by the ciliary body (Caprioli, 1992, Hart, 1992). IOP is formed by
both active and passive processes, in the ciliary epithelium and circulates from the
posterior to the anterior chamber of the eye via the iris. Aqueous then drains via the
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trabecular meshwork and uveosecleral pathways. The former pathway, known as the
“conventional route” is the main route of aqueous outflow (Llobet et al., 2003)). The
latter pathway is known as the non-conventional pathway. This is responsible for only a
minority of aqueous egress. Goldman’s equation, PO = (F/C) + Pv , summarizes the
relationship between IOP and aqueous inflow and outflow (Hart, 1992). PO = the IOP in
mmHg, F  = rate of aqueous production in micro-litres per minute (μl/min), C = facility 
of outflow in micro-litres per minute per millilitre of mercury (μl/min/ mm Hg), Pv is 
the episcleral venous pressure in mmHg.
Current paradigms suggest that the main factor that determines IOP is the outflow
facility of aqueous humour, and has been reviewed extensively elsewhere (Tan et al.,
2006, Tamm and Fuchshofer, 2007). In brief, the trabecular meshwork pathway provides
the main route for aqueous egress from the anterior chamber (Hart, 1992, Llobet et al.,
2003). This tissue is divided structurally into three regions and aqueous flows between
the cells of these layers until it reaches the endothelial cells of the Canal of Schlemm.
The inner layer is the uveal layer. This is formed from connective tissue arising from the
iris and ciliary body stromas which is then covered by endothelial cells. This layer has
large intercellular spaces and offers little resistance to aqueous outflow. The second
layer is the corneoscleral meshwork which is formed from connective tissue lamellae
and shows greater organization, smaller intercellular spaces and greater resistance to
outflow. The layer with the greatest resistance due to it’s narrow intercellular spaces and
cells entrenched in extracellular matrix is the cribriform or juxtacanalicular meshwork.
Aqueous flows through this resistant layer before finally crossing a lining of endothelial
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cells, using both para- and intercellular routes, to enter the canal of Schlemm. In a
“healthy” eye, outflow resistance is balanced by aqueous formation in the ciliary body.
Pressure within the eye, intraocular pressure, rises in response to this resistance until it is
sufficient to force aqueous through the trabecular meshwork into the Canal of Schlemm
(Tamm and Fuchshofer, 2007). This resistance to outflow increases with age and also in
various forms of glaucoma including POAG. POAG related changes found in the
trabecular meshwork are not dissimilar to age related changes (Tamm and Fuchshofer,
2007).
1.3.3.3.1.2 DISTRIBUTION OF INTRA-OCULAR PRESSURE
Difference population based studies have investigated the distribution of IOP in normal
and glaucomatous eyes and their findings suggest that mean IOP can vary between
populations (Katavisto and Sammalkivi, 1964, Armaly, 1965, Hollows and Graham,
1966, Wallace and Lovell, 1969, Alsbirk, 1970, Kahn et al., 1977a, Kahn et al., 1977b,
Shiose and Kawase, 1986, Shiose, 1990, Sommer et al., 1991, Shiose et al., 1991, Klein
et al., 1992a, Dielemans et al., 1994, Mitchell et al., 1996, Leske et al., 1997, Jacob et
al., 1998, Bonomi et al., 1998, Weih et al., 2001, Rotchford and Johnson, 2002, Hashemi
et al., 2005, Xu et al., 2005). The mean IOP in white Caucasian adult populations,
whether investigated by Schiotz tonometry or Goldman Applanation Tonometry, has
consistently been estimated to being between approximately 15 to 16 mmHg, with a
standard deviation of 2.5-2.8mmHg in White Caucasian populations, though standard
deviations as high as 3.23 mmHg and mean IOPs of 16.8mmHg have been recorded
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(Armaly, 1965, Wallace and Lovell, 1969, Burr et al., 2007). “ Normal IOP “ is obtained
stochastically based on the mean IOP ±2 standard deviations. Hence “normal” IOP in a
white Caucasian population is 15-16mmHg on average, and even though the value
increases with age, 21-22mmHg is generally accepted as the upper limit of normal.
1.3.3.3.1.3 RELATIONSHIP BETWEEN INTRA-OCULAR PRESSURE AND GLAUCOMA
Strong evidence suggests IOP is intimately related to glaucoma. Population based cross-
sectional studies conducted on different continents – from Beaver Dam, to the Blue
Mountains to Tanjong Pagar and Tajimi to Chennai (Klein et al., 1992a, Klein et al.,
1992b, Mitchell et al., 1996, Foster et al., 2003, Iwase et al., 2004, Vijaya et al., 2005)
have shown that an increased IOP is associated with an increased prevalence of
glaucoma. This relationship between IOP and glaucoma is a dose-dependant one
(Sommer et al., 1991). Randomized clinical trials have proven that lowering IOP,
whether by means of medication, surgery or argon laser trabeculoplasty, slows the
onset/progression of glaucomatous optic neuropathy and visual field deterioration
(Feiner and Piltz-Seymour, 2003, Heijl et al., 2002, Burr et al., 2005, Maier et al., 2005,
Vass et al., 2007). For example, the Early Manifest Glaucoma Trial randomized patients
with early glaucoma to observation or reduction in IOP with betaxolol and argon laser
trabeculoplasty by 25%. Reduction in IOP clearly reduced the progression of glaucoma,
leading to a 17% reduction in the treatment group, for a number needed to treat of 6
(Heijl et al., 2002). Furthermore, in individuals with bilateral POAG, the eye with the
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higher IOP tends to lose field more quickly-this occurs even if both IOPs are <21 mmHg
(Leske et al., 2003). Animal models of glaucoma have confirmed and allowed further
investigation of the biological basis for this relationship (Lindsey and Weinreb, 2005,
Morrison, 2005, Rasmussen and Kaufman, 2005, Weinreb and Lindsey, 2005). Overall,
it is believed that raised IOP induces a series of events which eventually leads to the
death of retinal ganglion cells by apoptosis (Guo et al., 2005).
1.3.3.3.1.4 MECHANISMS OF GLAUCOMATOUS OPTIC NEUROPATHY
The main mechanisms for glaucomatous optic neuropathy (GON) secondary to raised
IOP (or involving raised IOP) are known as the mechanical and vascular theory of
glaucomatous optic neuropathy and are reviewed in detail elsewhere (Halpern and
Grosskreutz, 2002, Flammer and Mozaffarieh, 2007).
1.3.3.3.1.4.1 THE MECHANICAL THEORY OF GLAUCOMATOUS OPTIC NEUROPATHY
In brief, the mechanical theory suggests that when intraocular pressure rises above
physiological levels, the pressure gradient across the lamina cribrosa increases leading to
pressure induced backward bowing of the lamina cribrosa, misalignment of the pores
within the connective tissue complex and subsequent deformation and mechanical stress
to the retinal ganglion cells, their axons and supporting cells (Quigley et al., 1981,
Quigley and Addicks, 1980c, Quigley and Addicks, 1981, Morgan et al., 1998). Retinal
ganglion cells are damaged both directly and indirectly by the mechanical stress induced
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by this raised pressure. This stress has been shown to obstruct both anterograde and
retrograde axoplasmic flow of the optic nerve (Anderson and Hendrickson, 1974). The
ability of retinal ganglion cells to survive and thrive can be seen as a dynamic balance
between various factors promoting their continuing existence and other factors
encouraging apoptosis and hence extinction. Obstruction of retrograde axoplasmic flow
has been demonstrated to impede the movement of neurotrophic factors, for example
brain-derived neurotrophic factor (BDNF) and its receptor, to the perikaryon of the
retinal ganglion cell and cause the accrual of these factors at the level of the lamina
cribrosa (Hollander et al., 1995, Quigley, 1995, Quigley et al., 2000, Pease et al., 2000).
Deprivation of the retinal ganglion cell soma of neurotrophic factors is believed to
stimulate apoptotic cell death (Halpern and Grosskreutz, 2002). Raised hydrostatic
pressure has also been shown to cause the activation of glial cells, cause changes that
may impair their neuro-protective and supportive function and increase the secretion of
neurotoxic substances such as tumour necrosis factor alpha (Martin et al., 2002, Tezel
and Wax, 2000, Yan et al., 2000). Such changes would also promote the apoptotic death
of retinal ganglion cells. In addition, raised IOP can cause the atypical deposition of
various forms of extracellular matrix proteins such as different forms of collagen, elastin
and basement membrane material, which may alter the biomechanical, and possibly
biochemical, environment of the optic nerve leading to some of the changes
characteristic of glaucomatous optic neuropathy (Hernandez et al., 1990, Johnson et al.,
1996).
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1.3.3.3.1.4.2 THE VASCULAR THEORY OF GLAUCOMATOUS OPTIC NEUROPATHY
In the vascular theory, glaucomatous optic neuropathy is thought to arise due to
impaired perfusion of the optic nerve head secondary to raised IOP and/or other factors
(Halpern and Grosskreutz, 2002, Flammer and Mozaffarieh, 2007, Grieshaber et al.,
2007). This reduced blood supply has been postulated to lead to oxidative stress and
ischemic damage to the retinal ganglion cells, axons and their supporting cells. Cellular
ischemia can lead to glutamate mediated cytotoxcity and also withdrawal of
neurotrophins secondary to a reduced energy supply leading to the apoptotic cell death
of retinal ganglion cells as described (Chung et al., 1999). Oxidative stress can reduce
energy supplies, hamper intracellular homeostatsis of ions such as calcium, promote
oxidative damage of proteins, lipids and DNA and subsequently induce
neurodegeneration (Tezel, 2006). Blood flow to the ONH depends on perfusion
pressure, which is defined as the difference between IOP and systemic blood pressure.
Raised IOP may cause mechanical compression of ocular vasculature, effect
haemodynamics and reduce the perfusion of distal tissues (Harris et al., 1996, Joos et al.,
1999, Chung et al., 1999). Hence IOP has a central role to play in this paradigm as well.
1.3.3.3.1.4.3 VASCULAR DYSREGULATION AND GLAUCOMATOUS OPTIC
NEUROPATHY
Factors that are IOP independent, as well as factors that are IOP dependent have been
identified as potentially contributing to the advancement of damage secondary to
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impaired perfusion. Vascular dysfunction, such as issues with auto-regulation or
vasospasm, or abnormal vasoconstriction can also give rise to ischaemia (Chung et al.,
1999, Grieshaber et al., 2007). This vascular dysregulation can be classified as primary
or secondary (Grieshaber et al., 2007). Patients with primary vascular dysregulation
syndrome (PVD) show atypical responses to certain stimuli. Patients on average, have
colder hands, lower blood pressure, a reduced sensitivity to thirst, an increased
sensitivity to certain medications, altered sleep patterns and sensitivity to
vasoconstriction. A higher prevalence of PVD is found in women, Japanese populations
and professionals compared to blue collar workers. Secondary vascular dysregulation
occurs in association with other systemic conditions such as autoimmune diseases like
multiple sclerosis, rheumatoid arthritis, and systemic lupus erythrematosus and
infections diseases such as bacterial meningitis and acquired immune deficiency
syndrome. Other conditions like certain tumours, other HLA-B27 positive diseases such
as ulcerative colitis and certain drugs like interferon have also been associated with
vascular dysregulation (Grieshaber et al., 2007). Only primary vascular dysregulation
however is a significant risk factor for certain forms of glaucoma (Grieshaber et al.,
2007). The reason for this difference is unclear but it has been postulated that the
increased levels of ET-1 observed in the systemic circulation may lead to a widespread
increase in vascular tone and a reduction in baseline blood flow to ocular tissue but
causing little interference to local ocular autoregulation. In patients with PVD however,
the response to a local reduction in perfusion secondary to physical or psychological
stress appears to be impaired, hence increasing the potential for ischaemia related optic
nerve injury.
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The regulation of ocular blood flow requires a dynamic equilibrium between
vasoconstriction and vasodilatation and involves a number of different mechanisms and
factors including endothelium derived vasoactive factor endothelin-1, and nitric oxide.
Patients with glaucoma have been found to have increased levels of ET-1 in their
aqueous humour as well as an increased response to the inhibition of nitric oxide
synthase compared to controls (Tezel et al., 1997a). In addition to it’s role in
vasoregulation, there is evidence to suggest that ET-1 may cause glial cell activation at
the optic nerve head, disrupt axoplasmic flow, promote the apoptosis of retinal ganglion
cells and induce extra-cellular matrix remodeling (Prasanna et al., 2002, Taniguchi et al.,
2006, Lau et al., 2006, He et al., 2007) Other studies have demonstrated that some
patients with open angle glaucoma may have a number of local circulatory issues
including dysfunction of endothelial cells, deficiencies in retinal, choroidal and
retrobulbar circulations and problems with autoregulation (Schwartz and Kern, 1980).
1.3.3.3.1.4.4 OXIDATIVE DAMAGE AND IMMUNE FACTORS IN GLAUCOMATOUS
OPTIC NEUROPATHY
What ever the initial mechanism of injury to glaucomatous tissue, subsequent oxidative
stress and neuronal injury may stimulate the immune system (Tezel, 2006). Though the
initial immune response may assist regeneration and repair of damaged tissue, a chronic
inflammatory state may lead to further damage and deterioration. There is evidence to
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suggest patients with open angle glaucoma may have increased immune activity. In one
hospital based study, 30% of patients with glaucoma had one or more concurrent
immune-related diseases compared to 8% of patients with ocular hypertension
(Cartwright et al., 1992). Glaucoma patients have been found to have elevated levels of
auto-antibodies to a number of molecules and structures including structures of the optic
nerve and retina (Tezel et al., 1999, Romano et al., 1999, Joachim et al., 2005), aberrant
immunoglobulins such as antibodies to DNA, RNA, nuclear antigens and monoclonal
paraproteins (Wax et al., 1994) and antibodies to heat shock proteins (Wax et al., 1998,
Tezel et al., 1998). Several components of the complement cascade and have been found
to be up-regulated and abnormal cellular immunity has also been noted in patients with
open angle glaucoma compared to age matched controls, adding further credence to the
hypothesis that immune dysregulation may play a prominent role in glaucomatous optic
neuropathy (Stasi et al., 2006, Yang et al., 2001). Immune related destruction may be
direct such as Fas/Fas ligand interaction between primed T-cells and retinal ganglion
cells or indirectly through the secretion of pro-inflammatory cytokines such as TNF-
which promotes further inflammation as well as apoptosis (Yang et al., 2001, Tezel and
Wax, 2000).
1.3.3.3.1.4.5 NORMAL TENSION GLAUCOMA
In reality, the relationship between raised IOP and glaucomatous optic neuropathy is
more complex than initially envisioned by ophthalmologists of the past. There is
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considerable overlap between the distribution of IOP in disease-free individuals and
those with POAG. Many epidemiological studies have demonstrated that glaucomatous
optic neuropathy can be observed in individuals with an IOP level below the statistically
defined upper limit of normal. (Hollows and Graham, 1966, Iwase et al., 2004, Klein et
al., 1992b, Sommer et al., 1991). For example, in a cross-sectional epidemiological
study set in Tajimi City, Japan, Iwase et al found 92% of patients diagnosed with POAG
had an IOP of less than 21mmHg (Iwase et al., 2004). These individuals, who display
glaucomatous optic neuropathy but with an IOP within the statistically normal range
have been referred to by a variety of names – patients with “normal tension glaucoma”
(NTG), “low-tension glaucoma” or “low pressure glaucoma” by some schools of
thought. In other studies, the prevalence of normal tension glaucoma in the population
has been found to be much less. In the Beaver Dam Study which consisted of
individuals of white Caucasian ancestry, approximately a third of individuals diagnosed
with definite OAG had an IOP less than 22 mmHg (Klein et al., 1992a, Klein et al.,
1992b). In the Baltimore Eye Survey, 24% of OAG patients had an IOP of <21 mmHg
(Sommer et al., 1991). For patients with a screening IOP of < 16 mmHg, the prevalence
of OAG was 0.65%. In the baseline study group of the Early Manifest Glaucoma Trial, a
randomized, controlled clinical trail which compared the effect of lowering IOP
immediately versus no treatment or delayed treatment, 53.5% of patients in the treatment
group and 50% of patients in the control group had baseline IOPS of < 21 mmHg (Heijl
et al., 2002). IOP however, appears to be important in the progression of glaucoma even
for some patients whose IOP is within the statistically normal range, as lowering IOP
can reduce the progression of GON even within this group. The Collaborative Normal
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Tension Glaucoma Study (CNTGS) randomized 140 eyes with normal tension glaucoma
to either no treatment or medical or surgical treatment
(Collaborative_Normal_Tension_Glaucoma_Study_Group_A, 1998,
Collaborative_Normal_Tension_Glaucoma_Study_Group_B, 1998). A reduction of IOP
by 30% lead to a significant reduction in glaucoma progression in the treatment group.
However, the relationship between IOP and NTG is far from clear. Reduction of IOP
does not always slow or abrogate disease progression
(Collaborative_Normal_Tension_Glaucoma_Study_Group_A, 1998,
Collaborative_Normal_Tension_Glaucoma_Study_Group_B, 1998, Heijl et al., 2002).
12% of patients in CNTGS with a significant IOP reduction according to protocol,
continued to progress, suggesting perhaps a 30% reduction in IOP is insufficient to halt
disease progression or that other factors independent of IOP are important in the
pathogenesis of NTG. Furthermore, a significant percentage of patients, 65% of
randomized eyes, did not show progression through the time period of the study, and
curiously, untreated IOP was not identified as an significant independent risk factor for
the progression of the disease despite it’s effect on prevalence (Drance et al., 2001). A
number of retrospective studies have attempted to investigate if asymmetric IOP leads
to asymmetric visual field loss in NTG. In these studies, with patients with asymmetrical
NTG demonstrated a correlation between mean IOP and asymmetric visual fields
ranging from 22 to 86% of cases (Cartwright and Anderson, 1988, Haefliger and
Hitchings, 1990, Crichton et al., 1989, Poinoosawmy et al., 1998). However, this finding
has not been supported by all studies. For example, the Low Pressure Treatment Study, a
randomized multi-centre, prospective, double blind study where NTG patients were
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randomized to brimonidine tartrate 0.2% or 0.5% timolol maleate investigated the
relationship between IOP asymmetry and visual field loss. Neither mean deviation nor
corrected pattern standard deviation were found to be correlated to IOP (Greenfield et
al., 2007).
Whether NTG should be considered a separate disease entity is a topic of great
contention – a debate that has raged since as far back as the 1800s when von Graefe is
said to have retracted his initial description of NTG after strong opposition of this
concept from his peers (Caprioli, 1998). Opponents of categorizing OAG into high and
normal pressure entities view NTG as a variant of POAG. Glaucoma patients with NTG
and POAG, both show widely varying rates of disease progression and the course of the
disease can not be significantly differentiated between the two. Definition for NTG over
the years has also been inconsistent, particularly in studies published before 1992 (Lee
et al., 1998, Sycha et al., 2003). However, opponents of the NTG concept highlight that
the division between “normal” and “abnormal” IOP is almost an arbitrary one, based on
an IOP value that is approximately two standard deviations above the mean IOP of a
roughly normal distribution. Several studies have also found central corneal thickness in
patients with NTG is on average, lower, and in patients with ocular hypertension, is on
average higher, than those with POAG or individuals who are disease free (Copt et al.,
1999, Morad et al., 1998). Central corneal thickness influences applanation tonometry.
Hence POAG patients with thinner than average corneas are in danger of being branded
as having NTG and disease-free individuals with thicker than average corneas are in
danger of being regarded as having ocular hypertension. When Copt et al. corrected for
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corneal thickness in their study, a third of patients with NTG were reclassified as having
POAG and over a half of patients initially thought to have ocular hypertension were re-
classified as normal (Copt et al., 1999).
Furthermore, like many biological parameters, IOP also has a circadian rhythm, and can
show daily fluctuations ranging from 3 to 6 mmHg, with a fluctuation greater than
10mmHg being deemed pathological (Katavisto, 1964, Kitazawa and Horie, 1975). IOP
shows diurnal variation, being higher in the early morning and later in the day.
However, nocturnal IOP has been found to be lower than diurnal IOP when measured in
the sitting position but is higher than diurnal IOP when measured supine. In one report,
two thirds of glaucoma patients and over 90% of healthy controls had IOP peaks during
the nocturnal period (Mosaed et al., 2005). There is also evidence that IOP can also
show seasonal variation (Bengtsson, 1972, Blumenthal et al., 1970, Qureshi, 1996),
postural variation (Anderson and Grant, 1973, Jain and Marmion, 1976), have variations
associated with refractive error, ordinary blinking and hormonal changes (Qureshi et al.,
1996). IOP may also be influenced by a variety of systemic factors including systolic
blood pressure and body mass index (Bengtsson, 1972). Hence a single IOP
measurement during daytime, is a mere snapshot of the intra-ocular pressure of the eye
at that moment in time, and may not reveal it’s true profile (Weinreb and Liu, 2006). A
diurnal curve established by taking several measurement at different times over the
course of several days may provide more information but still only estimates a small
proportion of possible variation. Hence, using a single or even multiple measurements
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of IOP to use as the sole criterion to differentiate between two forms of open angle
glaucoma and establish a different disease entity may not be a sound philosophy.
Proponents of NTG as a separate disease entity from POAG argue that there is some
evidence that NTG patients have a different clinical course as certain clinical features
are more commonly associated with NTG patients compared with POAG patients. For
example, some studies that have shown that optic discs in NTG more commonly show
shallow cupping or saucerization, with a thinner neuro-retinal rim area, especially in the
infero-temporal pole (Caprioli and Spaeth, 1985, Fazio et al., 1990). A higher prevalence
of optic disc haemorrhages have also been associated with NTG compared to POAG
(Kitazawa et al., 1986, Sugiyama et al., 1997, Jonas and Budde, 2000). Visual field loss
in NTG compared to POAG has been described as deeper, steeper and more likely to be
paracentral (Caprioli and Spaeth, 1984, Hitchings and Anderton, 1983). Certain factors
which were mentioned whilst discussing the pathogenesis of glaucomatous optic
neuropathy such as cardiovascular risk factors (Goldberg et al., 1981, Waldmann et al.,
1996) evidence of vascular dysregulation such as an increased prevalence of optic disc
haemorrhages (Kitazawa et al., 1986, Healey et al., 1998), a decrease in capillary nail-
fold blood flow velocity and reduced finger blood flow following exposure to the cold
(Gasser and Flammer, 1991, Drance et al., 1988), greater nocturnal hypotension (Kaiser
et al., 1993, Hayreh et al., 1994, Meyer et al., 1996) as well as an increased prevalence
of conditions associated with vasospasm such as migraine (Phelps and Corbett, 1985,
Broadway and Drance, 1998, Drance et al., 2001, Cursiefen et al., 2000) are found more
consistently in patients with NTG than high tension glaucoma. Some studies have found
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endothelin-1 levels tend to be higher in NTG patients compared to patients with high
tension glaucoma (Cellini et al., 1997, Sugiyama et al., 1995) Female gender (Orgul et
al., 1995) and a wide variety of immune factors such as an increase in the prevalence of
immune-related diseases (Cartwright et al., 1992), abnormal antibodies and other
immune phenomena (Wax et al., 1994, Wax et al., 1998, Tezel et al., 1998, Tezel et al.,
1999, Yang et al., 2001) are also often more frequently associated with NTG (Kiuchi et
al., 2006). These findings have not been supported by all studies (Carter et al., 1990,
Demailly et al., 1984, Kaiser et al., 1995). Many of these factors, as discussed above, are
believe to contribute to glaucomatous optic neuropathy either synergistically or in an
IOP independent way.
1.3.3.3.1.4.6 OCULAR HYPERTENSION
In addition to a population of people with glaucomatous optic neuropathy without raised
pressure, a population of individuals exist, who consistently show an IOP above the
normal range but fail to develop glaucomatous optic neuropathy. This phenomena, is
known as ocular hypertension. Ocular hypertension is 10 times as common as glaucoma
and only a minority of ocular hypertensives progress to develop glaucoma (Kitazawa et
al., 1977, Gordon et al., 2002). The Ocular Hypertension Treatment Trial, OHTS, a
large, multi-centre controlled clinical trial, randomized 1636 patients with ocular
hypertension to either observation or treatment. Ocular hypertension was defined as an
IOP between 24 and 32 mmHg in one eye and between 21 and 32mmHg in the other
eye, normal visual fields and optic discs and open drainage angles on gonioscopy. At
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approximately 5 years follow up, only 4.4% in the treated group and 9.5% in the
observation group had developed POAG. The European Glaucoma Prevention Study, a
multi-centre, randomized, double-blind controlled clinical trial also investigated if the
onset of POAG could be prevented or delayed in patients with ocular hypertension by
treatment (Miglior et al., 2007a, Miglior et al., 2007b, Miglior et al., 2005). The
inclusion criteria differed slightly from OHTs - IOP had to be between 22 and 29mmHg
in at least 1 eye on 2 consecutive measurements taken at least 2 hours apart. Patients
were randomized to either a placebo or dorzolamide. Only 13.4% of treated patients and
14.1.% of patients on placebo developed POAG. Despite these differences in results
both OHTs and EPGS identified IOP as an important risk factor for the progression of
ocular hypertension to POAG. Even though EPGS could not demonstrate a significant
difference in results between treating with placebo versus dorzolamide, a 1 mm Hg
baseline higher IOP was associated with an 18% higher risk of progressing to POAG. A
review and meta-analysis of different randomized controlled trials have shown that
lowering IOP in both ocular hypertension and manifest glaucoma reduces the risk of
long term visual field loss (Maier et al., 2005, Vass et al., 2007).
1.3.3.3.1.4.7 MORE COMPREHENSIVE PARADIGMS OF GLAUCOMATOUS OPTIC
NEUROPATHY
The existence of ocular hypertension and normal tension glaucoma, suggests there are
different populations of individuals where IOP has a different effect on the optic nerve
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head. Hence the relationship between IOP and glaucomatous optic neuropathy is not as
straightforward as previously thought. However, though IOP is now no longer
considered a prerequisite for the diagnosis of glaucoma, together with age, it still
remains one of two major risk factors, as well the only treatable component of the
disease (Suzuki 2006, Friedman 200d4, Gordon 2002). A more comprehensive paradigm
which embraces and explains the existence of primary open angle glaucoma, ocular
hypertension and normal tension glaucoma would be to view glaucomatous optic
neuropathy as the effect of IOP on a susceptible optic nerve head – depending on the
vulnerability of the optic nerve head the effect of a given IOP would differ (Burgoyne et
al., 2005). An IOP which is physiological to one optic nerve head will be pathological to
another. In addition, in some cases of glaucomatous optic neuropathy, IOP dependent
mechanisms may predominate whereas in others, more IOP independent mechanisms
such as immune mediated processes may dominate.
1.3.3.3.1.4.8 BIOMECHANICAL MODELS OF GLAUCOMATOUS OPTIC NEUROPATHY
Glaucoma is an optic neuropathy that is characterized by the progressive degeneration of
both the retinal ganglion cells and their axons (Weinreb and Khaw, 2004). Clinically this
is characterized by glaucomatous excavation of the optic nerve head. Though there may
be important contributions to glaucomatous optic neuropathy from other sites of damage
such as within the photoreceptors (Janssen et al., 1996, Panda and Jonas, 1992), the
retinal ganglion cell stroma, the lateral geniculate body and the visual cortex (Yucel et
al., 2003, Yucel et al., 2000, Yucel et al., 2001, Gupta and Yucel, 2001, Gupta and
65
Yucel, 2003, Gupta and Yucel, 2007c, Gupta and Yucel, 2007b, Gupta and Yucel,
2007a, Gupta and Yucel, 2006, Gupta et al., 2006, Gupta et al., 2008), pioneering work
by Harold Quigley and associates suggest that the initial site of damage in glaucoma
occurs at the lamina cribrosa of the optic nerve head (Quigley and Addicks, 1980a,
Quigley and Addicks, 1980b, Quigley et al., 1982, Quigley and Addicks, 1981, Quigley
et al., 1983). The lamina cribrosa and its associated blood supply, and supporting tissue,
is the Achilles heel of an otherwise sturdy corneo-scleral coat. In higher primates the
lamina cribrosa consists of a three dimensional network of flexible byzantine beams of
connective tissue located at the centre of the optic nerve head. Encased within these
beams and within the adjacent sclera run the intra-laminar and inter-scleral capillaries
from the short posterior ciliary arteries. The lamina cribrosa supports the retinal ganglion
cells both structurally and functionally as their axons exit the globe via its complex
pores from the relatively high pressure environment of the intraocular space to a
comparatively low pressure environment of the retrobulbar compartment. The scleral-
corneal coat creates a relatively closed structure around the ocular contents, helping to
maintain a stable shape which is vital for the optical properties and function of the eye.
Under physiological conditions, this intraocular pressure is maintained by a complex
equilibrium between aqueous humour formation and subsequent escape thought the
trabecular meshwork and uveo-scleral pathways (Hart, 1992). IOP generates a force
within the eye and the eye wall. Mathematical and engineering methods, in particular
finite element modeling, have been used to describe the effect of IOP on ocular tissue
whilst defining the optic nerve head as a biomechanical structure (Burgoyne et al.,
2005). Within these paradigms, the ocular coats, including the optic nerve head, are seen
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as being constantly exposed to a certain level of IOP related stress, which is a certain
force per unit cross sectional area. This is vital in order to maintain a stable shape for the
globe. Stress can consist of simple forces of tension or compression, or be more complex
such as shear, hydrostatic or biaxial (for a discussion and review of these definitions see
Ashby and Jones (Ashby and Jones, 1984)). A certain stress generates a certain strain,
which is the deformation of the tissue in response to stress. Bellezza, Hart and Burgoyne
proposed the tissues of the optic nerve head -load bearing tissues such as the
peripapillary sclera, scleral canal and lamina cribrosa as well as neuroretinal tissue,
associated supporting cells and vasculature, are constantly exposed to IOP related
stress, even at physiological levels of IOP (Bellezza et al., 2000). In this biomechanical
model, the effect of IOP related stress on ocular tissues depends not merely on the level
of IOP but on the susceptibility or the individual properties of the optic nerve head
experiencing this force. This paradigm embraces and encompasses both the
“mechanical” and “vascular” models, abrogating any need for what is essentially an
unnatural separation (Burgoyne et al., 2005, Van Buskirk and Cioffi, 1993, Van Buskirk
and Cioffi, 1992). It also explains the existence of both high and normal pressure
varieties of primary open angle glaucoma as well as ocular hypertension - the three
entities being part of a spectrum of similar pathologic processes, with optic nerve heads
of varying vulnerability, requiring different levels of IOP to cause glaucomatous
damage.
Bellazza, Burgoyne et als’ paradigm proposes that the effect of the stress and
subsequent strain induced at a certain IOP, is dependent upon the response of that tissue
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that experiences it. Stress and strains that are deemed “physiological” for an individual
tissue will provoke changes in surrounding tissues that are considered a part of normal
aging (Burgoyne et al., 2005). Pathological levels of stress will stimulate changes that
hasten the pattern of disease that is recognized as glaucomatous optic neuropathy. As the
susceptibility of the optic nerve head to IOP increases, the level of IOP required to
induce glaucomatous optic neuropathy decreases. Levels of IOP which are physiological
to one optic nerve will be pathological to another. The effect of a certain IOP generated
stress on the optic nerve depends on the biomechanics of the individual optic nerve
head, which in turn is influenced by its material properties and geometry (anatomy).
The material properties of a tissue describes its ability to resist deformation under an
applied load – it can be considered to be the compliance or stiffness of a particular
material. Materials are often described as linear or non-linear depending on the
association between load and deformation. Non-linear materials do not have a constant
Young’s Modulus as their relationship between load and deformation is not constant.
Biological soft tissue such as the sclera tend to be non-linear, anisotropic viscoelastic
materials (Ethier et al., 2004, Downs et al., 2003, Downs et al., 2005). Hence sclera
shows an increased resistance to strain at higher loads. If the sclera is loaded in one
direction, the initially gathered collagen fibres embedded in their extra-cellular matrix
gradually unfold. This unfurling of collagen fibres is probably responsible for its
nonlinearity, and its fibre orientation responsible for its anisotropy.
The second factor that contributes to ONH biomechanics is the geometry of the lamina
cribrosa and sclera – the form and size of the scleral canal, the density of peripapillary
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sclera, configuration and thickness of the collagenous beams that form the lamina. Three
dimensional biomechanical models of the optic nerve head and surrounding sclera
investigating the effect of geometrical variation on stress, have demonstrated that the
highest stresses occur where the optic canal has a small radius of curvature and where
the peripapillary sclera is thinnest. Considerable attention has been focused on the
biomechanics of the lamina cribrosa and surrounding area (Bellezza et al., 2000,
Burgoyne et al., 2004, Burgoyne et al., 2005, Edwards and Good, 2001, Ethier et al.,
2004, Hernandez, 2000, Levy and Crapps, 1984, Levy et al., 1981, Morgan et al., 2002,
Morgan et al., 1995). There is evidence to show that retro-displacement or “backward-
bowing” of the slender lamina induced by increased IOP, can lead to structural damage
of the ganglion cell axons and the blockage of axoplasmic flow as axons pass through
the misaligned lamina sheets (Quigley and Anderson, 1976, Levy and Crapps, 1984,
Quigley et al., 1983, Anderson and Hendrickson, 1974, Minckler et al., 1977). It is
hypothesized that damage to the optic nerve occurs via compression, shearing or
distension of the retinal ganglion cells as they exit the globe via the lamina cribrosa
(Sigal et al., 2007) as well as damage to other supporting tissue such as astrocytes,
endothelial cells and their supporting pericytes by IOP lead stress and strain. The
damage incurred and the susceptibility of the ONH will depend on not merely the
pressure but the biomechanical reaction of the vascular supply and tissues of the optic
nerve head, and the subsequent oxidative stress and cellular response to a given pressure.
The more susceptible the optic nerve, the lower the pressure required to damage it.
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Since the 1970s, an increasing amount of evidence has suggested a relationship between
peripapillary atrophy (PPA) and glaucoma (Primrose, 1970, Wilensky and Kolker, 1976,
Nevarez et al., 1988, Buus and Anderson, 1989, Jonas et al., 1992, Jonas and Xu, 1993,
Jonas et al., 1989, Jonas and Naumann, 1989, Araie et al., 1994, Jonas et al., 2002, Lee
et al., 2002, Xu et al., 2007c). Histologically PPA is characterized by areas of varied
pigmentation and chorio-retinal atrophy in what is known as alpha zone PPA, and a
reduction in the numbers of photoreceptors and loss of retinal epithelial cells in the case
of beta-zone PPA (Fantes and Anderson, 1989, Kubota et al., 1993, Curcio et al., 2000).
This biomechanical paradigm provides a possible explanation for this association –
factors of the surrounding peripapillary area may mean this area is more vulnerable to
IOP (or other factor) induced PPA, the presence of which may in turn cause the optic
nerve to be even more susceptible to damage at certain IOPs. The optic nerve head
shows both great inter and intra-individual variation (Dandona et al., 1990, Sing et al.,
2000). These individual differences in material properties and geometry helps account
for differences in optic nerve head susceptibility to differing levels of IOP. Hence
certain combinations of tissue geometry, rigidity and perfusion may be more susceptible
to damage at levels of IOP within the “normal” range, whereas others with a more robust
combination of these factors will be able to withstand higher levels of IOP lead stress
and strain. Inter-population difference in optic nerve head morphology may help account
for the variation in susceptibility amongst different populations to open angle glaucoma
(Racette et al., 2003).
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1.3.3.3.2 CENTRAL CORNEAL THICKNESS
1.3.3.3.2.1 THE STRUCTURE OF THE CORNEA
The cornea could be considered a transparent extension of the more opaque sclera and a
part of the anterior segment of the globe (Pepose and Ubels, 1992). It is multifunctional.
It acts as a barrier between the anterior chamber of the eye and the external world and
also refracts and transmits light to the posterior pole. To aid these functions its five
layered structure is highly specialized and combines high tensile strength and
transparency. Central corneal thickness has been reported to be an important risk factor
in the progression of ocular hypertension to glaucoma, as well as being frequently
associated with the initial diagnosis of glaucoma (Leske et al., 2008, Gordon et al., 2002,
Dueker et al., 2007). The evidence for this is discussed below.
1.3.3.3.2.2 CORNEAL THICKNESS AS A RISK FACTOR FOR THE PRGORESSION OF
OCULAR HYPERTENSION TO GLAUCOMA
The first major study to demonstrate the importance of central corneal thickness as a risk
factor for the progression of ocular hypertension to glaucoma was the Ocular
Hypertension Treatment Study (OHTS). OHTs was a landmark multi-centre
randomized controlled clinical trial. The primary aim of this trial was to evaluate the
safety and efficacy of topical ocular hypotensive medication in preventing or delaying
the onset of glaucomatous optic neuropathy or visual field loss in subjects with ocular
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hypertension at a moderate risk for developing POAG. Its secondary aim was to identify
risk factors to predict which subjects with ocular hypertension were most likely to
develop glaucoma. Participants with thin corneas (555μm or less) had a three-fold 
increased risk of developing POAG compared with those who had a corneal thickness of
more than 588μm. Though cross sectional studies had previously documented (Alsbirk, 
1978, Argus, 1995, Herndon et al., 1997, Herman et al., 2001, Emara et al., 1999, Morad
et al., 1998, Wolfs et al., 1997) an association between central corneal thickness and the
diagnosis of ocular hypertension, NTG and POAG, OHTs was the first prospective study
to demonstrate that thinner central corneas are a risk factor for the progression of ocular
hypertension to POAG. Since then, this finding has been supported by others (Medeiros
et al., 2003a, Medeiros*** et al., 2003, Medeiros et al., 2003b, Medeiros et al., 2005,
Leske et al., 2008). It is now widely accepted that in best clinical practice, the
assessment of risk of a glaucoma suspect should include the measurement of CCT
(European_Glaucoma_Society_II, 2003, Dueker et al., 2007,
American_Academy_of_Ophthalmology, 2008, Behki et al., 2007).
1.3.3.3.2.3 CORNEAL THICKNESS AS A RISK FACTOR FOR THE PRESENCE
GLAUCOMA
The evidence for central corneal thickness as a risk factor the presence of glaucoma is
more equivocal. A number of studies, including population based studies in Barbados
and Rotterdam, have found a thinner CCT to be associated with the occurrence of
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glaucoma (Bechman et al., 2000, Nemesure et al., 2003, Wolfs et al., 1997).
Furthermore, a thinner central cornea has been associated with increased glaucomatous
visual field loss as well as increased optic nerve head damage (Congdon et al., 2006,
Herndon et al., 2004, Jonas et al., 2005, Kniestedt et al., 2006., Sullivan Mee et al.,2005,
Sullivan-Mee et al., 2006a, Sullivan-Mee et al., 2006b). These findings are not
supported by all studies ( Argus, 1995, Foster et al., 2003, Herndon et al., 1997,Iwase
et. al., Vijaya et. Al., 2005). There is little evidence so far to suggest that a thinner
central corneal is a risk factor for the progression of glaucoma (Congdon et.al., 2006,
Jonas et.al., 2005, Kim and Chen 2004, Leske et. al., 2003, Stewart et.al., 2006, Weizer
et al., 2004).
1.3.3.3.2.4 CORNEAL THICKNESS IN OCULAR HYPERTENSION AND GLAUCOMA
Two main theories have arisen to explain the possible role of central corneal thickness in
ocular hypertension and glaucoma. Though multivariate analysis in the Ocular
Hypertension Treatment Study had demonstrated that the effect of CCT on the
progression of ocular hypertension to glaucoma was independent of IOP, the first theory
centers around CCT’s role in the measurement of IOP. The second theory postulates
that corneal thickness may be a surrogate for some yet unknown biological factor,
possibly reflecting a biomechanical aspect of the optic nerve head.
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1.3.3.3.2.4.1 CORNEAL THICKNESS IN APPLANATION TONOMETRY
Since it’s introduction in the 1950s, the clinical gold standard for measuring IOP has
been Goldman applanation tonometry (Kniestedt et al., 2008). The Goldman applanation
tonometer is a variable force tonometer based on the Fick-Imbert Law- which states that
“the pressure within a sphere is equal to the force needed to flatten part of the sphere
divided by the area flattened” (Hart, 1992). Theoretically this law applies to perfect, dry
and infinitely thin spheres. The cornea is not dry, infinitely thin nor spherical. Different
factors may effect the accuracy of IOP measured by GAT – reviewed by Whitacre and
Stein (Whitacre and Stein, 1993, Whitacre et al., 1993) Damji (Damji et al., 2003) and
Hart (Hart, 1992) The main sources of error include the following: The tear film bathing
the cornea forms a meniscus between the surface of the cornea and the applanation
prism. This may lead to measurement errors in two ways. First, the meniscus may be
assumed (incorrectly) to be part of the corneal contact area. Second, the surface tension
of this meniscus can also effect the force required for applanation. A small volume of
aqueous is displaced during applanation which leads to a small but significant increase
in IOP. Finally, the flattening of the cornea will be partially dependent on its physical
properties. The cornea itself has a certain rigidity (or modulus of elasticity) which resists
the applanation of its surface.
GAT attempts to minimize these potential errors by maintaining only a small area of
contact, so that the portion of cornea flattened and aqueous displaced is minimal. The
force required to flatten a circular area of cornea with a diameter of 3.06 mm is
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measured. This area was chosen in part as one at which the surface tension of the tear
meniscus and the rigidity of the cornea approximately offset each other. In addition,
based on the measurement of cadaver eyes, Goldman and Schmidt assumed a central
corneal thickness of 500μm. It was also assumed that corneal thickness would not vary 
greatly in the population. They did however recognize that applanation tonometry could
be influenced by the physical properties of the cornea such as thickness, curvature and
modulus of elasticity, so readings could only be considered reliable if the cornea was
what they deemed, “normal.” (Whitacre and Stein, 1993, Chihara, 2008).
Subsequently, the importance of CCT in the measurement of IOP in vivo, has been
demonstrated by a number of studies, starting with work by Ehlers and colleagues
(Ehlers et al., 1975). Ehlers et al. performed manometry and either Perkins or Drager
tonometry simultaneously on 29 eyes about to undergo intraocular surgery. A systemic
error proportional to the true IOP and CCT when IOP was measured by applanation
tonometry was found. Ehlers et al. calculated that intraocular pressure when measured
by Goldman Applanation Tonometry, is most likely to correspond to intracameral IOP
when the central corneal thickness is 520μm. Similar results have been reported by 
others using similar methodology (Whitacre and Stein, 1993, Kohlhaas et al., 2006,
Feltgen et al., 2001). There have been a variety of other reports demonstrating a positive
correlation between corneal thickness and IOP, as well as increased corneal thickness in
ocular hypertension and decreased corneal thickness in normal tension glaucoma
(Dohadwala et al., 1998, Foster et al., 1998, Bhan et al., 2002, Eysteinsson et al., 2002,
Ko et al., 2005, Li et al., 2002, Lleo et al., 2003, Doughty and Jonuscheit, 2007). The
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relationship between intraocular pressure and CCT has also been the subject of a recent
meta-analysis (Doughty and Zaman, 2000) and will not be reviewed here. Overall, thick
corneas tend to overestimate intraocular pressure, whereas relatively thin corneas
underestimate intraocular pressure (Doughty and Zaman, 2000). Different
algorithms/correction factors have been proposed to reduce the influence of CCT on
IOP but none have gained universal acceptance (Dueker et al., 2007).
1.3.3.3.2.4.2 CORNEAL THICKNESS AS A SUSCEPTIBILITY FACTOR
The second hypothesis suggests that central corneal thickness may be a surrogate for
biomechanics of the optic nerve head or some other yet unidentified biological factor.
The Ocular Hypertension Treatment Trial found CCT was a powerful predictor of
glaucoma in both univariate and multivariate analysis, suggesting that the effect of CCT
on the progression of ocular hypertension may be independent of IOP (Gordon et al.,
2002). This finding has been independently confirmed in the more recent European
Glaucoma Prevention Study (Miglior et al., 2007a). Hence underestimation of intra-
ocular pressure by Goldman applanation tonometry associated with a thinner CCT, may
only partly explain the relationship between thin corneas and increased glaucoma risk.
Another possibility that has been postulated to explain this association is that perhaps,
CCT (and other biomechanical or physical properties of the cornea such as hysteresis) is
a surrogate index for an inherent biomechanical (or other) property of the eye such as the
thickness of the peripapillary sclera or degree of bowing of the lamina cribrosa.
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Considering the cornea is an extension of the sclera and lamina cribrosa as is related to it
by anatomy, physiology and development, this is not a far fetched hypothesis. However,
though more evidence is beginning to emerge, there is little information to date about
CCT as a biological risk factors or its association with optic nerve head parameters.
Studying these possible associations are problematic. With current technology there is
no easy way to measure the thickness of the lamina cribrosa or surrounding sclera of the
optic nerve head in vivo. Most of the studies published so far are also limited by small
numbers and a lack of genetic homogeneity, even though it is now well established that
many of the quantitative traits related to glaucoma, including CCT show inter-
population variation and are highly heritable (Toh et al., 2005).
Mark Lesk and colleagues attempted to circumvent the problems of measurement by
using cup depth assessed by scanning laser tomography as a surrogate for the position
of the lamina cribrosa to investigate the relationship between corneal thickness and
lamina cribrosa compliance (Lesk et al., 2006). Patients with thin corneas with ocular
hypertension or open angle glaucoma had greater movement (compliance) of their
lamina cribrosa, as well as a smaller improvement in optic nerve head blood flow after
IOP reduction than those with thicker corneas. Leske et al. hypothesized that a thin
cornea may be connected to a thin sclera which in turn may reflect a thin lamina
cribrosa. A thin lamina would be more vulnerable to movement induced by fluctuations
in IOP – either physiological due to diurnal variation, or iatrogenic due to glaucoma
therapy. Movement of the lamina may lead to the damage of RGC axons, associated
vasculature and supporting cells as previously described. Nicoela et al. (Nicolela et al.,
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2006) however, did not find any relationship between central corneal thickness and
optic nerve parameters following IOP modulation.
As the thickness of the lamina and peripapillary sclera is difficult to measure in vivo,
studies have sought to define the relationship between the thickness of the anterior sclera
and CCT to find indirect evidence for an association between lamina cribrosa and
posterior sclera with CCT. CCT has been correlated to scleral thickness in some studies
(Albekioni et al., 2003, Oliveira et al., 2004, Oliveira et al., 2006) but not others
(Oliveira et al., 2006).
The ultra structure of the posterior sclera, its collagen content and extra-cellular matrix
in animal models of myopia, confers different biomechanical properties compared to
emmetropic eyes (McBrien and Gentle, 2003). The lamina cribrosa of highly myopic
eyes is also significantly thinner than non myopic eyes (Jonas et al., 2004). Myopia is
also an independent risk factor for glaucoma (discussed in the section below). Hence
others have attempted to investigated if there is a correlation between refractive error
and/or axial length and CCT (Oliveira et al., 2006). In a retrospective cross sectional
study of ocular parameters from patients from an ophthalmology clinic in New York,
Shimmiyo et al (Shimmyo and Orloff, 2005) found no correlation between CCT and
axial length. Both CCT and refractive error show average differences between
populations, hence it follows that the relationship between these variables may also
show such differences. Subgroup analysis of self reported ethnicity, broadly described as
being of “Hispanic”, “ Asian” “Caucasian “ or “African American” did not demonstrate
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any correlation. (Shimmyo and Orloff, 2005). In a similar study by Oliveira et al
(Oliveira et al., 2006), 140 patients from a New York Ophthalmology clinic of varying
self reported ethnicity were investigated. CCT was not found to correlate to either
refractive error or axial length. It did however, correlate with scleral thickness but only
at the scleral spur.
Jonas et al investigated the relationship between CCT and the thickness of lamina
cribrosa directly by the examination of 111 enucleated non-glaucomatous eyes (Jonas
and Holbach, 2005). The thickness of the central and peripheral lamina cribrosa and
peripapillary sclera were all found to be statistically independent of mean central corneal
thickness. The authors admitted that histological artifact introduced during preparation
could account for this lack of association.
There is little information about the association of CCT to other optic nerve head or
glaucoma associated parameters, and the evidence to date is conflicting. Soans et al
(Soans et al., 2004) examined the relationship between CCT and asymmetric disc
cupping in the eyes of 41 patients with glaucoma. The eyes with the greater
glaucomatous cupping had a thinner cornea compared to the fellow eye. This difference
was statistically significant. In a study of 51 patients with ocular hypertension and 35
normal subjects, CCT correlated significantly with RNFL measurements and with only
four of the ONH parameters investigated (cup to disc area ratio, cup area, rim area and
horizontally integrated rim width). Ocular hypertensive patients with a central corneal
thickness of less than 555μm had significantly thinner RNFLs compared to ocular 
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hypertensive with thicker corneas and normal subjects with thick corneas. However, in a
similar study of 109 healthy volunteers who were part of the Advanced Imaging in
Glaucoma Study, CCT was not associated with retinal nerve fiber layer thickness. In a
study by Iester et al (Iester and Mermoud, 2001), CCT not found to be correlated to
RNFL. Henderson et al (Henderson et al., 2005) found a correlation between retinal
nerve fibre layer thickness and corneal thickness in patients with ocular hypertension.
Ocular hypertensives with thinner corneas had a thinner retinal nerve fiber layer. In a
more recent study by Pakravan et al (Pakravan et al., 2007) of 137 patients of 9 different
self reported ancestry, an inverse correlation between CCT and optic disc area was
found. The authors concluded that as well as overestimating IOP, a thicker central
cornea may also be indicative of a smaller (and hence more robust) optic nerve head, the
converse being true for individuals with a thinner central cornea. The Ocular
Hypertension Treatment Study (Budenz et al., 2006) found thinner central corneas were
one of the baseline risk factors associated with associated the development of optic disc
hemorrhages, a known risk factor for GON (Uhler and Piltz-Seymour, 2008). Others
have not found an association between the two (Jonas et al., 2005a).
From these conflicting reports, it is apparent that the role of central corneal thickness in
glaucoma onset and progression remained to be clarified, with very limited information
available about the relationship between CCT and optic nerve head parameters. At the
time this project was being established, there were no published population based
studies which had investigated the relationship between central corneal thickness and
optic nerve head parameters. Such information would be valuable in attempting to
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clarify if there is a connection between central corneal thickness and biomechanical or
other parameters of the optic nerve head.
1.3.3.3.3 CUP TO DISC RATIO
Axons of retinal ganglion cells, the retinal nerve fibre layer, converge to form the optic
disc and subsequently the optic nerve. The convergence of the axons forms a central
depression in the disc known as the optic cup. Since the introduction of the
ophthalmoscope by Helmotz in the mid 1800s, certain optic nerve changes have been
associated with glaucoma. The section above has discussed the possible role of optic
nerve head susceptibility in the pathogenesis of glaucomatous optic neuropathy at
length. There is also consistent and strong evidence that increased cup-to-disk ratio (of ≥ 
0.5) is an independent risk factor for the progression of ocular hypertension and
glaucoma (Friedman et al., 2004). Though progressive thinning of the neuroretinal rim
or enlargement of the cup is considered the quintessence of advancing glaucoma, the
Ocular Hypertension Treatment Study showed that relatively larger ratios preceded the
diagnosis of glaucoma as well. However, several factors make it difficult to establish if
disc size is a truly independent risk factor in glaucoma susceptibility (Friedman et al.,
2004, Gordon et al., 2002, Klein et al., 2004b). First, it could be argued the increased
cup-disc ratios in these patients may be an indication of early structural damage and not
a risk factor. Furthermore disc parameters show great inter and intra-population
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variation but comparison between studies are hindered by the difference techniques used
to measure and monitor disc variables.
1.3.3.3.4 MYOPIA
Cross-sectional and case control studies, from across the continents have also found
associations between glaucoma and myopia (Daubs and Crick, 1981, Ponte et al., 1994,
Mitchell et al., 1999, Grodum et al., 2001, Yoshida et al., 2001, Ramakrishnan et al.,
2003, Wong et al., 2003, Xu et al., 2007b). Analogous to studies in glaucoma, studies on
refractive error are difficult to compare as definitions for myopia and hyperopia depend
on demarcating specific values, but there is no consensus for these definitions either.
Problems associated with studies investigating both glaucoma and myopia are further
compounded by a lack of consensus definition or diagnostic criteria for both diseases.
Not all studies however have supported the association between glaucoma and myopia.
For example. In the follow up of 647 ocular hypertensive subjects, Quigley et al did not
find myopia to be a risk factor for the development of glaucomatous visual field loss in
ocular hypertension (Quigley et al., 1994). The results of randomized clinical trials have
also been inconsistent (Gordon et al., 2002, 2002, Leske et al., 2003).
The exact biological reason for the association between myopia and glaucoma is unclear.
There is evidence that the increased risk (at least in myopia ≥ 4D) is not due to an 
increased association with raised IOP (Chihara et al., 1997) but is an independent risk
82
factors for glaucoma. This association may be related to the structure of the myopic eye
which differs from emmetropic eyes (Fong et al., 1990, Saw et al., 2005, Jonas et al.,
2004). Myopic eyes have longer axial lengths and deeper anterior chambers. The lamina
cribrosa is thinner and shows greater deformability in myopia than in emmetropia (Jonas
et al., 2004). This greater compliance will make the ONH more vulnerable to
fluctuations in IOP and subsequent RGC damage.
1.3.3.3.5 OTHER OCULAR FACTORS
Pigment dispersion and exfoliation syndrome are both associated with open angle
glaucoma (Sowka, 2004a, Sowka, 2004b,Boland and Quigley, 2007), though strictly
speaking, not with primary open angle glaucoma as the term primary suggests, with this
form, the cause of the optic neuropathy is unknown. Other putative risk factors include
optic disc haemorrhages and peripapillary atrophy (Primrose, 1970, Wilensky and
Kolker, 1976, Kitazawa et al., 1986, Nevarez et al., 1988, Buus and Anderson, 1989,
Jonas et al., 1992, Jonas and Xu, 1993, Jonas et al., 1989, Jonas and Naumann, 1989,
Araie et al., 1994, Jonas and Iester, 1995, Sugiyama et al., 1997,Jonas and Budde, 2000,
Lee et al., 2002, Yamamoto et al., 2004, Xu et al., 2007c) which were discussed in the
sections before and choroidal thickness (Yin et al., 1997).
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1.3.3.4 ENVIRONMENTAL RISK FACTORS
There has been no environmental risk factor consistently associated with the onset or
progression of POAG (Pasquale and Kang, 2009). Even smoking, one of the most
common environmental risk factors associated with a large number of chronic diseases
including the acceleration of ocular conditions such as macular degeneration and
cataract (Solberg et al., 1998) has not been associated consistently with the onset or
progression of POAG (Edwards et al., 2008). There is some evidence that exercise can
reduce intraocular pressure (Qureshi, 1996).
1.3.3.5 FAMILY HISTORY / GENETICS AS A RISK FACTOR FOR PRIMARY OPEN
ANGLE GLAUCOMA
Family history is now recognized as an important risk factor for the development of
POAG. Cross sectional epidemiological studies have demonstrated that 10 to 50% of
POAG patients have a reported family history of the disease (McNaught et al 2000)
though nearly a third of cases may be under-reported. The risk for developing the
disease amongst first degree relatives is 2 to 10 fold (Tielsch 1994, Wensor 1998, Wolfs
1998). Furthermore, several large population based studies have demonstrated that the
prevalence of glaucoma varies between populations of self reported ethnicity
(summarized in table 1.3). A recent meta-analysis (Rudnicka 2006) calculated the
average estimated prevalence of POAG in those over 70 years of age was 3% in Asian
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populations, 6% in white Caucasian populations and 16% in populations of black
African and Caribbean origin (table 1.6). The clinical course of POAG also differs in
these populations. POAG for example, shows more rapid and early progression in blacks
than white Caucasians, with the risk of irreversible blindness also being greater amongst
the former (reviewed by Racette 2003, Wadhwa 2005). The predominant type of
glaucoma also varies across ethnic groups, with population based studies suggesting that
primary angle closure glaucoma predominates amongst East Asians and Eskimos whilst
POAG is the more dominant form found in white Caucasians and those of Afro-
Caribbean origin (Congdon 1992, He 2006).
The genetic basis of glaucoma is further supported by twin studies (Gottfresdottir 1999,
Teikari 1987 and 1992). A prospective study by Gottfresdottir in 1999, for example,
looking at 50 monozygotic twin pairs and their spouses, found concordance rates of
open angle glaucoma in twin pairs (98%) exceeded that of spouse-twin pairs (72%).
Since then, several genetic loci associated with POAG have been described and a
number of genes implicated and are summarized in the table below.
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1993 GLC1A 1q21-q31 137750 MYOC (Sheffield et al.,
1993)
1996 GLC1B 2cen-q13 606689 - (Stoilova et al.,
1996)
1997 GLC1C 3q21-q24 601683 - (Wirtz et al., 1997)
1998 GLC1D 8q23 602429 - (Trifan et al., 1998)
1998 GLC1E 10p15-p14 137760 OPTN (Sarfarazi et al.,
1998)
1999 GLC1F 7q35-q36 603383 - (Wirtz et al., 1999)
2004 GLC1J 9q22 608695 - (Wiggs et al., 2004)
2004 GLC1K 20p12 608696 - (Wiggs et al., 2004)
2005 GLC1G 5q22 609887 WDR36 (Monemi et al.,
2005)
2005 GLC1I 15q11-q13 609745 - (Allingham et al.,
2005)
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2005 GLC1L 3p21-22 137750 - (Baird et al., 2005a)
2006 GLC1M 5q22.1-q32 601535 - (Pang et al., 2006)
2006 GLC1N 15q22-q24 611274
-
(Wang et al., 2006b)
2007 GLC1H 2p15-p16 - - (Suriyapperuma et
al., 2007)
The first locus for POAG, mapped to chromosome 1 band q21-q31 locus, was identified
by linkage analysis in a 37 family member pedigree affected with an autosomal
dominant form of juvenile open angle glaucoma (Sheffield et al., 1993). The locus was
named GLC1A – GLC for glaucoma, 1 for ‘primary open angle’ and A for the first
linkage site. The finding was confirmed in subsequent linkage studies in both JOAG and
POAG and the gene, known as myocilin (MYOC) or the TIGR gene, identified. The
association between myocilin and POAG was confirmed by Stone et al (Stone et al.,
1997)who screened 330 unrelated POAG patients and 471 controls. MYOC mutations
were found in 3.9% of POAG patients but only 0.2% of controls (p<0.05). Subsequent
analysis of MYOC mutations have shown their frequency to be between 2 to 4% in
glaucoma patients (Fingert et al., 1999). These mutations are found in patients from a
variety of ethnic backgrounds. Sequence analysis of the myocilin gene suggests protein
in the region of 55kDa (reviewed elsewhere – see Johnson (Johnson, 2000) and Libby
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(Libby et al., 2005) widely expressed in both ocular (the trabecular meshwork, the retina
and the ciliary body) and extraocular tissues (Fingert et al., 1998). In vitro, myocilin has
been observed to modify fibroblast dispersal (Peters et al., 2005), be upregulated in the
central nervous system response to injury and hinder the development of neuritis
(Jurynec et al., 2003), over-expression/extracellular myocilin has been observed to effect
the function of mitochondria as well as reduce the adhesive properties of trabecular
meshwork cells (Wentz-Hunter et al., 2004a, Wentz-Hunter et al., 2004b, Sakai et al.,
2007). MYOC’s alternate name of TIGR (trabecular meshwork inducible glucocorticoid
response protein) arose as it was identified as being upregulated in trabecular meshwork
cells that had been treated with dexamethasone (Nguyen et al., 1998). Despite these
observations, myoclin’s normal physiological function in vivo remains unclear. Over 70
disease causing myocilin mutations have been identified and there is some evidence to
suggest that method by which mutant myocilin facilitates glaucomatous optic
neuropathy is through it’s aggregation in trabecular meshwork cells, causing increased
resistance to aqueous egress and subsequently increased IOP (Nguyen et al., 1998,
Lutjen-Drecoll et al., 1998, Fautsch et al., 2000, Clark et al., 2001, Fautsch et al., 2006,
Naskar and Thanos, 2006). This theory is not supported by all studies (Caballero et al.,
2000, Gould et al., 2004, Zillig et al., 2005).
The second POAG gene identified was optineurin (optic neuropathy inducing protein),
OPTN, initially identified by linkage analysis of a large British pedigree in which 15 of
46 members had normal tension glaucoma (Sarfarazi et al., 1998). The GL1E locus was
mapped to 10p15-14. Known to be expressed in the retina and to have a role in
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apoptosis, OPTN was identified as a good candidate. Individuals with specific OPTN
mutations are known to have a more relentless form of NTG but on the whole, OPTN
variants are a rare cause of normal tension glaucoma. OPTN is known to interact directly
with several different proteins involved in cellular morphogenesis and membrane
trafficking (see Sarfarazi and Rezaie 2003 (Sarfarazi and Rezaie, 2003) for a
comprehensive review). The exact mechanism by which OPTN contributes to the
glaucoma phenotype remains to be elucidated.
A third gene WDR36, was identified as a possible candidate following the discovery of
the GLC1F locus by linkage analysis (Monemi et al., 2005). A role in glaucoma
pathogenesis via T cell activation has been postulated for its gene product. The WDR36
D658G mutation was present in a large GLC1G-linked family and though other disease
susceptibility mutations were described, this variant was the only one which was
statistically significant in cases compared to controls. This has not been replicated
elsewhere (Hewitt et al., 2006) and a recent analysis of WDR36 sequence variants did
not show consistent segregation with POAG afflicted individuals, though certain
variants were found more frequently in patients with more severe disease, suggesting
that the role of WDR36 may be as a glaucoma modifier rather than a causative gene
(Hauser et al., 2006).
Over 20 other gene variants associated with POAG have been reported from association
studies (Copin et al., 2002, Fujiwara et al., 2003, Funayama et al., 2006, Inagaki et al.,
2006, Ishikawa et al., 2005, Junemann et al., 2005, Juronen et al., 2000, Lam et al.,
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2006, Lin et al., 2002, Lin et al., 2004, Lin et al., 2003a, Lin et al., 2003b, Lin et al.,
2006, Liu et al., 2007, Logan et al., 2005, Mabuchi et al., 2005, Melki et al., 2004,
Shibuya et al., 2008, Tosaka et al., 2007, Tsai et al., 2003, Tsai et al., 2004, Tunny et al.,
1998, Tunny et al., 1996, Unal et al., 2007, Vickers et al., 2002, Pang et al., 2006,Wang
et al., 2006a). Most have been reported in single studies and not always replicated in
other. The actual role of these genes in POAG remains to be clarified (Hewitt et al.,
2006).
Mutations in known POAG genes and classic Mendelian inheritance accounts for only a
minority of POAG patients (Fan et al., 2006). More and more evidence suggests that in
the majority of cases, POAG is not a single gene disorder but a complex trait (Fan et al.,
2006, Hewitt et al., 2006). Like other diseases of late onset, the susceptibility (or
liability) to POAG can be considered to be normally distributed and the net result of
genetic and environmental influences (Wright et al., 2003). For POAG to be manifest, a
certain threshold of liability must be surpassed. This high level of complexity has added
an extra degree of difficulty in identifying associated susceptibility genes.
1.4 DIAGNOSIS
The diagnosis of POAG is made primarily by the presence of glaucomatous neuropathy
(cupping) and a compatible visual field defect in the presence of an open, normal
anterior chamber angle, without the presence of other ocular abnormalities which may
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contribute to these changes. (European_Glaucoma_Society, 2003). Raised intra-ocular
pressure used to be included as part of the definition, but population based studies have
consistently confirmed that many patients with glaucoma have an IOP below 21mm-Hg.
(Hollows and Graham, 1966, Iwase et al., 2004, Klein et al., 1992b, Sommer et al.,
1991). IOP now is considered to be a risk or contributing factor rather than the sole
causative factor. However, over the years, there has been little consensus on the criteria
used for the diagnosis of glaucoma and no consensus on the methods and standards used
to define optic disc damage or visual defects. Criteria for diagnosis has varied from
using visual field and optic disc criteria, to visual field or optic disc criteria alone, to disc
changes and IOP criteria to intraocular pressure alone. For example, in a review of 182
articles published between 1980 and 1995, by Bathija and Gupta et al. in 1998, only
66% of articles included in the analysis included a definition for open angle glaucoma.
Of these articles, 36% used both optic disc and visual field changes, 13% used optic disc
or visual field changes, 26% used only visual field criteria, 20% used only IOP and 5%
used only optic disc criteria. The definition for normal tension glaucoma, a subset of
POAG, and ocular hypertension has also been found to be highly variable (Tavares et
al., 2006, Lee et al., 1998). A lack of a clear gold standard definition for glaucoma, can
lead to a false dichotomy between detection of damage (going from disease to no
disease) and disease progression (going from mild to more severe disease). This
variability in definition, classification, and criteria used for diagnosis has made
comparison and summation of results from glaucoma related studies problematic.
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1.5 MANAGEMENT
The goal of glaucoma management as described by the European Glaucoma Association
and the American Academy of Ophthalmology as well as a number of other care
guidelines, is to maintain a patient’s quality of life by preserving visual function at, as
stated by the EGA “ at a sustainable cost” (European_Glaucoma_Society, 2003) The
cost described is not merely a financial one to the individual or society but also one in
terms of treatment side effects and inconvenience. The mainstay of POAG treatment
remains the lowering of intraocular pressure either by means of medication, surgery or
laser and over the past few years a number of multicentre trials have confirmed the
merits of lowering IOP in primary open angle glaucoma as well as ocular hypertension
(Gordon et al., 2002, Kass et al., 2002, Anon, 1998b, Anon, 1998a, Heijl et al., 2002,
Lichter et al., 2001). Management involves lowering an individuals IOP to a certain
“target IOP”, and then maintaining IOP at that level (European_Glaucoma_Society,
2003). The target IOP for an individual or eye is the level of IOP in that individual or
eye, at which further glaucoma optic neuropathy will not occur. Methods for calculating
target IOP have been described but in practice, the individual response to IOP is so
variable, this is difficult to establish accurately for each individual and eye. Other
putative treatments, such as neuro-protective agents, have been suggested as well but
their role in POAG management remains to be clarified (Weinreb, 2007).
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1.6 PROGNOSIS
Despite a number of large studies demonstrating the value of lowering IOP in POAG
and OHTN, for a number of individuals this does not arrest or slow the progression of
glaucoma (Kass et al., 2002, Anon, 1998b, Heijl et al., 2002, Lichter et al., 2001). This
suggests that there may be other factors, not just IOP important in the progression of
glaucomatous optic neuropathy in these individuals.
1.7. THE FUTURE OF GLAUCOMA MANAGEMENT
The fact that is relentlessly highlighted then re-emphasized about primary open angle
glaucoma is the heterogeneous nature of the disease. Unfortunately, in the case of
glaucoma, one size does not fit all and it is only by truly understanding the details of its
aetiology and pathogenesis will we be able to diagnose, treat, monitor, and hopefully,
one day prevent the disease. The behavior of primary open angle glaucoma shows great
inter-individual as well as inter-population variation. Ideally, based on our knowledge of
the genetic and environmental factors that may influence the disease, and the cascade of
events which eventually lead to its expression in each individual, we would be able to
assess an individual’s susceptibility to disease and provide personalized programs for
disease prevention, treatment, monitoring and prognosis. The treatments we use would
be tailored to suit each individual not just based on our comprehensive understanding of
disease pathogenesis but also taking into account individual responses to drugs.
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However, for this dream of personalized medicine to become a reality, we need a better
understanding of the genetic and environmental factors that may influence primary open
angle glaucoma susceptibility.
The primary goal of this PhD is to establish a study investigating the inheritance of
quantitative traits related to primary open angle glaucoma in the Scottish population
isolate of Orkney. The study will be designed to be a long term project to collect
quantitative trait data for a quantitative trait analysis to continue after the conclusion of
this PhD. The ultimate aim of this study is to identify new genes associated with a
predisposition to POAG and to locate regions of the genome influencing disease risk.
Chapter 2 summarizes and describes the aims, objectives and research questions for this
PhD thesis. Chapter 3 gives an overview of the project and our rationale for using this
particular approach and a description of setting up the initial project. Chapter 4
continues with this theme, describing the handling and analysis of data. Chapter 5 is an
overview of the results followed by further results and discussion in chapters 6 to 8.
Chapter 9 brings these results together in a final discussion.
1.8. SUMMARY
Primary open angle glaucoma is a progressive optic neuropathy which is the primary
cause of irreversible blindness in the world. Treatment involves lowering intra-ocular
pressure but for a number of patients this does not abrogate or slow disease progression.
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Many risk factors have been associated with the disease but only age, ancestry, family
history, intraocular pressure, central corneal thickness and optic nerve head parameters
have been associated relatively consistently across studies. The aetiology and
pathogenesis of POAG is poorly understood but available evidence suggests it is multi-
factorial. Genetically, POAG can be considered a complex disease where both genetic
and environmental factors act in concert to cause the disorder. Though several genes and
loci have been identified, they appear to be responsible for only a small number of
POAG cases. Hence, a considerable amount of work is required before the aetiology and




1.1 AIMS AND OBJECTIVES
1.1.1 The primary objective of this PhD project was to design and establish a
study investigating the inheritance of quantitative traits associated with
primary open angle glaucoma in the Scottish population isolate of Orkney.
The study was designed to be a long term project to collect quantitative trait
data for a genetic analysis to continue after the conclusion of this PhD. The
final aim of the Orcades Eye Study is to identify new genes associated with a
predisposition to POAG and to locate regions of the genome influencing
disease risk. During the time frame of this PhD, funding was sourced,
premises found and infrastructure built, ethical approval finalized, volunteers
recruited, tools and protocols for data collection, entry and storage trialled
and confirmed. Also data on over 10 quantitative traits associated with
POAG was collected. These traits included entral corneal thickness (CCT),
intraocular pressure (IOP) and optic nerve head (ONH) parameters such as
rim area, cup area, cup volume, cup depth and peripapillary atrophy.
Refractive error and axial length were also measured as myopia is a risk
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factor for POAG. Chapter 3 discusses in depth the reasons for this particular
choice of population and study design, describes how funding was sourced,
equipment and premises chosen and discusses the methods used for
phenotyping. Chapter 4 will discuss data management and analysis.
1.1.2 The secondary aim of this PhD was to describe the findings from this initial
sample of data collected during this time period. We analysed the
distribution and preliminary statistics of the ocular quantitative traits of
central corneal thickness, intra-ocular pressure and optic nerve head
parameters as these are well established risk factors for primary open angle
glaucoma (Leske and Rosenthal, 1979, Leske, 1983, Boland and Quigley,
2007). There is evidence that quantitative traits such as IOP, CCT and ONH
parameters show variation between populations (Katavisto and Sammalkivi,
1964, Armaly, 1965, Hollows and Graham, 1966, Wallace and Lovell, 1969,
Alsbirk, 1970, Kahn et al., 1977a, Kahn et al., 1977b, Shiose and Kawase,
1986, Shiose, 1990, Sommer et al., 1991, Shiose et al., 1991, Klein et al.,
1992a, Dielemans et al., 1994, Mitchell et al., 1996, Leske et al., 1997, Jacob
et al., 1998, Bonomi et al., 1998, Weih et al., 2001, Doughty and Zaman,
2000, Rotchford and Johnson, 2002, Racette et al., 2003, Hashemi et al.,
2005, Xu et al., 2005, Rudnicka et al., 2006). However there is very little
information regarding the distribution of quantitative traits associated with
glaucoma from a Scottish population, let alone Orkney. Hence the analysis of
these traits will allowed us to investigate the mean values and normative
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ranges for this population in addition to providing information about possible
genetic architecture from phenotypic data.
Despite central corneal thickness being one of the most powerful predictors
for the progression of ocular hypertension to glaucoma, and despite the
increasing interest in the cornea as a possible surrogate for some factor
reflecting the optic nerve head or optic nerve head biomechanics, there is
little information regarding the relationship between corneal thickness to
other optic nerve head or refractive parameters. The evidence that is available
is often conflicting and derived from genetically heterogeneous populations
of self reported ancestry (Soans et al., 2004, Pakravan et al., 2007). When
glaucoma exhibits such genetic heterogeneity, it follows that the relationships
between its associated quantitative traits may also show inter-population
variation. The archipelago of Orkney has been geographically isolatedfor
many centuries, with high levels of endogamy and a reduced population size
which has lead to reduced genetic diversity in the archipelago compared to
more admixed populations found, for example, in some ophthalmology
clinics of the United States sometimes used in these studies (McQuillan,
2009, McQuillan et al., 2008). We also therefore investigated the relationship
between the quantitative traits related to glaucoma in this study sample. Few
published studies have investigated the relationship between quantitative
traits from such a wide range of parameters, as we plan to gather.
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2.1.3 Finally we had planned to investigate the heritabilities of these traits, followed
by a definitive genetic analysis using association and linkage methods to identify
genes and regions of the genome asscociated with glaucoma related quantitative
traits .
1.2 RESEARCH QUESTIONS
1.2.1 Population based studies from across the world have demonstrated that
quantitative traits associated with primary open angle glaucoma such as
intraocular pressure and optic nerve head parameters can vary between
populations. What are the distributions of the quantitative traits associated
with primary open angle glaucoma from the population isolate of Orkney ?
In particular what are the distributions of central corneal thickness, intra-
ocular pressure and optic nerve parameters ? Chapter 4, sections 4.1.2 to
4.1.6 inclusive describes the measurement of these traits, chapters 6-8, the
results, and in figures 6.1, 7.1, 8.1-5 demonstrate the distribution of CCT,
IOP and optic nerve head parameters respectively.
1.2.2 The genetic and environmental factors which influence these traits amongst
the Orkney population are also different compared to other populations. How
do these trait distribution and values compare to other published populations?
In the results chapters 6-8, table 6.5, 7.3 and 8.2 compare Orcades results
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with other published populations for the traits of CCT, IOP and optic nerve
head parameters respectively.
1.2.3 Research analyzing the relationship between these traits have highlighted
important associations between traits, such as the correlation between
intraocular pressure and central corneal thickness (Doughty and Zaman,
2000). However, these findings have not been consistent across populations.
Are there any relationships between the quantitative traits measured in our
study and do they reflect the findings of other groups? Overall, chapter 4,
sections 4.1.2 to 4.16 describe the measurement of these quantitative traits,
and , section 4.3.3 discusses the multivariable analysis, and tables 6.2, 6.4
and 7.2 summarizes the results with further discussion within the text of
chapters 6 to 8. The relationships described belwo are of particular interest.
1.2.3.1 It has been suggested that the thickness of the cornea may be a surrogate
for some yet undescribed biomechanical factor of the optic nerve head and
surrounding sclera (Brandt, 2007). This research has been hampered by the
difficulty of studying the optic nerve head in vivo. In our study, we will
collect data on a multitude of optic nerve parameters including optic disc
area, optic cup area and optic cup depth (as a surrogate for lamina cribrosa
compliance) and peripapillary atrophy which from the evidence provided by
biomechanical models of the optic nerve head we postulate will increase the
susceptibility of the optic nerve head to IOP related stress and strain and has
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already been described as a risk factor for open angle glaucoma (Primrose,
1970, Wilensky and Kolker, 1976, Nevarez et al., 1988, Buus and Anderson,
1989, Jonas et al., 1992, Jonas and Xu, 1993, Jonas et al., 1989, Jonas and
Naumann, 1989, Araie et al., 1994, Lee et al., 2002, Bellezza et al., 2000,
Burgoyne et al., 2005, Xu et al., 2007c). Is there a relationship between
central corneal thickness and optic nerve head parameters? We postulate that
a thin central cornea which is associated with an increased risk of primary
open angle glaucoma will be associated with factors that will increase the
vulnerability of the optic nerve head such as an increased lamina cribrosa
compliance and increased peripapillary atrophy. Section 4.1.6 describes the
measurement of CCT, section 4.1.5 details the analysis of optic nerve head
parameters, section 4.3.3 describes the multivariable analysis, and table 6.2
summarizes the results with further discussion sections 6.2 and 8.2.
1.2.3.2 In addition, myopia is an independent risk factor for glaucoma and the ultra
structure of the posterior pole in animals models of myopia confers different
biomechanical properties compared to emmetropic eyes (Daubs and Crick,
1981, Ponte et al., 1994, Mitchell et al., 1999, Grodum et al., 2001, Yoshida
et al., 2001, Jonas et al., 2003a, Ramakrishnan et al., 2003, Wong et al.,
2003, Shimmyo and Orloff, 2005, Oliveira et al., 2006, Xu et al., 2007b).
Hence is there any relationship between refractive error/axial length, as a
surrogate for scleral structure with central corneal thickness. We postulate
that corneal thickness will show a negative correlation with refractive
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error/axial length as elongation of the globe may be coupled with thinning of
the cornea. Section 4.1.2 describes the measurement of refractive error, 4.1.3
describes the measurement of axial length. Central corneal thickness and a
description of the multivariable analysis occurs in sections 4.1.6 and 4.3.3 as
previously stated, and results summarized in table 6.2 with futher discussion
in section 6.2.
1.2.4 What are the heritabilities of these quantitative traits?
1.2.5 What genes and regions of the genome are associated with these traits ?
Due to a number of reasons discussed in detail in Chapter 5, the start date of the
project was postponed and after the project was started, it was subject to a number
of problems which lead to delays in its continuation. We were unable to reach our
target sample size of 1000. Hence during the second year of the PhD, the objectives
and research questions were revised and limited upto and including question 2.24.
In addition, all volunteers who participated were not genotyped in time for analysis
within the time frame of this PhD and only a limited number of individuals in the
team had access to this genetic information. Due to limited manpower, and the lack
of access to the genetic data, time constraints of the PhD, only a limited amount of
analysis in a limited number of individuals could be accomplished within this time
frame.
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The study of quantitative traits influencing POAG has already provided evidence
for possible disease mechanisms. This project will lead to an improved
understanding of the underlying aetiology and pathogenesis of primary open angle
glaucoma, with the potential for developing new methods of diagnosis and
treatment using this knowledge, in the future.
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CHAPTER 3
ESTABLISHING THE ORCADES EYE PROJECT
3.1 OVERVIEW
The following two chapters describe setting up the Orcades Eye Project. Chapter three
concentrates on overall study design including the choice of equipment, population and
premises, to the sourcing of funds, conversion of premises. Chapter 4 concentrates on
data collection, management and methods of analysis.
3.2 DEFINING THE PHENOTYPE
Much of the research into the genetics of glaucoma has involved treating glaucoma as a
binary or qualitative trait. This approach poses several problems. The first is the lack of
a standard definition for the very heterogeneous disease that is buried beneath the
solitary term “glaucoma”. This is demonstrated in table 1.3 which shows the differences
in definition between published epidemiological studies. This is further compounded by
the different methods of visual field, optic disc and IOP assessement, and criteria used to
diagnose glaucomatous optic neuropathy, visual field defects and “normal” intraocular
pressure. This was investigated more formally in a literature review by Bathija et al.
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(Bathija et al, 1998) and in the Rotterdam study when Wolfs et al., demonstrated the
importance of having a standard definition for open angle glaucoma even further by
showing the prevalence of open angle glaucoma in Rotterdam could vary 12 fold (from
0.1 to 1.2%) depending on how a case of open angle glaucoma was defined, different
definitions for the disease having been obtained from other major population based
studies (Wolfs et al., 2000).
The second is the prevalence of POAG. The prevalence is only around 1-4% in the over
50 population of white Caucasian ancestry. Though this prevalence is sufficient for
POAG to be classified as a common disease, a considerable amount of effort still needs
to be expended in order to find a sufficient number of cases for a meaningful genome-
wide association study, if association methods are to be used. POAG is also a disease of
late onset. Hence, finding large enough pedigrees for linkage analysis is problematic. A
method of circumventing some of these issues is, rather than studying the disease itself,
is to dissect the disease into contributing components in the form of quantitative traits.
In general, a quantitative trait or QT, could be considered to be one whose distribution is
continuous, for example blood pressure, as opposed to a discrete trait such as blood
group. QTs can be subdivided into three main categories (Hartl, 1999). Metric traits
include many traits of clinical importance such weight, blood pressure, intraocular
pressure and axial length. These traits can take any numerical value and are measured on
a continuous scale. Meristic traits consist of integers and are measured by counting. For
example, egg production and bristle number. Finally, threshold traits are traits which on
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the surface appear to be binary traits, but reflect an underlying continuous liability
determined by the interaction of both genetic and environmental factors. Once a certain
threshold is exceeded, the defined trait becomes manifest. This paradigm probably
describes the pathogenesis of most common disorders including glaucoma.
The genetic basis for such a continuous distribution in accordance to Mendel’s rules was
expounded in the early 1900s by R.A. Fisher (Fisher, 1918, Plomin et al., 2009). Fisher
showed that the continuous distribution shown by quantitative traits could be accounted
for by Mendelian inheritance if multigenic inheritance was assumed. In the majority of
QTs, this continuous distribution will reflect the collective action of both multiple
genetic and environmental factors. Discrete variation that may be observed with the
genotype frequency distribution alone is likely to be blunted by environmental factors
and the discrete assemblage converted to a smooth curve. Even for traits associated with
single genes, such as phenylalanine levels, a continuous phenotypic distribution is
possible if there is sufficient environmental variation (Relethford, 2007). As both genetic
and environmental factors are involved, QTs are often referred to as complex traits.
Because of possible involvement of multiple genes sometimes the term “polygenic trait”
is used as well. The genetic loci involved with these traits are known as quantitative trait
loci or QTLs.
QTL mapping has been used successfully to identify disease associated loci and genes in
a number of common diseases including, diabetes and body mass index (Sladek et al.,
2007), schizophrenia (Moises et al., 1995) and asthma (Ober et al., 1998, Ober et al.,
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2000, Laitinen et al., 2001). In turn, case-control GWAS strategies have lead to the
identification of loci which influence quantitative traits such as the inflammatory
response in Crohn’s Disease (Plomin et al., 2009). Glaucoma is an excellent candidate
for a QTL based strategy as it is readily separated into QTs that are clinically important
risk factors for the disease and are also relatively easy to measure accurately. These
traits include central corneal thickness (CCT), intraocular pressure (IOP), anterior
chamber depth (ACD), and optic nerve head parameters such as cup disc ratio (CDR)
which were discussed at length in chapter 1.
There is mounting evidence that these three risk factors, IOP, CCT and CDR have a
considerable genetic component. All show inter-population variation. IOP, for example,
is on average higher in those of black African descent than white Caucasians, with the
rise of IOP with age being more marked in the former population (Shiose, 1990, Semes
et al., 2006). Individuals of Afro-Caribbean origin also have larger optic discs and
thinner cornea compared to Caucasians (Racette et al., 2003). In addition, these traits
show moderate to high heritability.
The origins of the term heritability remains undetermined but there is evidence to
suggest it has been used since the 19th century (Bell 1977). It’s meaning appears to have
undergone several incarnations. Initially the term was used to suggest the transmission
of characteristics from one generation to another in the broadest sense around the early
to mid 1800s. Its current usage arose around the early to mid 1900s and it’s final
incarnation credited to the geneticist Jay L. Lush (Bell, 1977). Currently the term
107
describes the relative contribution of hereditary in determining a particular phenotype,
formally defined as the “proportion of genotypic variance relative to phenotypic
variance,” (Falconer and McKay 1996). Under a polygenic model, phenotype, P, can be
considered as the function of genetic effects, G, coupled with environmental effects, E,
expressed as P = G + E. This can also be expressed as a function of variance
components (VP = VG + VE). These components can be used to define different types of
heritability. Heritability in the broad sense describes the ratio of total genotypic variance
to total phenotypic variance (h2B = VG/VP). VG can be further divided into additive,
dominance and epistatic effects. Dominance effects arise due to the interaction of alleles
at the same locus whereas epistatic effects are secondary to the interaction of alleles at
different loci. Narrow sense heritability is defined as the proportion of genetic variation
due to additive genetic variance (h2N = VA/VP). Additive effects occur when the effects
of alleles at several loci combine to contribute towards the phenotypic value. Though
often no distinction is made between broad and narrow sense heritability, it is additive
genetic variation which is the main cause of resemblance between relatives (Hill et al.,
2008). A number of study designs and statistical techniques have been developed to
estimate heritability, using a variety of study designs such as twin and family based
designs regression/correlation methods, variance components and maximum likelihood
(Burton et al.,2005, Rice and Borecki 2001, Thomas 2004). The value of heritability lies
between 0 and 1 as it is a ratio between two components. The interpretation of this
value is complex, with a number of associated caveas (Burton et.al.,2005). Despite
these limitations, it can guide the choice of trait and population when designing
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advanced genetic studies as the power of a study to discover new genes is positively
associated with it’s heritability.
Early calculations of the heritability of IOP in the normal eye based on family studies
ranged from 0.4 to 0.9 (Armaly, 1967, Levene et al., 1970); heritability of the size of the
normal optic nerve head between 0.6 to 0.8 (Schwartz et al., 1975) and CCT between
0.6 to 0.7. Population-based studies support the theory that both IOP and cup-to-disc
ratio are moderate to highly heritable traits (Klein et al., 2004a, Chang et al., 2005)-
further supported by twin studies for all three QTs (Schwartz et al., 1975, Kalenak and
Paydar, 1995, Toh et al., 2005). By the time this project was established, several novel
loci had been described as potential linkage regions for IOP on chromosomes 2, 5, 6, 7,
10, 12, 13, 14, 15 and 19 (Charlesworth et al., 2005, Rotimi et al., 2006, Duggal et al.,
2007) and for maximum vertical cup disc ratio on chromosome 1p23 (Charlesworth et
al., 2005).
IOP, CDR and CCT are all readily measurable QTs, which are less complex to
investigate and analyze than POAG itself. By investigating QTs associated with
glaucoma rather than disease per se, the issues which plague disease definition
disappear. Measurements can be taken within the general population, amongst
individuals without the disease, which greatly enhances statistical power. By measuring
multiple QTs it will be possible to investigate genetic overlap between QTs. By studying
the QTs associated with diseases of late onset, QTs which tend to be physiological,
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anatomical or biomechanical variables, again, rather than disease per se, it becomes
possible to use linkage methods as well if information is collected from pedigrees.
Hence for the Orcades Eye Project, we have chosen to study the following QTs
associated with POAG: CCT, IOP, ACD, and optic nerve head parameters. As well as
being an ocular condition which contributes to a significant amount of visual impairment
both locally and globally, and hence worthy of investigation in it’s own right, different
forms of refractive error are also associated with glaucoma (Wu et al., 2000, Saw et al.,
2005, Greve and Furuno, 1980). The majority of components that are associated with
refraction are also easily and reliably measured. So in addition to the above QTs, we will
take this opportunity to gather data about axial length (AL) and corneal curvature.
3.3 STUDY POPULATION
3.3.1 CHOICE OF POPULATION
The choice of population is an important factor when establishing a study to map disease
related genes (Wright et al., 1999). The term “population isolate “ describes a group of
potentially interbreeding individuals who have had little genetic interchange with
surrounding populations over many generations (Jobling et al., 2004). The reasons for
isolation may be geographical- for example the isolates of Finland and Iceland, or
religious, such as Ashkenazi Jewish populations and the Hutterites, or there may be
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other socio-cultural reasons such as those of the European Roma. The term
“transnational isolate” is sometimes used to describe populations which may show a
wide geographical dispersion, but remain genetically isolated due to the practice of
endogamy, or within group marriage (Kalaydjieva et al., 2001). Isolate populations
proffer certain advantages over more outbred ones in the mapping of both Mendelian
and complex diseases. These features of isolates have been reviewed extensively
elsewhere (Kristiansson et al., 2008, Varilo and Peltonen, 2004, Peltonen et al., 2000)
and are discussed briefly below.
There are several characteristics of isolate populations that make them interesting in the
context of disease gene mapping. Many isolates tend to be formed originally by a small
number of individuals. This can cause a genetic phenomenon known as the “founder
effect”, defined by Ernst Mayr in 1963 as “ the effect of establishing a new population
by a few original founders…..who only carry a small fraction of the total genetic
variation of the parental population.” (Mayr, 1963). When a new population is
established (the founder event), the population may be formed by only a limited number
of individuals. The remote Atlantic archipelago of Tristan de Cunha for example, was
originally founded by around 20 individuals in the early 19th century (Roberts, 1971).
These original founders will only carry a subset of alleles of the parent population. Some
alleles from the ancestral population will be lost and others enriched. Hence the genetic
diversity of the new population will be decreased compared to the parent population
(Ridley, 2004). Even if the original population was substantial, the founder effect can
occur if a population passes through a “bottleneck” - that is the population diminishes in
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size due to, for example, catastrophic climatic or disease related events, war or famine,
leaving only a few survivors. For example, since being established in the early 19th
century, Tristan da Cunha has experienced two major population bottlenecks due to
accidents/emigration – the first around 1860 when the population plummeted from 103
to 33 individuals and the second around 1890 when the population decreased from 106
to 59 individuals (Roberts, 1971). There is also evidence that our lineage, as a species,
may have undergone severe population bottlenecks in the past – bottlenecks which many
account for some of the reduced diversity observed in humans (Hawks et al., 2000,
Rampino and Ambrose, 2000).
The next phenomenon of interest which will influence allele frequencies is genetic drift.
The term “genetic drift” describes the chance fluctuation in allele frequencies due to the
random contribution from each individual to subsequent generations in a finite
population (Jobling et al., 2004). The impact of drift depends on the allele frequency of
the founders as well as the demographic characteristics of the population such as
population size, growth rate and fertility distribution. Isolation may also reduce
opportunities for exogamy. Limited population size will mean that there will be a high
probability that any marriage that occurs in the population will be between related
individuals - even if attempts are made to avoid consanguinity. Inbreeding in a
population can be measured using the inbreeding coefficient which measures the
probability that two alleles of an individual will be identical by descent (Hartl, 1999).
This tends to be higher in isolate populations compared to more heterogeneous ones.
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With successive generations, the population will undergo repeated cycles of inbreeding
and genetic drift. If a population is rebounding from a recent catastrophe, it will
experience further inbreeding and drift – the more prolonged the recovery, the greater
opportunity drift has to affect allele frequencies (Peltonen et al., 2000). Even if the
genetic variation of the original founders was representative of the parental population
though reduced in frequency, drift will encourage a change in allele frequencies. Hence,
one of the main consequences of genetic isolation is population subdivision, or the
emergence of a population that exhibits partial genetic differentiation compared to
surrounding populations. On average, members of the isolate tend to be more closely
related than members of adjacent populations. However, common marker alleles and
common haplotypes are less likely to perish completely – unless the original number of
founders was miniscule (Peltonen et al., 2000). Finland for example, has for many
centuries remained somewhat isolated from it’s European neighbors geographically but
even more so culturally as it’s main language, Finnish, a language of Finno-Ugric
descent, whose closest linguistic brethren is Magyar and Estonian, is unintelligible to the
majority of its neighbors (Kere, 2001). The genetic isolation of Finland has allowed a
change in disease allele frequency within the population compared to other more
heterogeneous European populations – a phenomenon labeled the “Finnish Disease
Heritage.” Around 40 disease phenotypes have been found to more be common in
Finland than other parts of the world. Diseases of ophthalmic importance include Usher
Syndrome, Cohen Syndrome, cornea plana, x-linked choroideremia and retinoschisis.
However, other genetic conditions common in populations of European descent such as
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cystic fibrosis, are rare in Finland. Some common alleles however, have similar
frequencies to other European populations (Kere, 2001).
This reduced genetic diversity caused by an the initial founder effect and subsequently,
some alleles driven to fixation and others to extinction by genetic drift, and increased
levels of inbreeding has obvious advantages for the mapping of Mendelian diseases, and
several isolates have been used successfully to identify genes associated with a number
of conditions of ophthalmic importance. These include Cohen Syndrome (Falk et al.,
2004), complete achromatopsia (Sundin et al., 2000, Rojas et al., 2002), cone rod
dystrophies (Sankila et al., 2000, Jalkanen et al., 2006) Usher Syndrome (Ebermann et
al., 2007, Ouyang et al., 2003, Ness et al., 2003), and retinitis pigmentosa (Koenekoop et
al., 2003, van Soest et al., 1994).
Reduced genetic heterogeneity also has advantages in complex disease mapping, One of
the problems that can add further background “noise”, obfuscate the association signal
and hence hamper the mapping of complex disease genes is the locus and allelic
heterogeneity associated with common complex diseases (Kristiansson et al., 2008).
Even within an isolate, it is likely that genetic heterogeneity exists. However it is
reasonable to assume that compared to more heterogeneous populations, the number of
susceptibility alleles will be much reduced.
The basis for genome-wide association studies is the “common disease common variant
hypothesis” which suggests that the genetic component of common diseases is partly
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due to allelic variants that are relatively frequent (1-5%) in the population (Manolio et
al., 2009). Despite the considerable success of GWAS in identifying a number of
susceptibility alleles associated with common diseases over the past few years (Maller
et al., 2006), for many common diseases only a small proportion of heritability has been
identified. For example, the estimated heritability for human height is around 80% and
although around 40 susceptibility loci have been identified, this only accounts for about
5% of observed phenotypic variance (Manolio et al., 2009). There are several possible
explanations for this “missing heritability”. The idea pertinent to this discussion is the
possibility that rare variants, risk alleles found at low frequency (less than 1%) in the
population, may play an important role in common disease susceptibility. The founder
effect, bottlenecks and drift may enrich the frequency of certain rare alleles in
population isolates, thus increasing their probability of detection in genome-wide studies
(Kristiansson et al., 2008).
In addition to reduced genetic diversity, several other characteristics of isolates make
them attractive study populations in complex disease mapping. In monogenic conditions,
the genetic component plays the predominant role in disease aetiology. In common
complex disorders, in addition to genetic factors, environmental factors are important, so
reducing environmental variance will aid disease gene mapping. In isolate populations
environmental influences tend to be more homogenous (Peltonen et al., 2000). Isolates
often have shared religious/cultural beliefs, a more homogenous diet and lifestyle
compared to more urbanized, admixed societies. Demographic records and genealogy
information are sometimes more complete and accessible and it is possible to find large
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extended pedigrees. For example, since it’s initial founding in the early 19th century,
detailed demographic records have been kept in Tristan de Cunha (Roberts, 1971). Many
Nordic countries such as Iceland and Finland have extensive registries of marriages,
births, migration and deaths dating back several centuries (Peltonen et al., 2000).
Furthermore, levels of linkage disequilibrium are also purported to be extended over
larger regions in certain “younger” isolate populations, which would be advantageous in
complex disease mapping efforts (Service et al., 2006). Isolates such as Finland and
Sardinia for example, require around 30% less markers to attain genome-wide coverage
than more heterogeneous populations.
Isolate populations have been used to identify a number of putative loci and a number of
disease genes associated with common diseases and quantitative traits such as asthma
(Ober et al., 1998, Ober et al., 2000, Laitinen et al., 2001), schizophrenia (Moises et al.,
1995), diabetes and body mass index (Hanson et al., 1998), blood pressure (Perola et al.,
2000), ischemic heart disease (Pastinen et al., 1998), familial hyperlipidemia (Pajukanta
et al., 1999) and multiple sclerosis (Kuokkanen et al., 1997, Kuokkanen et al., 1996). Of
notable ophthalmic importance is the identification of LOXL 1 (lysyl oxidase-like 1)
associated with exfoliative glaucoma in Iceland (Thorleifsson et al., 2007, Marx, 2007).
Isolates have also contributed to our understanding of the genetics of age-related
macular degeneration (Magnusson et al., 2006, Edwards et al., 2005), refractive error
(Stambolian et al., 2004, Ibay et al., 2004, Stambolian et al., 2006, Wojciechowski et al.,
2009, Biino et al., 2005) and glaucoma (Gencik et al., 1982, Plasilova et al., 1998,
Morissette et al., 1995, Faucher et al., 2002, Baird et al., 2003, Baird et al., 2005a, Baird
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et al., 2005b, Charlesworth et al., 2005, Craig et al., 2001).We planned to use the
Scottish population isolate of Orkney to locate genes associated with quantitative traits
related to primary open angle glaucoma.
3.3.2 THE SCOTTISH POPULATION ISOLATE OF ORKNEY
The Orkneys consist of an archipelago of islands off the north coast of Scotland.
Separated from mainland Scotland by geography and for a few centuries, by history,
Orkney shares many of the hallmarks of an isolate population such as Iceland or Finland.
Section 3.3.2.1 provides a more detailed description of Orkney’s geography and history,
followed by a discussion of its genetic heritage. Today the islands of Orkney are
connected to mainland Scotland, and to each other by a series of ferry and air links.
However, even though travel to the archipelago and between the islands has improved
considerably over time, sea and weather conditions are often inhospitable. Coupled with
Orkney’s distance from much of Scotland and the rest of Europe means that even today,
Orkney remains somewhat isolated from her mainland brethren, and would have been
considerably more inaccessible in the past. In addition to this geographical isolation,
there is evidence that endogamy was common during the 19th and 20th centuries (Boyce
et al., 1973) Emigration and reduced fertility has caused a steep decline in the
archipelagos’ population, with the population decreasing almost fourfold in size from a
high in the 1860s to an all time low in 2001 (McQuillan et al., 2008, McQuillan, 2009).
This reduced population size coupled with endogamy, means many marriages that have
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occurred, have been between related individuals. The culmination of these factors means
that Orkney will have reduced genetic diversity compared to more heterogeneous, urban
populations.
Despite the high levels of emigration, it is not however uncommon to still find
generations of the same family remaining in Orkney (McQuillan, 2009). Large pedigrees
means that linkage methods as well as association strategies can be used during genetic
analysis. This is further facilitated by the detailed demographic and genealogical
information available about Orkney’s inhabitants which allows pedigrees of current
volunteers to be traced back for several generations (Roberts and Roberts, 1983).
When this study was being designed, a cross-sectional family based genetic study, the
Orcades Study, had already been established in Orkney by Dr. James Flett Wilson and
his team at the MRC Human Genetics Unit and the University of Edinburgh. The aim of
the Orcades Study at that time was to map disease genes associated with quantitative
anthropometric traits as well as QTs related to cardiovascular disease and some other
biochemical parameters. Dr. Wilson’s long-term plan was to extend phenotyping to
include other quantitative traits such as bone mineral density. Rather than establishing a
new study in a new isolate, our plan was to utilize infrastructure and volunteers already
available from the existing Orcades Study and eventually, genome-wide data as well, to
investigate quantitative traits associated with primary open angle glaucoma.
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3.3.2.1 A BRIEF HISTORY OF ORKNEY
About 10 miles off the north coast of Caithness, lies the archipelago known as the
Northern Isles of Orkney. Composed of around 70 small islands and skerries, the islands
are divided into three main groups – the North Isles, the South Isles and Hrossey, which
is also known as the Mainland (see figure 3.1). The number of islands that are populated
has declined over the past century and only around quarter of these islands are now
inhabited (Boyce et al., 1973). The capital of Orkney is Kirkwall, and along with
Stromness, the only other major town in Orkney. Both are situated on Hrossey. The
main islands that lie north of Kirkwall, known as the North Isles, are Shapinsay,
Stronsay, Sanday, Eday, Egilsy, Westray, Papa Westray, Rousay, Wyre, Gairsay and
North Ronaldsay. South of Kirkwall lie Flotta, Hoy, Graemsay, South Ronaldsay and
Burray. The latter two islands are connected to the East Mainland by a series of barriers
known as the Churchill Barriers, erected during the second World War to guard the
natural harbor of Scapa Flow from enemy invasion.
The history of Orkney has been discussed extensively elsewhere (Davis, 2007, Omand,
2003, Schei, 2007, Thomson, 2008, Berry, 1986) and will be reviewed only briefly here.
The history of the people of Orkney can be divided into three main periods. The first
phase dates back to pre-history, from Mesolithic times until Norse invaders colonized
Orkney when the second period begins. The final phase of Orcadian history commences
when Scottish rule dawns in Orkney in the 1400s. These periods are discussed in more
detail below.
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FIGURE 3.1: THE ARCHIPELAGO OF ORKNEY
(SOURCE: COURTESY OF VISITORKNEY, KIRKWALL, ORKNEY, KW15 1GU)
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3.3.2.1.1 PRE-HISTORIC ORKNEY
Evidence for the occupation of Orkney extends to pre-history. (Davis, 2007, Omand,
2003, Thomson, 2008, Berry, 1986, Schei, 2007) However, archaeological evidence
regarding the inhabitants of Orkney is scant in the time preceding the Neolithic period.
The early inhabitants of Orkney were probably hunter-gathers whose existence is
difficult to prove as they left little tangible evidence except for a few stone flakes and
charred remains (Towrie, 2007). A burnt hazel nut discovered during excavations at a
Bronze Age burial mound in Tankerness in 2007 was carbon dated to being between
6820 to 6660BC suggesting that Orkney may have been inhabited as far back as
7000BC. Despite the lack of remains preceding the Neolithic period, the assortment of
structures from this era in Orkney is unparalleled in the United Kingdom.
The Neolithic Age in Orkney is believed to have commenced around 4000BC and
continued for a period of around 2000 years (Schei, 2007). By this period, it is likely that
the nomadic tribes of hunter gatherers had gradually developed into a more agricultural
society requiring permanent dwellings. The red sandstone ubiquitous in Orkney would
have been easy to fashion with stone age tools and proved to be a common building
material at this time. One of the earliest settlements on record in Orkney as well as
northern Europe is the Knap of Howar, which stands on the island of Papa Westray. This
structure has been carbon dated to around 3600 to 3100BC. The sophisticated design of
the house has suggested that there must have been earlier less developed farms which
are yet to be discovered. Other famous Neolithic structures providing further insight into
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pre-historic Orkney include Skara Brae (figure 3.2A), a cluster of stone houses
unearthed around 1850 from their hiding place by storms moving the sand dunes that
had cocooned them for several thousand years (Bailey, 2007, Schei, 2007); a number of
burial tombs including Maeshowe on the Orkney Mainland and Midhowe on the island
of Rousay (figure 3.2B); the henge monuments of Brodgar and Stenness (figures 3.2C
and 3.2D) (Bailey, 2007, Schei, 2007).
FIGURE 3.2A: SKARA BRAE
122
FIGURE 3.2B: MAESHOWE
FIGURE 3.2C: STANDING STONES OF STENNESS
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FIGURE 3.2D: RING OF BRODGAR
With the dawn of the Bronze Age, around 2000BC, there is evidence that there may
have been a change in living and burial practices (Davis, 2007, Schei, 2007, Thomson,
2008). Though bronze artifacts have been discovered in Orkney, there is little proof of
mining activity or the manufacture of such goods. Living and burial practices changed,
away from communal living and burial such as seen in Skara Brae and Maeshowe, to
more scattered communities and solitary cists. From around 1500BC, significant
climatic changes are believed to have occurred. Temperatures declined and rainfall
increased. The island may have become more isolated due to the increasingly
inhospitable conditions. Great changes also occurred in the Iron Age of Orkney (circa
600BC – 715AD) that followed. Further impressive feats of engineering in the form of
roundhouses and broch building occurred.
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It was during this period that the first reference to Orkney is made in written work. The
Greek geographer and explorer Pytheas from the area which is now modern Marseille,
claimed to have circumnavigated the British Isles (c.325 BC) (Thomson, 2008). In his
writing he allegedly made reference to an area of northern Britain he referred to as the
“Orkas”. It is also during this period, that the involvement of what is now considered to
be a confederation of tribes, known as the Picts, with Orkney is thought to have
occurred. The exact origin of the Picts remains unclear. The earliest recorded use of the
name is in the year 296 in the works of Eumenius, pangyrist to Flavius Valerius
Constantius (Ferguson, 1911). The world is believed to mean the “painted ones” from
the Latin verb “to paint” (Davis, 2007). From 297 AD onwards, the Picts are referred to
with increasing regularity in Roman records (Fisher, 1999). Some sources recognize two
phases of Pictish culture (Davis, 2007). The first is an early pre-Celtic phase until
around 100 AD witnessed by Romans such as the General, Agricola, around 82 or 83
AD. Agricola is known to have circumnavigated the British Isles, visiting Orkney at the
time, though there are no records of Roman impressions of the archipelago. His son-in-
law Tacitus recorded that Orkney was not only discovered but also conquered by the
Romans (Thomson, 2008). Similar claims have been made in other classical writings. In
43AD, an Orcadian Chief allegedly surrendered to the emperor Claudius (Thomson,
2008). There is little other evidence to support these assertions, and it is possible these
claims may have been greatly exaggerated to suggest that the Roman Empire stretched
into the far reaches of Britannia.
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83 AD witnessed the Roman slaughter of around 10,000 Picts as Rome attempted to
secure more of Scotland. The battle site is believed to be somewhere within current
Abderdeenshire and is recorded by the Romans as Mons Graupius. Despite this early
victory, Rome never managed to crush the Picts and following a succession of smaller
skirmishes, retired behind Hadrians’ and Antoine’s Walls to defend the northern frontier.
It is possible that the losses incurred by the Picts during this time, both in life and in
social stability, paved the way for the arrival and integration of the Celts (Davis, 2007).
The second phase of Pictish culture in Orkney is characterized by Picts who embraced a
Celtic language and way of life. The Picts of Orkney left behind a heritage of carved
“symbol stones” , Celtic crosses, and some sources attribute broch building to the Picts
(Davis, 2007) Another possible remnant of Gaelic influence is the continuing presence
of place names such as “Pickaquoy”, perhaps referring to the Picts of antiquity
(Thomson, 2008). There are few written records during this time, but occasionally the
archipelago is mentioned. During the visit of St. Columba of Iona to the Highlands, the
presence of an Orcadian King in the court of Bridei mac Malelchon or Maelchu (King of
the Picts c.555 to 585 AD) is mentioned (Ritchie, 2003, Schei, 2007). In various annals
several expeditions against Orkney have been recorded – Aedan mac Gabrain (King of
Argyll 574 to 608 AD), Bridei mac Bile (King of the Picts 872 to 693 AD) and in
709AD another Irish annal records a further war with the Orkneys. This period is
thought to have forged closer links between the archipelago and the mainland and
strengthened the Christian presence on the islands. By the advent of The Norse Period
(c.780-1500 AD), Orkney was considered a Christian nation with an influential and
wealthy church.
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3.3.2.1.2 ORKNEY AND THE NORSE
The Viking Age dawned for most of Britain with the ravaging of Lindisfarne (793AD)
followed by a succession of attacks on other British lands (Schei, 2007). The presence of
the Norse can be traced by archaeological remains further in Orkney, to around 780AD.
Whether the Norse established themselves in Orkney via mass genocide or by more
peaceful means is still a matter of considerable debate. By around the 9th century,
Orkney was an established Norse earldom, and the subsequent 300 years of Norse
history (or legend) is covered in the Orkneyinga Saga, the saga of the Orkney Earls, a
work believed to be written sometime around the 12th century by an unknown Icelander
(Thomson, 2008). Following the battle of Largs in 1263, Norse influence in Scotland,
including Orkney began to wane. In the 14th century Denmark, Norway and Sweden
were united under a single monarchy in accordance with the Kalmar Treaty. The
Earldom of Orkney officially remained under Nordic rule until 1468 when Princess
Margrete of Denmark, the daughter of King Christian the I, married King James the III.
As a part of the dowry, cash-strapped Christian, pledged Orkney and subsequently
Shetland to James. By the 1470s, Orkney had been annexed to the Scottish Crown.
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3.3.2.1.3 ORKNEY UNDER SCOTTISH RULE
By this period Viking dominance of the seas had been replaced by British mercantile
and fishing fleets. Scots moved north, married with local Orcadians and gradually
integrated into the religious, political and economic fabric of Orkney. Use of the Norn
language spoken by the locals gradually declined. This was a period marred by rebellion
(1528), poor leadership and two periods of famine (1631,1696) when thousands perished
(Thomson, 2008). During this period, the bedraggled remnants of the Spanish Armada
also floundered in the tempestuous seas off the North Coast. The survivors of the El
Gran Grifon were shipwrecked on the Fair Isle. Other Spanish sailors found refuge and
some subsequently married and settled in Westray. The descendents of these unions
were named the “Dons” of Westray (Thomson, 2008, Anderson, 1988). On May the 1st
1707, the Act of Union united the Kingdoms of Scotland and England into the single
Kingdom of Great Britain.
By the 1700s Orcadian farming was in much need of improvement. Orkney, for much of
it’s history, had initially been a farming community with subsequent forays into the
fishing industry. The methods of farming being implemented were archaic, inefficient
and impractical. Methods of “best practice” which were known at the time which would
have improved yield were not implemented (Thomson, 2008). With the dawn of the 18th
century other opportunities for employment arose. From the early 1700s, The Hudson
Bay Company ships, bound to northern Canada, would sojourn in Stromness to hire
much of the company’s labor force. By the late 1770s, a large majority of employees in
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the lower echelons of the company were Orcadian. Even the minimum monetary reward
of joining the company was far greater than that of a farm servant in Orkney, so the
appeal of a few years labor in Canada are understandable. Many Oracdians settled in
Canada, sometimes with Native American wives. Some are said to have returned to
Orkney accompanied by their wives and children, possibly introducing Cree connections
into the Orcadian gene pool (Berry, 1986). Other vessels such as whaling fleets also
recruited at Orcadian ports and prompted the emigration of young men from the islands.
Further losses of men occurred during the Napoleonic Wars. Press gang activity was rife
during this time and it is believed that around 2000 Orcadian men, about a 12th of the
population at the time, served in the Navy. By the late 18th century, there was a boom in
the kelp industry but by 1830, prices had dropped dramatically. This had serious
economic consequences for much of Orkney and especially some islands of the
archipelago such as North Ronaldsay which had gradually concentrated on the kelp
industry at the detriment of farming. With the economic collapse of the kelp industry,
interest was rekindled in farming. Once farming was revived with new knowledge and
methods being integrated, prosperity blessed the islands once more and Orkney
managed to retain more of her inhabitants.
The 20th century brought World War I and II and despite it’s position in the far north of
Britain, Orkney did not remain untainted by these wars (Schei, 2007, Thomson, 2008).
The presence of a natural harbor, Scapa Flow, and its position in the North Sea, made
Orkney a good of choice of navel base to protect northern interests in both World Wars.
Life on the islands changed considerably during these times. With the influx of armed
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forces and detention of prisoners of war on the islands, the population sometimes
swelled to quadruple its norm. Various defensive structures were built, some which
remain today. The landscape of Orkney was further changed when in the 1970s Orkney
became involved in North Sea Oil industry, and built an oil terminal on the island of
Flotta. Over the last few decades, the Flotta oil terminal has offered essential
employment to the area and revenues from oil have helped bolster Orkney’s economy.
Though crude oil shipments from the North Sea to the terminal have declined over the
last few years, the energy industry continues to contribute substantially to modern day
Orkney.
3.3.2.1.4 ORKNEY TODAY
Orkney as it stands today, consists of a population of around 20,000 (Anon, 2006b,
Anon, 2008). There has been a slight increase in the population since the last census in
2001 and the considerable decline in Orkney’s population that had been predicted in the
latter half of the 20th century has not occurred because of increased migration to the
archipelago. Since the expansion of the European Community in 2004, there has been a
substantial immigration of non-Orcadian individuals to the islands, with a relatively well
balanced age profile. However, depopulation, especially of the smaller islands, remains a
significant problem which public bodies are keen to address. There is a changing age
profile in the archipelago, with a loss of young people between the ages of 16 and 24 to
higher education and a relative increase in the population above the age of 55. Orkney
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has one of the lowest average unemployment rates in Scotland (below 2%), with
Orkney’s economic activity rate in 2006 being around 4% above the national average
(Anon, 2008). In 2003, 32.5% of the Orcadian work force were employed by the “health,
education and public administration” sectors (Anon, 2006b). A further 25.3% were
employed by “distribution, hotels and restaurants”, construction employed around 9.6%,
with “transport and communications” employing a further 8.4%. Though once farming
and fishing were the mainstay of employment in Orkney, in 2003, the agriculture and
fisheries sectors together only employed 7.2% of the total workforce.
Kirkwall is the capital of Orkney and can be found on the north coast of the Orkney
mainland (see figures 3.1 and 3.3). The origins of Kirkwall can be traced back to Norse
times, and from a single street in medieval times, Kirkwall has expanded to become the
largest town and commercial hub of Orkney (Bailey, 2007). Kirkwall today is an
eclectic mix of the old and new. The magnificent 12th century red sandstone edifice that
is St.Magnus Cathedral, sharing its space with more contemporary architecture.
Kirkwall now boasts a busy harbor and a thriving tourist industry as this once remote
port is now easily accessible by both land and sea, with flights from all major Scottish
Airports (Aberdeen, Edinburgh and Glasgow) as well as ferries from mainland Scotland
and Shetland. The other Orcadian islands are linked to the Mainland of Orkney by ferry
and flight services. It is in the burgh Kirkwall, the centre of Orkney’s commerce and
transport links, we chose as the base for the Orcades Eye Project along with other arms
of the Orcades Study.
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FIGURE 3.3: KIRKWALL, ORKNEY
(SOURCE: COURTESY OF VISITORKNEY, KIRKWALL, ORKNEY, KW15 1GU)
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3.4 THE ORCADES STUDY
3.4.1 OVERVIEW OF THE ORCADES STUDY
The Orkney Complex Disease Study (Orcades) is an ongoing, family based, cross
sectional study which was established by Dr. James Flett Wilson (JFW) and colleagues,
of the University of Edinburgh and the MRC Human Genetics Unit to study genetic
factors associated with cardiovascular diseases, a variety of anthropometric traits such as
height and weight as well as a number of biochemical and hematological parameters in
the Scottish population isolate of Orkney. Dr. Wilson’s long term plan was to extend
phenotyping to include a variety of other quantitative traits such as bone mineral density
and intelligence quotient. The Orcades Study is now one of five population isolates of
the European Special Populations Research Network (EUROSPAN), the aims and
objectives of which are described on their homepage at the following URL:
http://homepages.ed.ac.uk/s0565445/index.html. Other participants include CROAS, the
Croatian Study, (Campbell et al., 2007, MICRO isolates in South Tyrol Study {Pattaro,
2007 #3090), the North Sweden Population Health Study (Johansson et al., 2009) and
the Erasmus Rucphen Family Study (Pardo et al., 2005).
By 2005, the Orcades Study had recruited around 1000 volunteers for the measurement
of the above quantitative traits. To enter the study, participants had to be over 18, with at
least one grandparent from the north isles of Orkney. The Orcades Study at the time was
housed in a van which acted as mobile unit, traversing the islands. A number of nursing
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staff lead data collection and the collection of blood for genotyping, the analysis of
various hematological and biochemical parameters, as well as storage for the future. By
2006, it was ready for a more permanent residence, and recruitment was to be extended
to include individuals with a grandparent from the West Mainland as well as the North
Isles.
3.4.2 FUNDING
Funding was required for the purchase of ophthalmic equipment to measure QTs, a
salary for VKKK, travel, computer equipment and also static premises for the eye study
as well as other arms of the Orcades Study. The existing Orcades Study was to provide
clerical and administrative support, genetic data and nursing staff in the field to meet the
University health and safety requirements. A research proposal was jointly written by
VKKK and Alan Wright (AFW) with contributions regarding Orkney and Orcades
Study provided by JFW. Funding was sought from a variety of sources (the Chief
Scientist’s Office of the Scottish Executive, Fight for Sight, the International Glaucoma
Association, the Medical Research Council, The Scottish Hospitals Endowment
Research Trust and the Ulverscroft Foundation). £30,000 in the form of a clinical
fellowship was awarded to VKKK from the International Glaucoma Association
(Ashford, Kent, TN24 8DH, http://www.glaucoma-association.com/) in September
2005. £250,000 was secured from the Chief Scientist’s Office of the Scottish Executive
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in the form of a project grant in June 2006. A final £20,000 was acquired by AFW from
the MRC Human Genetics Unit towards capital equipment.
3.4.3 ETHICAL APPROVAL
Ethical approval had already been secured from the NHS Orkney Local Research Ethics
Committee (LREC) by JFW in 2001 for the Orcades Study. This included approval for
some ocular procedures (the measurement of refraction, intra-ocular pressure and ocular
dimensions by ultrasound) but not some of the others we planned (visual acuity, optical
coherence tomography, confocal scanning ophthalmoscopy and the examination of the
eye using a slit lamp). We therefore sought an amendment to the NHS Orkney LREC
approval to include these traits. Ethical approval was granted before the study
commenced in 2007.
3.4.4 PREMISES
Once funding was secured, premises were sought on the main island of Orkney, the
Mainland. At the time (July 2006), only one suitable property was available in Kirkwall.
The property had previously been owned by the local Orkney newspaper, the Orcadian,
and was situated on one of the main shopping streets of Orkney, Victoria Street (see map
of Kirkwall, figure 3.3).
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The location was ideal – in the centre of Orkney’s capital Kirkwall on one of the main
streets, adjacent a historic landmark (the St.Magnus Cathedral) and near the hub of
Orkney’s public transport links. Unfortunately the premises had been unused for over a
decade and would require complete renovation (see figures 3.4A-C below).
FIGURE 3.4A: EXTERIOR OF PREMISES
*
FIGURE 3.4B: INTERIOR OF PREMISES (RECEPTION)
* Source: Photograph from the property schedule of Drever and Heddle, Estate Agents, Kirkwall, Orkney
2006.
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FIGURE 3.4C: INTERIOR OF PREMISES (KITCHEN)
Negotiations with the owner regarding rent and renovations followed by the actual
renovations occurred from the summer of 2006 until the spring of 2007. The plan was to
convert the property into a custom made research centre which housed the eye project as
well other arms of the Orcades Study. The negotiations were protracted and the
renovations delayed for a variety reasons such as inclement weather so the start of the
eye project, initially planned to be in September 2006, was delayed by several months.
By April 2007, refurbishment was complete and it was finally possible for the
equipment to be moved in and the eye project commenced. Figures 3.5A-C show the
newly refurbished Orcades Study Centre and some of the common areas. Figures 3.5D-F
shows the layout and the interior of the Orcades Eye Room.
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FIGURE 3.5A: THE ORCADES STUDY CENTRE
FIGURE 3.5B: WAITING AREA
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FIGURE 3.5D: LAYOUT OF EYE ROOM
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FIGURE 3.5E: ORCADES EYE ROOM







Whilst the premises were being renovated, equipment was procured in accordance with
the procurement protocols of the University of Edinburgh and the MRC Human
Genetics Unit, Edinburgh with the aid of Mr. Andy Kordiak, Equipment Purchasing
Manager of the College of Medicine and Veterinary Medicine of the University of
Edinburgh. Specifically the following equipment was procured for the measurement of
ocular biometric traits:
 Heidelberg Advanced IOPac Pachymeter (Heidelberg Engineering, Germany,
supplier Haag Streit Ltd, Essex CM20 2TT) - for the measurement of central
corneal thickness
 Keeler Slit lamp (Keeler Ophthalmic Instruments, Windsor SL4 4AA) - for the
qualitative assessment of the eye and measurement of intraocular pressure
 Canon-RF 10 Autorefractor (supplier Haag-Streit Ltd, Essex CM20 2TT)
– for the measurement of refraction
 Carl Zeiss IOLmaster (Carl Zeiss Ltd, Hertfordshire AL7 1JQ) - for the
measurement of axial length
 Heidelberg Retinal Tomograph (Heidelberg Engineering, Germany Haag Streit
Ltd, Essex CM20 2TT) - for the measurement of optic nerve parameters.
In brief, a report of equipment required and reasons for choice of equipment was drawn
up and tenders sought from at least three vendors (Keeler Ophthalmic Instruments,
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Windsor SL4 4AA, Carl Zeiss Ltd, Hertfordshire AL7 1JQ, Haag Streit Ltd, Essex
CM20 2TT). The offers needed to meet delivery and installations dates (initially
believed to be September 2006), maintenance and call out requirements and vendors had
to be willing to accept the University of Edinburgh’s terms and conditions for supply.
Once offers had been obtained from the vendors, a final equipment selection was made
and purchases arranged. All furniture and equipment except for the Carl Zeiss
IOLmaster and the autorefractor were purchased via the University of Edinburgh. The
IOLmaster and autorefractor were purchased through the MRC Human Genetics Unit
with the aid of Mr. Eric Thomson. The documents and reports written for the
procurement of equipment have not been included in the body of this thesis due to their
bulk but are available for perusal.
3.4.6 SUBJECTS
By the time the Orcades Eye Project was being established, the overall Orcades Study
had already recruited around 1000 participants for the Orcades Study as a whole. Entry
criteria for the study at the time, was at least one grandparent from the North Isles of
Orkney. This was subsequently extended to include individuals with one grandparent
from the West Mainland. Many of these volunteers had already been evaluated for
various anthropometric and cardiovascular traits and had blood taken for genotyping and
the measurement of various biochemical parameters. The plan was for these volunteers
to return for the measurement of ocular traits as well as other QTs such as bone mineral
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density. The number of individuals required for a QTL study is difficult to estimate as
statistical power depends on family structure of the sample which was yet to be
described and also the size of genetic effects. Studies using 1000-2000 volunteers from
isolates such as Finland and Iceland have effectively mapped diseases associated with
QTLs such as schizophrenia and stroke. Hence we initially aimed to collect data on
ocular biometric traits from at least 1000 volunteers from the population isolate of
Orkney.
Clerical and administrative support was provided by the overall Orcades Study, and was
headed by Ms. Kay Lindsay at the Department of Public Health Sciences of the
University of Edinburgh. Invitations to the eye project were sent out centrally with a
description of the project (see Participant Information Sheet for ORCADES Eye Study,
appendix 1), a copy of the consent form (see appendix 2). The invitation provided
information about the eye project and other arms of the Orcades study as appropriate.
Clinics were subsequently set up once replies were returned. Initially individuals who
had been the first to participate in the Orcades Study were sent invitations. The reason
for this was two-fold. First, these early individuals were the ones most likely to have
their genotyping completed during the study period. Second, these individuals were
chosen to prevent “volunteer fatigue” as at least a year would have passed since they
were last asked to participate in the Orcades Study. Each volunteer was assigned a
unique identification number centrally, with the access codes known only to a very few
individuals, so data collection and storage and analysis was anonymized. Along with
other arms of the Orcades Study, the Eye project was advertised by word of mouth and
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through the local media (see figure 3.6). So as well as using previously recruited
volunteers, new participants were also actively sought for the project.
FIGURE 3.6: ARTICLES ABOUT THE ORCADES PROJECT IN THE LOCAL PRESS,
ORKNEY TODAY AND THE ORCADIAN
Volunteers who agreed to participate were assigned an appointment at the eye clinic.
Initially these lasted around an hour and subsequently, this time was decreased to 45
minutes. At an eye appointment, each volunteer was greeted, the overall eye project and
aims of the project as well as the examination process explained and informed consent
obtained. Details of the examination protocol are discussed in subsequent sections.
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3.4.7 GENOTYPING
All Orcades participants were genotyped using the Illumina Infinitum Hap300 platform
(Illumina, San Diego). Data cleaning and quality control procedures were carried out by
Dr. Veronique Vitart (MRC Human Genetic Unit, Edinburgh) and Dr. Ruth McQuillan
(Department of Public Health Sciences, University of Edinburgh). Participants with call
rates of less than 95%, SNPs with more than 10% missing, and SNPs failing a Hardy
Weinberg threshold of p=0.0001 were eliminated. IBD sharing between all first and
second degree relatives was assessed using the Genome program in PLINK (Purcell et
al., 2007) and individuals falling outside expected ranges were removed from the study.
Sex checking was performed using PLINK and individuals with discordant pedigree and
genomic data were removed. On completion of data cleaning and quality control
procedures, 186 individuals out of the 257 examined were available for genetic analysis.
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CHAPTER 4
DATA COLLECTION, MANAGEMENT AND ANALYSIS
4.1 DATA COLLECTION
Data collection occurred at the Oracdes Eye Clinic at the Orcades Centre on Victoria
Street, Kirkwall, Orkney (see figure 3.5A-F). Letters of invitations to join the eye project
were sent by administrative staff at the University of Edinburgh to volunteers already
participating in the Orcades study and to new volunteers who had expressed an interest
in the project. Volunteers who agreed to participate were assigned an appointment at the
eye clinic. Initially these lasted around an hour and subsequently, this time was
decreased to 45 minutes. At an eye appointment, each volunteer was greeted, the overall
eye project and aims of the project as well as the examination process explained and
informed consent obtained. Details of the examination protocol are discussed in
subsequent sections.











 Central corneal thickness
 Intra-ocular pressure
 Optic nerve head parameters
 Qualitative slit lamp examination/ +/- eye movements depending on history.
All participants were asked a brief ocular and medical history (a detailed health and
lifestyle questionnaire had already been taken for the majority of volunteers) covering
current ocular/medical conditions, past medical and ocular history, drug and family
history, and a brief social history to highlight tobacco and alcohol use. The reason for
the collection of this information is two-fold. Certain medical conditons such as diabetes
and hypertension, certain drugs such as tamoxifen, excessive tobacco and alcohol
consumption are associated with characteristic ocular changes. As each patient was
undergoing a complete qualitative slit lamp examination, if there are unusual findings
during the study, they might be explained by past medical/drug or social history. For
example, the presence of microaneurysms might be explained by an individual’s history
of diabetes. Furthermore, though this analysis will not be carried out in the initial stages
of this study, the association between systemic disease and glaucoma as well as between
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systemic disease and glaucoma related quantitative traits has been of interest for a
number of years. For example, systemic diseases thant have been associated with
primary open angle glaucoma including diabetes (Klein et al., 1994, Dielemans et al.,
1996, Mitchell et al., 1997, Bonovas et al., 2004), blood pressure (Dielemans et al.,
1995, Tielsch et al., 1995b, Bonomi et al., 2000b, Mitchell et al., 2004, Leskea et al.,
2004, Leske et al., 2007a) and cardiovascular disease (Lee et al., 2006) and thyroid
disease (Lee et al., 2004a) though these findings have not always been consistent across
large cross-sectional population based studies as well as longitudinal trials (Kahn et al.,
1977b, Leibowitz et al., 1980, Klein et al., 1993, Ponte et al., 1994, Leske et al., 1995,
Tielsch et al., 1995b, Tielsch et al., 1995c, Wang et al., 1997, Ellis et al., 2000, Drance
et al., 2001, Gordon et al., 2002, Geyer et al., 2003, Leske et al., 2003, Pache and
Flammer, 2006, Leske et al., 2007a). Glaucoma related quantitative traits such as IOP
have also been associated with systemic conditions. For example, hypertension has been
associated with increased IOP (Dielemans et al. 1995, Nemsure et al., 2003b), and
hypotension with decreased IOP (Klein et al., 2005) though again, these findings have
not been consistent across studies (Leske et al., 1995, Somner, 1996). Hence gathering
information regarding systemic disease as well as social history such as tobacco and
alcohol use will allow the exploration of associations between glaucoma related
quantitiative traits and systemic diseases such as hypertension and diabetes as well as
gene-environment interactions in the future.
Patients with a history of previous ocular trauma, surgery or ocular surface disease,
following examination by slit lamp, were excluded from the study if those factors were
148
likely to affect corneal integrity or ocular measurements. Ocular biometric traits were
measured as follows.
4.1.1 MEASUREMENT OF VISUAL ACUITY (VA)
The most commonly measured form of visual function is visual acuity
(American_Academy_of_Ophthalmology, 2002a, Elkington et al., 1999, Colenbrander,
2009). The first usage of the term is attributed to Francis Donders, a Danish professor of
physiology who had subsequently developed an interest in ophthalmology
(Colenbrander, 2009). In the mid 1800s, Donders defined visual acuity (VA) as a
subjects’ performance compared to a set standard – his concept of the “standard eye.” At
the time, the need for standardized vision charts had been recognized but the idea was
yet to be realized. “Reading samples” to test vision were available, but they were beset
with problems. Currently, the most commonly used chart for visual acuity measurement,
the Snellen chart, was developed by Donders’ colleague Herman Snellen, who Donders
had recruited to develop a vision chart that integrated his concept of visual acuity.
The Snellen Visual Acuity Chart was revolutionary in it’s time as Snellen used an
external standard to define letter (or “optotype”) size, so these charts could be
reproduced by others. Snellen’s method of assessing visual function rapidly gained
popularity. Though it has undergone several incarnations, the Snellen Visual Acuity is
still one of the most widely used methods of assessing visual acuity today. However,
Snellen’s Chart is not without it’s issues – issues which make it less suitable for research
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purposes (Hussain et al., 2006). Not all the optotypes on the chart are equally legible.
The change in optotype size is random, the progression between lines is unequal, and the
spacing between letters is not proportional which leads to increased visual crowding of
letters in the lower lines. These problems were circumvented in the vision chart
introduced by Bailey and Lovie in 1976, (Bailey and Lovie, 1976) – see figure 4.1
below.
FIGURE 4.1: KEELER 4M LOGMAR VISUAL ACUITY CHART
There are the same numbers of letters on each row, each letter is of equal legibility,
spacing between letters and between rows is in proportion to letter size. Letter size
shows geometric progression. The Bailey-Lovie chart with the sans-serif optotype
designed by Louise Sloan, was popularized by the Early Treatment of Diabetic
Retinopathy Study and has subsequently been used in many clinical studies (Ferris et al.,
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1982, ETDRS, 1991, Beck et al., 2003, Colenbrander, 2009). This was also the method
of visual function assessment we chose for this project.
VA was measured using a back lit Keeler “LogMAR 4m Test Type Chart” (Keeler,
Windsor, United Kingdom). “LogMAR” refers to the method of recording visual acuity
and is an abbreviation of the term logarithm of the “MAR” value. Louise Sloan
introduced the concept of “visual angle notation” (Colenbrander, 2009). It refers to the
ability to recognize each limb of an optotype which is 5 minutes of arc by 5 minutes of
arc. The much used Snellen notation is essentially a ratio – where the numerator
indicates the test distance and the denominator indicates at what test distance a “standard
eye” would be able to view a letter. 1 minute of arc equals a Snellen visual acuity of 6/6
(1.0), 2 minutes, 6/12 (0.5) etc. The MAR value is the reciprocal of the Snellen visual
acuity. What MAR stands for depends on the context of the assessment. It may represent
the minimum angle of resolution if used in the context of optics, or the minimal angle of
recognition in a clinical context or magnification requirement in visual rehabilitation.
LogMAR is the logarithm of the MAR value and was introduced into clinical use by
Bailey and Lovie. A visual acuity of 6/6 equals 0 in logmar notation, 6/12 is the
equivalent of 0.3. The advantage of the logMAR as opposed to MAR notation, the scale
is linear, the difference between each line of the chart being 0.1.
We used the recommended test distance of 4m in standardized illumination, following a
protocol based on the suggestions made by the International Council of Ophthalmology,
Visual Functions Committee and the Early Treatment Diabetic Retinopathy Study
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(Visual_Functions_Committee, 1984). At a test distance of 4m, reading only the top line
is scored at 1.0. Each subsequent line below is scored 0.1 less than the line above. Each
letter on each line has equal legibility and is scored 0.02 (i.e.0.1/5). Each eye was tested
in turn by covering alternate eyes with an occluder. If the top line could not be read, the
volunteer was moved to a test distance of 1m and re-tested. A value of 0.6 was added to
the score calculated as above to factor the new test distance. Volunteers able to only
count fingers or detect hand movements at 50cm were assigned a LogMar equivalent of
+2.00 and +3.00 respectively as suggested by Holladay (Holladay, 1997). Volunteers
whose visual function was either perception of light or no perception of light would have
their visual function scored as either “PL” or “NPL” respectively but no score assigned
as both categories measure the perception of a stimulus rather than acuity.
Visual acuity is not a QT and the aim of this assessment is to quickly establish the global
visual function of the eye. Some of the instruments described below require the patient
to fixate on a target, and hence a minimum level of acuity is essential.
4.1.2 MEASUREMENT OF REFRACTIVE ERROR
The eye as an optical system has been studied since the time of Ancient Greece. One of
the widely accepted theories is attributed to the Greek philosopher and physician Galen,
who suggested that a psychic spirit that flowed through the optic nerve and globe, bathed
the surroundings making matter visible (Katz and Kruger, 2009). By the 18th century,
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due to the considerable advancement in optics that occurred during the Renaissance
following the earlier work of the physicist Alhazen, the work of Johannes Kepler and
Christopher Scheiner, it was established that the formation of the ocular image worked
in a manner similar to the pinhole camera which had been described by Alhazen around
the 10th century. It was understood even at that time that the image formed was
determined by the refractive indices of the ocular media, the curvature of the various
ocular surfaces and the distance between these elements, but a thorough investigation of
these components was hampered by the lack of a techniques to measure them in vivo.
We now know that the refractive power of the eye is roughly equivalent to the
coordinated contributions of the refractive power of the cornea, the lens and the axial
length of the globe (American_Academy_of_Ophthalmology, 2002b) and a multitude of
methods are now available to measure these refractive components in vivo.
Autorefraction is an automated way of measuring the refractive state of the eye. The
Canon RF-10 is both an automatic objective refractor (Canon 2007) and was used
according to the manufacturer’s instructions to measure the overall refractive power of
the eye following VA measurements.
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FIGURE 4.2: CANON RF-10 AUTOREFRACTOR
The optic principles of the Canon Autorefractor are shown in figure 4.3 ( personal
communication from Chris van Wijk, RF 10, Product Specialist, Eye Care Systems
Department Canon Europa, Amstelveen, Netherlands). Rays of light are reflected by the
retina of the volunteer’s eye. The refractive state of the eye determines how these beams
exit. In an emmetropic eye, beams that exit will be parallel to the visual axis. In myopic
eyes rays will be convergent. Hyperopic eyes will show the converse – rays will be
divergent. Some of the exiting rays are diverted and projected onto a TV camera where
an image forms in the shape of a ring, where the sphere, cylinder and axis are calculated.
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FIGURE 4.3: PRINCIPLE OF THE CANON RF-10 AUTOREFRACTOR
(SOURCE: C VAN WIJK, CANON AS ABOVE)
In brief, the volunteer was positioned as per instruction manual with their chin against
the chin rest and the forehead on the forehead rest (see figure 4.4 below).
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FIGURE 4.4: SUBJECT POSITIONING
The height of the chin rest was adjusted so that the volunteer’s eye was in alignment
with the adjustment mark. If this alignment was done correctly, the volunteer’s eye
would appear on screen. The volunteer was then asked to look at the fixation target (a
red roof). If the pupil was off-centre, it was centered with the aid of the tracking ball and
the “start” switch pressed. The instrument would then automatically perfect the
alignment and completes the measurements. 3 sets of measurements were taken per eye
and a standard value calculated from these measurements. A print out of the
measurements was produced (see figure 4.5 below).
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FIGURE 4.5: REFRACTION RESULTS FOR CANON RF-10
The first column of results (SPH) is a measure of the spherical value, the second column
(CYL) shows a measure of the cylindrical value and the third column (AX) a measure of
the axis. The standard value, shown in square parentheses, was entered into the data
sheet. If the pupil was eccentric, the measurement was taken in manual mode. The
procedure for eccentric pupils in brief is as above, but final alignment of the pupil with
the alignment ring was done by the operator with the aid of the tracking ball.
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4.1.3 MEASUREMENT OF AXIAL LENGTH, ANTERIOR CHAMBER DEPTH, CORNEAL
CURVATURE AND WHITE-ON-WHITE
Techniques for measuring axial length (AL) have advanced considerably since the first
methods involving X-rays and head clamps were described in the mid-20th century
(Deller et al., 1947). AL is measured quite frequently in clinical practice as these
measurements are required to calculate intra-ocular lens power prior to
phacoemulsification. For many years techniques involving ultrasound were popular for
making these measurements. However, over the last few years a new technique, using
partial coherence inferometry introduced by Carl Zeiss (Carl Zeiss Meditech, Dublin)
has been gaining popularity. Axial length measurements in this project were made using
the technique employed by the Carl Zeiss IOLmaster (see figure 4.6 below).
FIGURE 4.6: CARL ZEISS IOLMASTER
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The Carl Zeiss IOLmaster utilizes a technique known as partial coherence inferometry
(also referred to optical coherence tomography/inferometry, Doppler inferometry), a
reflectance technique analogous to conventional ultrasound. Rather than measure the
velocity of ultrasonic waves, PCI measures the intensity of infrared light reflected back
from ocular tissue interfaces. The velocity of light is too high so that echo delay
techniques which measure ultrasound directly can not be employed and inferometry
must be used instead.
Though PCI is a technique similar to ultrasound, the measurements made by either
technique are not directly comparable. The dominant reflection in the acoustic axial
length originates from the inner limiting membrane (ILM) of the retina, whereas in PCI,
light is predominantly reflected from the retinal pigment epithelium. PCI has several
advantages over ultrasound. The AL measured by ultrasound is approximates to the
visual axis and extends from the anterior corneal vertex to the ILM. It is dependent on
the operator positioning the probe correctly on the cornea, perpendicular to the corneal
surface, in line with visual axis. Poor placement of the transducer, indentation of the
cornea during the procedure will lead to axial length errors. Measurements made by
optical coherence biometry are largely operator independent, non-contact with the
measurement of axial length being dependent on the subject fixing on a target. PCI has
high reproducibility (Carkeet et al., 2004, Hussin et al., 2006, Nemeth et al., 2003, Vogel
et al., 2001) and shows little inter and intra-observer variability. Because of it’s
considerable advantages, the IOLmaster has now largely supplanted the A-scan except
in the case of dense cataracts (Gale et al., 2006). The detailed use of the IOLmaster can
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be found elsewhere (Zeiss, 2005). In brief, the procedure was explained to the subject
and then the patient positioned appropriately, ensuring red alignment marks were level
with the subjects’ eyes.
FIGURE 4.7: SUBJECT POSITIONING FOR CARL ZEISS IOL MASTER
The visual axis of the subject is then checked by asking them to look straight at the
yellow fixation light. At this point six illumination LEDs are visible on the monitor.
These were centered around the pupil (see figure 4.8).
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FIGURE 4.8: INITIAL POSITIONING OF EYE
(1= FOCUSING LIGHTS, 2=CROSS HAIRS)
(SOURCE: (Zeiss, 2005)
The machine was switched to axial length measurement mode using the joystick button.
The subject was again asked to look straight ahead at the now red fixation light and open
their eyes wide as possible. The alignment of the IOLmaster was perfected so that the
reflection of the alignment light appeared as distinct as possible within the circle within
the cross hairs.
FIGURE 4.9: FINE ALIGNMENT OF EYE
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The automated measurement system was started by pressing the joystick. An average of
five measurements was taken per eye. The subject was then asked to lean back and rest
and the measurements evaluated for quality. To be accepted the measurement had to
have a valid signal curve (see figures below) a signal to noise ratio (SNR) of at least
greater than 2.0 and chosen measurements had to be within ± 0.05mm of each other as
recommended by the manufacturer. The figures below show examples of valid (figure
4.10) and poor (figure 4.11) signal curves.
FIGURE 4.10: VALID SIGNAL CURVES
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FIGURE 4.11: POOR SIGNAL CURVE
A minimum of 3 measurements per eye were required and the mean of these three
measurements used as the final axial length.
Once axial length measurements had been evaluated and stored, the subject was
repositioned and measurement of corneal curvature commenced. The eye was aligned as
above, and the subject asked to fix on the now yellow fixation light and open their eyes
as wide as possible. 6 peripheral measuring points appeared (see figure 4.12 below).
FIGURE 4.12: SETTINGS FOR KERATOMETRY
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The IOLmaster was aligned so that the points were well focused and symmetrically
placed within the circular cross hairs. The central area was not focused as it was
included in the measurement. Pressing the joystick button started the measurement
process. The software catches the image and then measures the distance between theses
spots to calculate the radius of curvature (Berry, 2010). 3 measurements per eye were
taken, and the mean of the three used as the final measurement.
Anterior chamber depth (ACD) was measured following corneal curvature. The subject
was warned that a white light would appear from the side, but to concentrate on the
yellow light in front of them. ACD in the IOLmaster was calculated as the distance from
the anterior vertex of the cornea and the anterior vertex of the lens. The white point was
focused so that it was distinct within the alignment rectangle on the screen, between the
cornea and lens, adjacent to but not within the lens. Pressing the joystick button started
the measurement process. ACD in the IOLmaster is measured using a slit illuminator
principle (Berry, 2010). A beam of light in the form of a slit is projected onto the
anterior segment at a known angle. By the position of the alignment rectangle, the
instrument knows the placement of the cornea and lens. The corneal curvature would
have been calculated previously and the depth of the anterior chamber is then computed
using trigonometry. 5 measurements are taken, and the mean used as the final value.
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FIGURE 4.13: MEASUREMENT OF ANTERIOR CHAMBER DEPTH
After measuring ACD, “white-to-white” distance, was measured. Though sometime
described as “corneal diameter” and interpreted as “anterior chamber diameter”, white-
to-white measurements represent the horizontal diameter of the iris. The subject was
asked to look at the yellow light and open their eyes as wide as possible. The IOLmaster
was adjusted so that the iris and pupil edge are in focus and the 6 focus points were
centered on the cross hairs (figure 4.14). The measurement was commenced by pressing
the joystick button. Once the measurement was taken, the markings appeared at where
the device presumed was the edge of the iris. These were checked to ensure they were
valid. The measurement was repeated three times and the mean value of the three
measurements used.
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FIGURE 4.14: MEASUREMENT OF WHITE ON WHITE
(SOURCE: CARL ZEISS 2005)
The IOLmaster automatically determines which eye is being measured. Measurements
of the other eye were taken by repeating the above procedure. A print out of the
measurements was obtained (figure 4.15). Each results sheet contained the volunteer’s
unique identifier, date of birth and examination date (these have been removed from the
figure to maintain confidentiality). Axial length values for both eyes are followed by
keratometry parameters, anterior chamber depth measures and finally white on white.
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FIGURE 4.15: RESULTS FROM THE CARL ZEISS IOLMASTER
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Autorefraction, keratometry and measurement of axial length, occurred before
pachymetry or tonometry to ensure the corneal surface was undisturbed.
4.1.4 GENERAL OCULAR EXAMINATION, MEASUREMENT OF INTRAOCULAR
PRESSURE
The slit lamp is a high powered compound binocular microscope – that is it is
constructed using several lenses, arranged to produce an image that has greater clarity
and magnification than could be achieved with a single lens – see figure 3.5e (AAO
2002). Other lenses and mirrors integrated into the instrument ensure the image
produced is upright and provide further magnification. The slit lamp is a standard
instrument in clinical practice and allows the different optically transparent layers of the
eye to be examined in great detail.
The aim of the slit lamp examination at this stage is to (1). Detect any ocular disease that
would preclude contact measurements (tonometry and pachymetry), such as severe
ocular surface disease (2). Highlight any pathology which make the volunteer’ results
inadmissible or difficult to interpret. For example, axial length measurements would be
influenced by encircling bands used for retinal detachment surgery (3). Reveal any
pathology which may influence intra ocular pressure. For example pseudoexfoliation or
pigment dispersion.
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Following slit lamp examination, and the installation of proxymetacaine and fluorescein,
IOP was measured using Goldman applanation tonometry, the principles of which were
described before. Three measurements were taken and an average of the three used
before mydriasis.
4.1.5 EVALUATION OF THE OPTIC NERVE HEAD
In glaucoma, over a third of ganglion cell fibres can be destroyed before changes can be
detected in the visual field (Harwerth et al., 1999, Kerrigan-Baumrind et al., 2000,
Quigley et al., 1989). The evaluation of cup disc ratio is one the cornerstones of
glaucoma management but subjective assessment of the optic nerve head shows high
inter and intra observer variation (Varma et al., 1992). More automated methods now
exist to analyze the optic nerve head. At the time this project was established, three main
instruments were commercially available for this purpose – a confocal scanning
ophthalmoscope, the Heidelberg Retinal Tomograph HRT (Heidelberg Engineering,
Dossenhiem, Germany), an optical coherence tomograph (Status OCT, Carl Zeiss
Meditec, UK) and a scanning laser polarimeter (GDX VCC, Carl Zeiss Meditech). These
have been compared and discussed extensively elsewhere (Kwartz et al., 2005, Zangwill
and Bowd, 2006). In brief, both OCT and GDx VCC concentrate on evaluating the
retinal nerve fibre layer, with measurements either made along a parapapillary
calculation circle in the latter or along a circle concentric with the optic disc, though not
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in the immediate parapapillary zone. Only the HRT directly evaluates the topography of
the optic nerve head.
The HRT (Heidelberg_Engineering, 2006) uses a 670nm diode laser to generate a three
dimensional topographic image of the optic nerve head using a confocal scanning
system. In brief, rather than flooding the entire specimen with light as in wide-field
microscopy, confocal imaging uses a point source of illumination, usually one or more
beams of laser, to scan across the object or specimen. Hence, only light in a narrow area
surrounding a set focal plane can be detected. A series of optical sections are acquired
for different positions along the optical axis, and these are constructed into a three
dimensional image (for a comprehensive introduction to laser confocal microscopy see
(Paddock, 2000)). Three models of HRT are available, the HRT I, II and III. At the time
the eye project was being set up, published research related to either HRT I or II and the
HRT III had only been available for commercial use for 18 months. It is in principle
similar to the earlier models but has been designed to be more user and patient friendly.
The project used the HRT III system to obtain quantitative optic nerve head parameters
such as rim area, cup area and cup volume. Measurements obtained from the HRT III
have been shown to have high degrees of reproducibility (Mikelberg et al., 1993,
Rohrschneider et al., 1994, Miglior et al., 2002) and are able to detect subtle quantitative
changes in optic nerve head morphology as well (Chauhan et al., 2000). Optic nerve
dimensions are not merely diagnostic or prognostic indicators in glaucoma management.
These parameters are true QTs and show high inter (and intra) individual variation (Sing
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et al., 2000). It is still unclear however, which factors ultimately help determine these
dimensions.
In addition, the HRT III allows the acquisition of peripapillary atrophy. As discussed in
the introduction, for the last three decades, there has been increasing amounts of
evidence to suggest that a relationship exisits between PPA and glaucoma (Primrose,
1970, Wilensky and Kolker, 1976, Nevarez et al., 1988, Buus and Anderson, 1989,
Jonas et al., 1992, Jonas and Xu, 1993, Jonas et al., 1989, Jonas and Naumann, 1989,
Araie et al., 1994, Lee et al., 2002, Xu et al., 2007c). Both PPA area and prevalence is
greater in individuals with glaucoma than without (Jonas and Naumann, 1989, Jonas et
al., 1989, Jonas et al., 1992, Jonas et.al 2002). There is also an association between
PPA, glaucomatous optic neuropathy and visual field defects (Jonas et al.,1989, Araie et
al., 1994). Progression of glaucomatous optic neuropathy have been associated with
larger areas of ß- zone PPA, as well as PPA-disc ratio (Jonas et al.,1989, Araie et al.,
1994) . These findings have not been universal (Nevarez et al.,1988, Puska et al., 1993,
Quigley et al, 1992). Biomechanial multifactorial models of glaucomatous optic
neuropathy as expounded by Belllaza et al. and discussed in chapter 1, provide a
possible explanation for this association. Data from finite element modeling has
demonstrated that peripapillary scleral thickness is one of the prinicple components that
determines the effect of IOP generated stress on optic nerve head tissue (Bellazza et al.,
2000). Decreasing wall thickness from 1.5mm to 0.5mm increased peripapillary scleral
stress from 8 to 27 fold, increasing the potential to cause tissue damage. A study by
Healey et al demonstrated that ß-PPA to have a high heritability (0.70, with a 95% CI of
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0.54-0.83) (Healey et al., 2007). Hence it’s possible association with glaucoma as well
as evidence to suggest a strong genetic component in it’s etiology, prompted us to
collect data on this quantitative trait as well as other optic nerve head parameters.
4.1.5.1 IMAGE ACQUISITION
The optic nerve head images were aquired and evaluated according to the
manufacturer’s instructions as can be found in detail elsewhere
(Heidelberg_Engineering, 2006). In brief, the volunteer’s unique identification number,
date of birth, gender and population affinity (Caucasian) was entered into the HRT III
system (figure 4.16). Their refraction was also entered as the magnification, scaling as
well as the absolute measurement results of the images are influenced by the refractive
state of the eye. Corrective astigmatic lenses were used if the volunteer’s cylinder was
greater or equal to 1.0D.
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FIGURE 4.16: HRT III DATA ENTRY WINDOW
Once the volunteer's data was entered and confirmed with an “OK”, the HRT III
automatically switched into the image acquisition mode and a live window appeared.
The volunteer was then positioned on the HRT III image acquisition module with their
forehead against the headrest and asked to look at the HRT III fixation target. The laser
beam of the acquisition module was adjusted so that beam was directly centered over the
pupil with no light visible on the iris or in the case of small pupils, an even fringe of
light framed the iris, and the camera. The camera was approximately 10 mm in front of
the eye (just out-with the range of the eye lashes).
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Once the beam was aligned, the volunteer was asked to look as their nose and then at the
flashing green fixation light. After the volunteer’s fixation was modified, the alignment
of the laser was re-checked. These actions centre the optic nerve head in the image
acquisition window. Finally, fine adjustments were made to achieve the best length of
the image quality bar and the camera lens adjusted using a “bracketing” method – the
objective was turned one position to the right or left. If the image increases in brightness,
the procedure was repeated in the same direction after a few seconds. If the image
decreases in brightness, the objective was moved in the other direction. This procedure
was repeated until the best image is obtained.
Just prior to starting image acquisition, the above procedures and the positioning of the
optic nerve head was rechecked, then the volunteer was asked to blink, keep their eyes
wide open and the acquisition button pressed to start the process. If any warning
message appeared after image acquisition, for example, due to eye movements, the
process was repeated.
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FIGURE 4.17: IMAGE OF ONH ACQUIRED BY HRTIII
Once the image was acquired (figure 4.17), the quality was checked. The quality of each
image was assessed both subjectively – a visual analysis of the RNFL and ONH for
shape, size, anatomical variation, the reflectance of a healthy RNFL, and also by
assessment of the standard deviation of the topography image as described by the
manufacturer (Heidelberg_Engineering, 2006). In brief, the standard deviation of the
topography images can be found on the top left hand corner of the Analysis Centre
window (see figure 4.17). This standard deviation represents a value calculated for each
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pixel of the topography image, then averaged over the entire image. If there is little
ocular movement during image acquisition, the images combined to form a mean image
are similar. If this is the case, there will be very high image quality accompanied by a
low standard deviation. If the standard deviation was greater than 30µm, the image
acquisition was repeated. In some volunteers, due to the presence of other factors such
as corneal scarring or lens opacities, it was not possible to improve image quality much
further even after dilating the pupil. Images which scored a standard deviation above
50µm were not used in the final analysis.
4.1.5.2 ANALYSIS OF THE OPTIC NERVE HEAD STRUCTURE USING THE
HEIDELBERG RETINAL TOMOGRAPH III
The Heidelberg Retinal Tomograph III (HRT III) allows the calculation of a series of
stereometric parameters. For these parameters to be computed, a contour line around the
ONH margin – the scleral or Elshnig’s ring - must be drawn using the software provided
as described (Heidelberg_Engineering, 2006). Briefly 5 contour points were placed
approximately equidistance around the optic disc margin, and the contour defined
(figures 4.18 and 4.19). The anatomic features of both reflectance and topography
images in pseudo-color and in black and white such as the pallor of the scleral ring, the
course of ONH blood vessels were utilized, as well as the surface height variation graphs
as described in the operating instructions manual (Heidelberg_Engineering, 2006) to
position the points and define the contour line.
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FIGURE 4.18: CONTOUR POINTS PLACED AROUND ONH MARGIN
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FIGURE 4.19: FINAL CONTOUR DEFINED
Care was made to ensure the contour line was drawn on the inside edge of the scleral
ring, crescent and/or PPA but not far within the rim tissue. The contour line was
positioned just outside the optic disc margin if there were any doubts as suggested in the
instruction manual. If any section of the optic disc was obscured, for example, the nasal
section by the presence of blood vessels, symmetry of the disc was assumed to define
the contour line to a physiological oval or circular shape.
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In order to calculate quantitative measures associated with PPA, a similar contour line
enfolding peripapillary atrophy was drawn. Contour points were placed on the inner
margin of PPA and drawn in a similar manner as described above. Images that were
considered quite complex to define were discussed with an expert (Dr. Brian Fleck,
Consultant Ophthalmologist, Princess Alexandra Eye Pavilion, Edinburgh) and a
consensus for the contour or PPA line reached.
FIGURE 4.20: ATROPHY WINDOW
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FIGURE 4.21: POINTS PLACED AROUND PPA
Once the contour line was drawn around the optic nerve head, the reflectance image was
subdivided into six regions by the software - temporal (T), temporal superior (TS), nasal
superior (NS), nasal (N), nasal inferior (NI), temporal inferior (TI). The convention for
describing angles used by HRT III software is that 0 is defined temporally in both right
and left eyes, then angular change progresses clockwise in the right eye and
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counterclockwise in the left eye so that superior sectors are on average at 90, nasal at
180 and inferior sectors at 270 regardless of the eye.
Once contour margins around the optic nerve head and PPA are drawn, the HRT III
software defines a reference plane to delineate the separation between the optic cup and
the neuron-retinal rim. The ideal theoretical position for the reference plane is beneath
the retinal nerve fibre layer, corresponding to the papillomacular bundles as this remains
relatively stable in glaucoma until the very end stages. The HRT III software attempts to
approximate this position by placing the reference plane 50µm below the average height
of the papillomacular bundle found between 350 and 356 of the ONH parallel to the
peripapillary retinal surface. The area of the image ensconced by the contour line but
above this reference place is considered to be neuro-retinal rim by the software. The area
beneath this plane is considered to enclose optic cup. Using the reference plane the
software calculates the retinal surface height which corresponds to RNFL thickness.
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FIGURE 4.22: STEREOMETRIC PARAMETERS
Twenty two optic nerve head parameters are calculated by HRTIII software which is
displayed in the stereometric parameters tab (figure 4.22). This includes areas for the
optic disc, rim and cup, a mean and a maximum cup depth, and a value for cup volume.
HRT III software also calculates a number of parameters for the PPA zone (see figure
4.29) including total area of PPA (in mm²), total angular extent, total radial extent, and
maximum distance from the contour line.
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FIGURE 4.23: PPA PARAMETERS
Though not shown on the on-screen analysis, the HRT III also calculates the following
parameters within 10 degree segments, with the first starting at 0 degrees temporal: 1.
PPA area in mm². 2. Average width of the PPA zone (in μm) and the rim area (in mm²). 
For left eyes, the 10 degree sections are arranged in an anti-clockwise manner and for
right eyes in a clockwise manner. The optic nerve and PPA parameters were exported
into a XLS file compatible with Excel (Microsoft, Redmond, WA, USA).
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4.1.6 MEASUREMENT OF CENTRAL CORNEAL THICKNESS
In ophthalmology pachymeters measure the thickness of the cornea. There are several
different methods available to measure CCT. The instrument we used in the project, the
Heidelberg Advanced IOPac hand held pachymeter, was based on an ultrasound
technique (Heidelberg Engineering 2007). See figure 4.24 below.
FIGURE 4.24: HEIDELBERG ADVANCED IOPAC PACHYMETER
In brief, CCT was determined by measuring the time taken for echoes of ultrasonic
waves to be reflected back from the anterior and posterior surfaces of the cornea. If the
velocity of the waves through the cornea is known, then thickness can be calculated as
velocity = distance/time (Airiani et al., 2006). Through CCT measurements made using
the newer technique of partial coherence inferometry (PCI) show less inter and intra
observer variability (Rainer et al., 2002, Nemeth et al., 2006), the high cost of PCI made
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this method out with the reach of this project. The probe was positioned at the centre of
the anaesthetized cornea, perpendicular to the corneal vertex, and acquisition
commenced. The average of 5 consecutive readings was used.
4.1.7 VOLUNTEER FEEDBACK
At the end of the examination period, there was time for the volunteer to ask further
questions regarding any aspect of the examination or project. If any abnormalities were
found on examination, these were discussed with the volunteer, and permission obtained
to write to their general practitioner (GP) if these finding were clinically significant.
Referrals made regarding glaucoma suspects were accompanied by a summary of the
measurements made in clinic and once a printer was installed, a copy of stereotactic
parameters from the HRT III. This was to provide the local ophthalmology team with as
much relevant information as possible to triage referrals efficiently. Subsequently,
volunteers were also provided with a copy of their auto-refraction, axial length and intra-
ocular pressure measurements (appendix 3). This was handed to them at the end of their
period of examination, and the values on the sheet explained then and there. All letters to
GPs were subsequently read and this protocol witnessed and approved by Dr. Brian
Fleck in October 2007.
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4.1.8 DATA COLLECTION INSTRUMENTS
All the data above except for the optic nerve parameters and IOLmaster measurements
were entered into a data collection form. Information for the sake of future quality
control of data such as the presence or absence of HRT/IOLmaster data and the reasons
for such an absence was also collected. An initial data collection sheet was refined and a
more efficient data collection sheet designed and used (see appendix 4) after a pilot
study of 25 volunteers. Information from the IOL master was printed out and stapled to
the back of the datasheet. The HRT III has a database which stores data generated by the
image acquisition module. This was converted into an Excel (Microsoft, Redmond, WA,
USA) format spreadsheet. Each data collection sheet was accompanied by a front sheet
(see appendix 4), which contained the volunteer’s details such as name, date of birth,
contact details, GP details. This sheet was designed to be removed from the main data
sheet at a later date to maintain anonymity of the volunteer.
The data collection form was designed to minimize free text and maximize the use of
binomial variables (yes/no) to facilitate both data entry and future analysis. To facilitate
accurate data entry, in general questions were placed on the left hand side of the page
and responses to these questions on the right, divided by a long vertical line. Similar
responses were placed along the same longitudinal. e.g. All “No’s” to questions were
placed beneath each other, so the operator’s eye would follow the data quickly and was
not forced to search a large page for information. A field for free text was included at the
end of the sheet so that any extra information could be recorded.
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4.2 DATA STORAGE
The data from the datasheet was entered into a database designed using Access 97
(Microsoft, Redmond, WA, USA).
FIGURE 4.25: ORCADES EYE DATABASE
This dated version of Access needed to be used to ensure the Eye Database was
compatible with other Orcades databases, all of which were based on Access 97. I
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designed the initial database but Ms. Lesely McGoohan, (Department of Public Health,
University of Edinburgh) kindly created and validated the first version. I subsequently
modified the initial code and refined the database, and completed the final validation.
This was done by entering 10% of the total datasheets, then double checking the entries
by hand and double checking any calculations by hand. Due to the limited capacity of
Access 97 databases, two databases had to be created – the first for the entry of all
quantitative and qualitative data except for data from the IOLmaster and HRT III, the
second for the entry of IOLmaster data. The HRT III had its’ own database.
The entry forms of the access database were designed to mirror the data sheet (including
the IOL master form), with questions and answers following the same format to assist
accurate data entry.
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FIGURE 4.26: ORCADES EYE DATABASE – VISUALLY RESEMBLES DATA COLLECTION FORM
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FIGURE 4.27: ORCADES EYE DATABASE – RESEMBLES IOLMASTER RESULTS SHEET
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Volunteers were identified by their ORCA number. Each data variable was assigned a
unique descriptive identifier. For example, the identifier for unaided visual acuity is
VA_UN. The majority of fields consisted of either of drop down menus where answers
merely need to be highlighted, or numerical fields. A minority of fields were designed
for free text.
FIGURE 4.28: ORCADES EYE DATABASE – BINARY DROP-DOWN MENU
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FIGURE 4.29: ORCADES EYE DATABASE –DROP-DOWN MENU FOR MEDICATION
Each field had a variety of checks to reduce data entry errors. For example, all date
fields had to be entered in the format dd/mm/yyyy. An error message was generated if a
date did not conform to this format, (for example, month=13), or a date out with the
specified range was entered. For example, if the date of birth of an individual was
entered as 20/05/2007 an error message would be generated. Numerical fields had range
checks and an error message was generated if the entry was out of this range. A mean
and standard deviation for each numerical value was calculated for interval data. After
all data had been entered into the database, a random 10% of the datasheets were re-
entered and compared to the initial entries to check the accuracy of data entry. No
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numerical discrepancies were found and less than 1% qualitative differences (for
example of a capital letter instead of a simple when typing in free text.).
4.3 DATA ANALYSIS
4.3.1 INTER-OBSERVER VARIATION
Inter-observer variation was completed in June 2008 with Dr. Brian Fleck, Consultant
Ophthalmologist at the Princess Alexander Eye Pavilion, Edinburgh for the quantitative
traits of central corneal thickness, axial length, corneal curvature, anterior chamber
depth, white-on-white and intraocular pressure. The measurement of refraction is
automated so there is little element of observer variation. Volunteers who lived on the
Mainland and had no problems with mobility were invited to attend inter-observer
variation clinics at the Orcades Study Centre. At the eye clinic, each volunteer had the
above QTs measured as previously described by VKKK and BWF. The order of
examiners alternated and both were blind to previous results and to each others findings.
Data was entered into a separate database and intra-class correlation coefficients
calculated using SPSS 18 (IBM, Chicago, Ill., USA). The calculation of optic nerve head
parameters is dependent on the contour line which is drawn by the examiner around the
optic nerve head or around PPA. Other parameters such as cup disc ratio are calculated
automatically but are dependent on the correct placing of this line. 10% of optic nerves
and all PPA had contour lines re-drawn by Mr. E.White, Glaucoma Research Institute,
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Moorfields Eye Hospital, City Road, London. Intra-class correlation coefficients were
calculated for disc area and PPA area. Results for inter-observar variation are presented
in chapter 5, section 5.2.
4.3.2 MULTIVARIABLE ANALYSIS
Descriptive statistics and multiple regression to investigate the relationship between the
different variables was carried out using Minitab 14 (Minitab Inc., State College, PA,
USA). Intra-class correlation coefficients for inter-observer variation analysis were
generated using SPSS 18 (IBM, Chicago, Ill., USA). As the Orcades Study is a family
based study with potentially high levels of relatedness between participants, it violates
one of the assumptions of multiple regression techniques – the assumption of
independence between observations. The common thread that unites all correlated
studies is that observations are clustered, and individuals or observations within the
same cluster are likely to have similar outcomes compared to observations between
clusters. For example, measurements within the same family are more likely to be
similar due to shared genetic and environmental factors than between families. This
within cluster correlation needs to be accounted for before the multivariate analysis
otherwise the statistical significance of the results may be inflated. Therefore prior to
carrying out multiple regression, residuals were generated using taking into account the
relatedness of individuals. This work was carried out by Dr. Veronique Vitart (MRC
Human Genetics Unit, Edinburgh) one of the members of the team with access to the
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genetic information in the study. In brief, using GenABEL software (Aulchenko et al.,
2007) to take into account the structure of the sample, residuals for the required
quantitative traits were generated taking into account the relatedness of the individuals
using whole genome genotypes, with age and sex fitted as fixed effects. The
rnktransform function of GenABEL was used on all traits to normalize their
distribution. The residuals generated were then used in multiple regression models to
investigate the relationship between these quantitative traits using Minitab 14 (Minitab
Inc., State College, Pennsylvania, USA). The volume of quantitative trait data generated
by this study is enormous. In addition to data on intraocular pressure, central corneal
thickness, axial length, anterior chamber depth, axial length, corneal curvature, white-to-
white, refractive error, over 30 quantitative traits are generated by the HRT III for the
optic nerve and surrounding peripapillary area. Because of a combination of time
pressure and limited manpower, we had to limit the number of traits we had analyzed to
take into account relatedness. Traits were chosen on the basis of biological importance
and credibility, and association with primary open angle glaucoma. In addition, we also
limited the analysis to one eye.
Information regarding both eyes was available for the majority of patients. To analyse
both or one eye, and if one eye, which eye should be anlaysed, is a common quandry in
ophthalmological research (Glynn & Rossner 1992, Murdoch et al., 1998). As both
genetic and global, though not local environmental factors are similar in both eyes,
theoretically, if we accept a complex model of disease and development, one eye is
likely to resemble the other. Ocular diseases however, can be unilateral. This could be
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because the disease is rare. For example, in 99% of cases, choroidal melanoma tends to
be unilateral (Murdoch et al., 1998). Or enviromental exposure is unilateral, for
example, in herpes simplex virus infection. In other diseases such as POAG, the cause
for unilateral disease is unclear. However, if unilateral, neither left nor right eye tends
to be favoured in ocular disease (Murdoch et al., 1998). The advantage of using a
single eye, is less complex statistical techniques can be utilized to analyse data.
However, by using only one eye information is lost, reducing the potential power of
the study. Furthermore, there is a potenial that bias could be introduced by the selection
of one eye over another. In cases where one eye is effected, for example, choroidal
melanoam or in unilateral glaucoma, the effected eye or eye with more extreme value
should be investigated.
The great advantage of using information from both eyes is it increases power. Two
approaches have been used, the first is the pooling or averaging of data, which also leads
to the loss of information, though some would argue less information is lost compared to
using one eye (Glynn & Rossner 1992, Murdoch et al., 1998). Loss of information
would be particularly great if the correlation between the two eyes is poor. The second
involves using information from both eyes separately. However, in this scenario,
correlation between the eyes need to be accounted for by using more advanced statistical
techniques such as generalized estimating equations. Not accounting for the correlation
between eyes will mean the final conclusions that are reached will be misleading,
estimates will be more precise and p values lower.
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Ideally we would have chosen both eyes from each participant and used statistical
techniques to account for the correlation in a manner analagous to accounting for
relatedness. However, for pragmatic reasons, and because there is little evidence in the
literature and in our own experience of laterality in ocular disease (Murdoch et al., 1998)
we limited the analysis to one eye. As discussed before, genetic information was
available to few members of the group and hence manpower was limited. The right eye
was chosen randomly. Subsequent analysis demonstrated (see results section), in the
majority of traits, there was no significant difference between eyes. Even if the
difference was statistically significant, it was not clinically significant. This
differentiation between clinical and statistical signficant is made throughout the results
section. This is because significance testing assesses whether any noted differencs
between groups are due to chance, the p value signifying the probability of obtaining the
given value or one more extreme if the null hypothesis is true (Petrie & Sabin 2005).
Even if there is a statistically significant difference does not necessarily mean that this
difference is important. In the context of this study, quantitative traits can only be
measured with accuracy to a certain degree. Any difference below this level is difficult
to interprate. For example, imagine the mean difference between intra-ocular pressure
in right and left eyes is 0.3mmHg and this difference is found to be statistically
significant. However, with Goldman applanation tonometry IOP can only be measured,
at the greatest, with any kind of accuracy to 1mmHg, and some would argue, only to
2mmHg as gradations on the machine are 2mmHg apart. Hence effect size is too small
to be meaningful in a clinical setting.
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4.4 SUMMARY
Preliminary data for the Orcades Eye Study was collected between April 2007 and
November 2007. Data was collected at the Orcades Centre, Victoria Street, Kirkwall
Orkney. Each appointment lasted on average 45 minutes, when the project was
explained, informed consent obtained, a brief medical and ocular history obtained and
data for a number of ocular biometric traits collected. This included refractive error
measured with a Canon-RF10 autorefractor, axial length, corneal curvature, white-on-
white measured by the Carl Zeiss IOLmaster, corneal thickness measured with the
IOPac Pachymeter and a number of optic nerve and peripapillary parameters using the
Heidelberg Retinal Tomograph III. In addition, volunteers underwent a qualitative
ocular assessment and had their intraocular pressure assessed using Goldman
Applanation Tonometry. At the end of the appointment volunteers were provided with
feedback regarding their ocular state, and referral letters sent to GPs as required. The
data from this examination was entered into an Access 7 database, entry validated and
data analyzed using mainly Minitab 14 Software. Optic nerve head parameters were
initially analyzed using HRT III software, converted into an Excel spreadsheet then
analyzed using Minitab 14. The Orcades Eye Study is a family based cross sectional





OVERALL CHARACTERISTICS OF STUDY SAMPLE
5.1 OVERVIEW
The following results are based on a total of 256 individuals who accepted the invitation
to participate in the Orcades Eye Study and eventually attended. 635 individuals were
invited. 257 initially accepted but one failed to complete the study.
Eyes which had undergone intraocular surgery were excluded from further quantitative
analysis except in the analysis of visual acuity (n=7, 5 phacoemulsifications, 1 retinal
detachment surgery, 1 phacoemulsification followed by subsequent retinal detachment
surgery). The following eyes were also excluded from further analysis except in the
analysis of visual acuity: The anterior segment of eyes which had undergone refractive
surgery (n=2); of an individual with granular corneal dystrophy; the eyes of a volunteer
with a form of congenital optic atrophy with a visual acuity of hand movements and
poor fixation; the eyes of a volunteer with severe osteoarthritis who found maintaining
the correct position for the use of some of the equipment difficult; the eyes of
volunteers with previous orbital cancer (n=2). 247 inidviduals participated in the
univariate analysis. By the time this data was ready for analysis, still only a limited
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number of individuals had been genotyped, so this number was reduced further to 175.
diagram 5.1 below summarizes the flow of participants in the study.
FIGURE 5.1: PARTICIPANT FLOWCHART
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FIGURE 5.2: AGE DISTRIBUTION OF THE STUDY POPULATION
Individuals in our sample had a mean age of 58 years with a standard deviation of 14
years to the nearest year, a minimum age of 23 years and a maximum age of 90 years on
the day of attendance. 37.9% of the cohort were male with a mean age of 58 years
(standard deviation 15 years). 62.1% were female with a mean age of 56 years (standard
deviation of 14 years). Table 5.1 shows the demographic characteristics of our sample
compared to the Orkney population, the Scottish population and the population of the
United Kingdom.
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TABLE 5.1: CHARACTERISTICS OF THE STUDY POPULATION COMPARED WITH THE POPULATION OF






16 - 29 years
30 - 44 years
45 - 59 years

































Total 256 19,245 5,062,011 58,789,194
 Census data, April 2001.
The past ocular, medical and drug histories of the study population are summarized in
tables 5.2, 5.3 and 5.4.
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TABLE 5.2: SELF REPORTED PAST OCULAR HISTORY
PAST OCULAR HISTORY NUMBER OF INDIVIDUALS n = 256













































TABLE 5.3: SELF REPORTED PAST MEDICAL HISTORY
PAST MEDICAL HISTORY NUMBER OF INDIVIDUALS n = 256





(Angina, previous MI, history of previous CABG)
Hypercholesterolemia
Heart Disease Other





































Gastro-oesophageal reflux disease/hiatus hernia/peptic ulcer
Diseases of the gall bladder, liver and pancreas






TABLE 5.3 (CONTINUED): SELF REPORTED PAST MEDICAL HISTORY
PAST MEDICAL HISTORY NUMBER OF INDIVIDUALS n = 256
(Percentage of Total Study Population)















Disorders of the ear, nose or throat





















TABLE 5.4: SUMMARY OF SELF REPORTED DRUG HISTORY
DRUG HISTORY NUMBER OF INDIVIDUALS n = 256
(Percentage of Total Study Population)
No medication
Medication for cardiovascular diseases
(including antihypertensives, antiplatelet drugs, lipid level
lowering agents and diuretics)
Medication for pulmonary diseases
(including bronchodilatators and antihistamines)
Medication for metabolic diseases
(including drugs for diabetes and thyroid disease)
Medication for gastrointestinal diseases
(including antacids, H2 blockers and proton pump
inhibitors)
Medication for psychiatric or neurological disorders
(including antidepressants)
Other








44.0% of the study population claimed to have smoked cigarettes at some point in their
life, having smoked for a mean of 15 pack years (95% confidence interval 12 to 18 pack
years). Only 11% of this 44% however, (approximately 5% of the total study population)
were current smokers. Other details of regarding smoking in the study population are
summarized in the table 5.5 and compared to data from the populations of Scotland and
the United Kingdom.
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TABLE 5.5: SMOKING HISTORY OF THE STUDY POPULATION COMPARED WITH THE ADULT
POPULATION OF SCOTLAND AND THE UNITED KINGDOM
STUDY POPULATION SCOTLAND* UNITED KINGDOM**POPULATION
Female Male All Female Male All Female Male All
Cigarette 6% 3% 5% 25% 27% 26% 21% 22% 21%
Cigar <1% 0 1% - - - <1% 2% 1%
Pipe 0 0 0 - - - <1% 1% <1%
CURRENT
SMOKERS
Other <1% 0 <1% - - - - - -
Cigarette 36% 45% 39% 19% 19% 19% 22% 30% 25%




Pipe 0 2% <1% - - - - - -
* The Scottish Government: Scottish Health Survey 2008
** Office for National Statistics: General Lifestyle Survey 2008, Smoking and Drinking Among Adults,
2008
81% of the total group admitted to having drunk alcohol in the past year. Of these
approximately a third (30%) claimed to be only “occasional drinkers” (defined as less
than 1 unit a week) with the remaining 70% claiming to have drunk at least 1 unit per
week. 19% claimed to be teetotal. Mean alcohol consumption amongst the regular
drinkers was around 8.5 units a week (95% confidence interval 7 to 10 units).
TABLE 5.6: ALCOHOL CONSUMPTION OF STUDY POPULATION COMPARED WITH THE ADULT
POPULATION OF SCOTLAND AND THE UNITED KINGDOM
STUDY POPULATION SCOTLAND* UNITED KINGDOM**
POPULATION
Female Male All Female Male All Female Male All
Non-drinker 24% 10% 19% 13% 10% - 17% 11% 14%
Occasional drinker
(<1 unit/week)
28% 20% 25% 18% 8% - - - -
Regular drinker
(>1 unit/week)





7.2 9.9 8.5 8.6 18 - 8.4 16.6 12.2
* The Scottish Government: Scottish Health Survey 2008
** Office for National Statistics: General Lifestyle Survey 2008, Smoking and Drinking Among Adults,
2008
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Figures 5.3, 5.4 and tables 5.7, 5.8 summarize the distribution of unaided and corrected


































Distribution of Unaided Visual Acuity
Right Eyes Left Eyes
FIGURE 5.3: DISTRIBUTION OF UNAIDED VISUAL ACUITY
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Distribution of Corrected Visual Acuity
Right Eyes Left Eyes
FIGURE 5.4: DISTRIBUTION OF CORRECTED VISUAL ACUITY
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Descriptive statistics for uncorrected and corrected visual acuity are reported in tables
5.7 and 5.8 respectively. 64% of study participants had an uncorrected logmar VA of
0.3 (Snellen equivalent of 6/12) or above in their right eye, and 58.4% in their left eye.
45.1% of participants had an uncorrected logmar VA of 0.18 (6/9 Snellen equivalent) in
their right eye and 41.6% in their left eye. 35.3% of participants had an uncorrected
logmar VA of 0 or greater in their right eye and 31.4% in their left eyes. The differences
in visual acuity between men and women, for both corrected and uncorrected visual
acuity, were not statistically significant at the 5% level (all p values greater than 0.05).
Two volunteers met the International Classification of Diseases 10th Edition (ICD-10)
criteria for visual impairment - “a visual acuity less than 6/18 in the better eye with the
best possible correction.” Both had been diagnosed with forms of optic atrophy.
5.2 INTER-OBSERVER VARIABILITY
Intra-class correlation coefficients ranged from 0.858 (95% confidence interval 0.693-
0.935) for intra-ocular pressure in the right eye to 1.000 (95% confidence interval 1.000-
1.000) for left axial length. Table 5.9 summarizes values for inter-observer variation,
and possible reasons for these results discussed in section 5.3.
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TABLE 5.9: SUMMARY OF INTER-OBSERVER VARIABILITY FOR OCULAR QUANTITATIVE TRAITS




Right 0.858 0.693-0.935Average IOP
Left 0.887 0.755-0.948
Right 0.988 0.969-0.995Central corneal
thickness Left 0.992 0.979-0.997
Right 0.975 0.945-0.988Average axial length
Left 1.000 1.000-1.000
Right 0.998 0.996-0.999Average K1
Left 0.999 0.999-1.000
Right 0.997 0.994-0.999Average K2
Left 0.997 0.993-0.999
Right 0.998 0.996-0.999Average R1
Left 0.999 0.999-1.000
Right 0.997 0.994-0.999Average R2
Left 0.999 0.997-0.999
Right 0.996 0.992-0.998Average ACD
Left 0.985 0.967-0.993
Right 0.980 0.955-0.991Average W
Left 0.979 0.951-0.991
ONH parameters Right/Left 0.977 0.967-0.984
PPA Right/Left 0.958 0.940-0.971
5.3 DISCUSSION
Establishing the Orcades Eye Project was a challenging endeavor. The location of the
Orcades Study Centre was ideal. Situated at the centre of Orkney’s commercial district,
with excellent transport links, it was easily accessible to Mainland Orcadians and
Islanders alike. Following the initial pilot study, the new data collection sheet and
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amended protocol worked well, and once the data base was tested, problems sorted out,
this too worked extremely well.
The initial analysis of this data is an epidemiological one. In general, the nature of
empirical research is such, that most conclusions are derived from incomplete
observations, or samples. The ideal strategy for investigating quantitative traits related to
primary open angle glaucoma would be to gather data from the entire Orcadian
population. Complete ascertainment strategies have been pursued by a number of studies
such as the Framingham Study in New England (Kahn et al., 1977a). Alternatively,
samples representative of the population can be sought, using some form of
randomization strategy (Kalsbeek and Heiss, 2000). Recorded attempts to estimate
population parameters using sampling strategies date back to the 18th century when
efforts were made to infer the population of France (Kalsbeek and Heiss, 2000). The use
of randomization strategies emerged in the 19th century, initially with some controversy
surrounding them, but then gradually gaining credence in the early part of the 20th
century (Stephan, 1948). Sampling has it’s advantages. It reduces the complexity and
cost of collecting data which is especially relevant if the population under study is large,
dispersed or resources are limited. Manpower and effort can be concentrated on a
smaller group with the potential to increase quality at the expense of quantity if
resources are limited. However, sampling can introduce sampling error. Despite using
strategies to limit bias, the sample may not be representative of the population in
question. The long-term aim of this project was to establish a population isolate study
investigating the inheritance of quantitative traits related to primary open angle
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glaucoma, with the objective of finding regions of the genome and genes associated with
its susceptibility. As we utilized volunteers and resources of the already established
cross-sectional family based genetics study the Orcades Cardiovascular Disease Study,
to establish this project, our recruitment strategy had to be in line with the aims,
objectives and long term strategy of the overall Orcades project. We also had limited
resources and time. These factors constrained what methods we could employ to recruit
volunteers. Volunteers who had been the first to participate in the cardiovascular and
anthropometric arms of the Orcades study, were given the opportunity to be the first to
participate in the ocular arms of the Orcades study. These were volunteers recruited
from the West Mainland and other Orcadian Islands. The reason for this was two fold.
First it was to prevent volunteer fatigue – volunteers had undergone a battery of
investigations for the cardiovascular and anthropometric arms of the project, so we
attempted to leave as much time between visits as possible. The second reason was these
volunteers were more likely to have genome-wide scans completed at the end of the data
collection period of the PhD. This method of ascertainment means our sample may not
be reflective of the rest of the indigenous population of Orkney. A comparison of age
distributions between our sample and a number of populations (table 5.1) shows that our
study sample has a lower percentage of participants in the 16-29 age group, a higher
number of participants who are 60 years and older and a higher proportion of females
taking part compared to the population distribution of age and gender in the populations
of Orkney, Scotland and the United Kingdom. Fewer participants in our study were
current smokers (5% versus 21%), and more participants claimed to be teetotal (19%
versus 14%) compared to national averages (table 5.5 and table 5.6). A wide range of
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medical and ocular problems were reported by our cohort (tables 5.2 and 5.3). The most
common self reported medical condition was hypertension (23.7% of the study
population). The prevalence hypertension in our sample was slightly lower than the
prevalence of hypertension reported in the Scottish Health Survey as well as the Health
Survey for England (approximately 33% of men and 31.7% of women in Scotland over
the age of 16 in 2003, approximately 31% for men and 28% for women in England in
2005 (Anon, 2006a)).
Visual acuity in our sample ranged from -0.38 to 3.00 logMAR, with 64% of
participants having an uncorrected logMAR acuity of greater than 0.3. Two volunteers
met the criteria for visual impairment as defined by ICD-10. Both individuals had been
diagnosed with forms of primary optic atrophy. The term “optic atrophy” describes the
morphology of the optic nerve following a disease process that involves the death of the
retinal ganglion cells and their axons (Sadun, 2008). Subjectively individuals have
varying levels of visual dysfunction depending on the nature of damage. The term
primary optic atrophy encompasses a wide variety of pathologies, united by a common
morphological appearance - disc pallor with loss of optic nerve fibers but otherwise little
disruption to the architecture of the optic nerve head. Causes of primary optic atrophy
are varied and range from hereditary forms to ischemic, inflammatory and neuro-
ophthalmic insults. One volunteer had been diagnosed as having “congenital optic
atrophy” and the second, as having “familial” optic atrophy. The prevalence of visual
impairment or blindness secondary to optic atrophy from population based surveys has
been found to be between 0.04 to 0.8% (Munoz et al., 2000, Tielsch et al., 1995a), which
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is not out with our finding of 0.78%. The prevalence of visual impairment in the United
Kingdom has been reviewed recently by Tate et al. in a report commissioned by the
Royal National Institute for Blind People (Tate et al., 2005) Overall, the leading causes
of visual impairment in Scotland and in the United Kingdom are age-related macular
degeneration, glaucoma and diabetic retinopathy (Bamashmus et al., 2004, Tate et al.,
2005), in contrast to our study. It is worth noting that though these findings are
interesting and help paint a picture of our study sample, the sample size is too small to
draw any meaningful conclusions or extrapolate to make generalizations regarding
visual impairment in the Orcadian population.
Intra-class correlation coefficients ranged from a low of 0.858 (95% confidence interval
0.693-0.935) for intra-ocular pressure in the right eye to a high of 1.000 (95%
confidence interval 1.000-1.000) for left axial length. The former value with wide
confidence intervals probably reflects the nature of intraocular pressure, as well the
nature of it’s measurement (Whitacre and Stein, 1993). Because a number of values for
ICC are very high, we re-examined the data and analysis but came to the same
conclusions.Such high levels of agreement have been previously reported in the
literature in other studies using partial coherence inferometry to measure ocular
biometric traits (Sacu et al., 2005, Wong et al., 2005, Shirayama et al., 2009) We believe
this value is a reflection on the reliability and reproducibility of the IOLmaster.
We had aimed to collect data on quantitative traits related to primary open angle
glaucoma from a minimum of 1000 volunteers. Unfortunately a number of problems
215
which we hadn’t anticipated, delayed the start and interfered with the progress of this
project. The initial date was delayed as negotiations with the vendor, and the legal
formalities required to procure the premises and carry out the required renovations were
protracted. The renovations were delayed further due to the paucity of appropriate
manpower and halted for a short period due to inclement weather. Several bouts of
equipment failure and staffing issues slowed/arrested data collection once it commenced.
At the start of the project, there were also problems with volunteer non-attendance. Once
a reminder “courtesy phone call” to volunteers a day or two before their appointment
was instituted, this non-attendance declined. Overall, we were able to collect
quantitative trait data from 256 volunteers. In retrospect, our original plans – to secure
funding, find and renovate premises, source appropriate equipment, train in the use of
that equipment, establish and refine standard operating procedures, set up, refine and
verify databases, recruit volunteers, then gather both quantitative and qualitative data
from 1000 volunteers, enter and analyze this data within the time frame of a PhD, was
unrealistic. However, the data that has been collected is of excellent quality. Once initial
problems had been solved, the data collection and entry procedures and database all
worked incredibly well. Though my role in data collection has now come to a close,
there are plans to continue to collect further POAG related quantitative trait data in
Orkney for a meaningful genetic analysis. To date, the only other population based study
which has collected such a wide range of POAG associated quantitative traits including





CENTRAL CORNEAL THICKNESS AND CORNEAL DIAMETER IN
THE SCOTTISH POPULATION ISOLATE OF ORKNEY
6.1 RESULTS
The distribution of corneal thickness and width are shown in figures 6.1 and 6.2, and
summary statistics reported in tables 6.1 to 6.4. Mean CCT in both eyes was 540µm
(95% confidence interval 536-544µm). Bivariate analysis suggested a highly significant
relationship between IOP and central corneal thickness (p=0.004) which was confirmed
on multivariate analysis (see table 6.2). We found no statistically significant relationship
between CCT and other ocular biometric parameters that were assessed including axial
length and optic nerve parameters. We also found no relationship between CCT and age
or gender (p = 0.124, p = 0.260 respectively on multivariate analysis).
Mean corneal diameter in our sample was 12.3mm in the right eye and 12.2mm in the
left eye (see table 6.3). The difference between the corneal diameters of right and left
eyes (0.0503mm) was statistically significant (paired t-test, p = 0.000) but not clinically
significant (95% confidence interval for mean difference 0.024-0.077mm). Neither age
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nor gender had an effect on corneal diameter. The only ocular biometric parameter to





















Right Eye Left Eye
Central Corneal Thickness
FIGURE 6.1: DISTRIBUTION OF CENTRAL CORNEAL THICKNESS






95% Confidence interval for mean 536-544 536-544
Standard Deviation 32 32
Range 455-629 453-624
Males Mean (95% confidence interval) 538 (532-544) 540 (534-546)
Females Mean (95% confidence interval) 541 (536-546) 539 (534-544)
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Age -0.4064 0.262 0.124
Gender -5.84 -5.85 0.260
Spherical Equivalent 0.032 0.087 0.714
Intraocular Pressure 1.2978 0.4479 0.004
Keratometry 228.0 119.6 0.059
Corneal Diameter 1.2113 0.8545 0.159
Anterior Chamber Depth 0.0162 0.0799 0.839
Axial Length 0.874 1.063 0.412
Nerve Fiber Layer Thickness 0.0799 0.0709 0.262
Rim Area -0.0767 0.0836 0.361
Cup Area 0.0965 0.1553 0.535
Maximum Cup Depth -10.99 21.37 0.608
PPA Area -0.1244 0.2243 0.580





















Right Eye Left Eye
Corneal Diameter
FIGURE 6.2: DISTRIBUTION OF CORNEAL DIAMETER






95% Confidence interval for mean 12.21 - 12.30 12.16 - 12.26
Standard Deviation 0.43 0.40
Range 11.3-13.7 11.3-13.2
Males Mean (95% confidence interval) 12.4 (11.5-13.3) 12.3 (11.5-13.1)
Females Mean (95% confidence interval) 12.2 (11.5-12.9) 12.1 (11.5-12.7)
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Age -0.0004 0.0023 0.875
Gender 0.01578 0.0477 0.741
Spherical Equivalent 0.0113 0.0085 0.183
Intraocular Pressure 0.0114 0.0081 0.159
Keratometry -80.539 9.649 0.000
Corneal Diameter -0.0455 0.0446 0.310
Anterior Chamber Depth 0.0423 0.0069 0.000
Axial Length -0.0321 0.1035 0.757
Nerve Fiber Layer Thickness 0.002 0.0069 0.775
Rim Area -0.0147 0.008 0.069
Cup Area -0.0047 0.0151 0.756
Maximum Cup Depth -0.390 2.059 0.850
PPA Area 0.0172 0.0217 0.429
PPA peripheral extent -0.0084 0.0188 0.656
6.2 DISCUSSION
Understanding corneal parameters has become increasing important in ophthalmology.
The Ocular Hypertension Treatment Study and other studies identified CCT, as an
independent risk factor for the progression of ocular hypertension to glaucoma (Gordon
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et al., 2002, Medeiros et al., 2003a, Medeiros** et al., 2003, Medeiros*** et al., 2003,
Miglior et al., 2007b). Though there is also some evidence which suggests that CCT is
important as a risk factor in the progression of glaucoma (Kim and Chen, 2004) this is
much disputed (Leske et al., 2003, Chauhan et al., 2005, Jonas et al., 2005a, Jonas et al.,
2005b) (Congdon et al., 2006). Corneal thickness is not just important as a glaucoma
related risk factor. In itself, it can be an indicator of corneal well being. In an age where
increasing numbers undergo refractive surgery, normative values can aid the decision
making process. For example, an intact CCT of 250μm is considered sufficient for the 
continuing mechanical stability of the cornea, but this number is based on a presumed
“normal” corneal thickness of 550μm (Price et al., 1999, Wilkinson et al., 2008). An 
understanding of the thickness of the cornea is imperative (including it’s relationship to
other variables such as aging and gender) as this changes it’s light scattering properties
which are utilized in various forms of anterior segment photography (Wegener and
Laser-Junga, 2009) and an understanding of anterior segment dimensions is invaluable
for the design and use of phakic intraocular lenses (Hosny et al., 2000).
Table 6.5 summarizes mean CCT in populations across the globe.
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1978 Inuit 7-89 Optical 523.7
Netherlands
(Wolfs et al.)


































































































(Casson et al.) 2008 Burmese 40 Ultrasound 521.9±33.3
Beijing Eye Study
(Zhang et al.)




2008 Indian 40-103 Ultrasound 520.7
Turkey
(Cankaya et al.)




2009 Malay 40-80 Ultrasound 541.2
Ethiopia
(Gelaw et al.)
2010 African 42.57±16.71 Ultrasound 518±32.92
Values for corneal thickness have shown a wide range in the literature from an average
of around 500µm suggested by Goldman and Schmidt in the context of applanation
tonometry to highs of 700 to 1000µm in pre 1950s reports (Doughty and Zaman, 2000).
Current studies across the globe have demonstrated that central corneal thickness shows
considerable inter-population variation, from a low mean of 495µm in a Mongolian
population (Foster et al., 1998) to a mean of 558µm in self reported White Caucasians in
Houston, Texas (La Rosa et al., 2001). Doughty and Zaman (Doughty and Zaman, 2000)
calculated mean “normal” central corneal thickness to be 534µm (from 300 studies) or
536µm, with a standard deviation of 31µm (from a dataset of 230 where variance was
specified). The mean CCT found in our study was 540µm, with a 95% confidence
interval between 536-540µm. Taking into account the accuracy of pachymetry, these
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findings are not dissimilar to the calculations of Doughty et al. (Doughty and Zaman,
2000) or the findings of other White Caucasian populations shown in table 6.5. The
distribution of central corneal thickness in our sample was unimodal and we found no
difference between the genders or any association with age.
The findings for a relationship between CCT and age and gender have been inconsistent,
with some studies reporting associations, such as a decrease of CCT with age (Foster et
al., 1998, Brandt et al., 2001, Nemesure et al., 2003) (Healey et al., 2005, Suzuki et al.,
2005) and difference between genders (Alsbirk, 1978, Suzuki et al., 2005, Zhang et al.,
2008) and many others finding little association with age or gender (Wolfs et al., 1997,
Eysteinsson et al., 2002, Healey et al., 2005), (Gelaw et al., Zhang et al., 2008). In our
study the only association we found between CCT and ocular parameters was a positive
correlation between CCT and IOP. This association has been well described in many
other studies (Wolfs et al., 1997, Foster et al., 1998, Eysteinsson et al., 2002, Suzuki et
al., 2005, Doughty and Jonuscheit, 2007, Zhang et al., 2008, Su et al., 2009, Gelaw et
al.). This has not been found to be the case in all populations however (Nemesure et al.,
2003). Examining the IOP-CCT relationship has been a means of assessing the effect of
CCT on IOP in a number of studies (Doughty and Zaman, 2000, Doughty et al., 2002)
(Doughty and Jonuscheit, 2007). Overall, a thicker than “normal” cornea will
overestimate intracameral IOP and a thinner than normal cornea will underestimate IOP
(Doughty and Zaman, 2000). This finding has not been universal. The Barbados Eye
Study for example did not find a statistically significant correlation between IOP and
CCT in participants of African-Caribbean or “mixed” ancestry but did find this
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correlation to be statistically significant in those of self reported White Caucasian
ancestry, suggesting this relationship may show inter-population variation (Nemesure et
al., 2003). This has clinical implications. In a population where CCT has little impact on
IOP measurements, its measurement becomes less of a priority. Clinical time, resources
and effort can be directed elsewhere. However, in a population such as ours where there
is a relationship between CCT and IOP, pachymetry is of great importance in the
assessment of an individual’s IOP, especially in the diagnosis and management of
glaucoma. Though many different guidelines suggest the measurement of central
corneal thickness in the assessment of patients with primary open angle glaucoma, this is
still not routine in clinical practice (European_Glaucoma_Society_II, 2003,
American_Academy_of_Ophthalmology, 2008) .
.
Multivariate analysis of the Ocular Hypertension Treatment Study dataset suggested that
the effect of CCT on the progression of ocular hypertension to glaucoma was
independent of it’s effect on IOP (Gordon et al., 2002, Miglior et al., 2007b). The second
explanation for this relationship between glaucoma and CCT, views central corneal
thickness as a possible surrogate marker for some yet un-described biological risk factor
such as some biomechanical aspect of the optic nerve head. During development. the
corneal stroma and sclera share a common mesenchymal origin, and arise as one
continuous coat (Moore and Persaud, 2007). Hence this hypothesis is grounded in reality
though the evidence for any such an association is limited. Lesk et al found that patients
with thinner corneas with ocular hypertension or open angle glaucoma showed greater
compliance of their lamina cribrosa (measured by using optic cup depth as a surrogate)
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than those with thicker corneas (Lesk et al., 2006) – a result which was not replicated by
Nicoela et al (Nicolela et al., 2006). A number of other studies had reported associations
between central corneal thickness and optic nerve head parameters when this project was
being established (Iester and Mermoud, 2001), (Soans et al., 2004, Henderson et al.,
2005, Pakravan et al., 2007). These studies were not population based and were carried
out on individuals with glaucoma (Soans et al., 2004) or ocular hypertension (Henderson
et al., 2005). Only Iester et al looked at normal eyes (n=44) (Iester and Mermoud, 2001).
CCT measured by ultrasonic pachymetry was not correlated to retinal nerve fiber layer
thickness measured by a confocal scanning laser polarimeter. At the time this project
was being established, to our knowledge there had been no population based studies
investigating the relationship between central corneal thickness and optic nerve head
parameters. More recently a few reports have emerged. The Beijing Eye Study found a
positive correlation between CCT measured by optic coherence tomography and optic
disc area measured by planimetry of digitized optic disc photographs (Zhang et al.,
2008). Thick corneas in this population were hence associated with larger optic discs.
This contradicts the findings of Pakravan et al. who reported an inverse correlation
between central corneal thickness and optic disc area but in patients with primary open
angle glaucoma of mixed self reported ancestry (Pakravan et al., 2007). Similar findings
to Pakravan et al. was reported in a healthy Turkish population. CCT was found to show
a negative correlation to disc area, rim area, rim volume and retinal nerve fiber thickness
(Cankaya et al., 2008). Gunvant et al. reported a correlation between optic rim area and
CCT in 272 eyes from 144 patients of unreported ancestry from Norwich with normal
tension glaucoma (n=50), ocular hypertension (n=48), primary open angle glaucoma
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(n=71) and glaucoma suspects (n=103). A statistically significant positive correlations
between central corneal thickness, rim area, mean RNFL thickness, RNFL cross
sectional area with all groups was described and a negative correlation between
maximum cup depth and mean cup depth reported in an analysis of all groups combined
(Gunvant et al., 2008). The latter results suggest that as corneal thickness decreases, the
lamina is probably more compliant, supporting Lesk’s finding using slightly different
methodology (Lesk et al., 2006). Very recently Mokbel et al. described an association
between thin CCT measured by pachymetry and with vertical and horizontal cup disc
ratio, smaller optic disc surface area assessed by HRT II and increased mean deviation
on visual field analysis in an analysis of 80 eyes of 50 POAG patients in Oman (Mokbel
and Ghanem, 2010). The Bridlington Eye Assessment Project, which was established to
screen for ocular disease in white Caucasian individuals over 65 years of age in North
Humberside, found no significant correlation between any global optic disc parameters
assessed by Heidelberg Retinal Tomography and central corneal thickness measured
using ultrasonic pachymetry, which supports our findings of no association between
central corneal thickness and optic nerve head parameters. In a histomorphometric study
of non-glaucomatous human eyes, neither Jonas et al who studied cadaver eyes, nor Ren
et al who studied Chinese eyes enucleated due to malignant melanoma, could find an
association between a central corneal thickness with lamina cribrosa or peripapillary
sclera (Jonas and Holbach, 2005, Ren et al., 2010).
We went further than other publications, and in addition to global optic disc parameters,
investigated the relationship between peripapillary atrophy and central corneal thickness.
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A number of studies have suggested an association between PPA and glaucomatous
optic neuropathy (Primrose, 1970, Wilensky and Kolker, 1976, Nevarez et al., 1988,
Buus and Anderson, 1989, Jonas et al., 1992, Jonas and Xu, 1993, Jonas et al., 1989,
Jonas and Naumann, 1989, Araie et al., 1994, Lee et al., 2002, Xu et al., 2007c). The
size of both alpha and beta PPA has been found to be greater in both size and frequency
in glaucomatous eyes compared to the normal population (Jonas et al., 1989, Jonas and
Naumann, 1989). Beta zone PPA has been correlated with the position of visual field
defects (Park et al., 1996). The extent and area of PPA has been found to be greater in
eyes with optic disc hemorrhages (Ahn et al., 2004, Sugiyama et al., 1997) associated
with the progression of ocular hypertension to glaucoma (Tezel et al., 1997b, Tezel et
al., 1997c), as well as the advancement of glaucomatous optic neuropathy and visual
field deterioration (Hayreh et al., 1998, Uchida et al., 1998), (Teng et al., 2010). Models
of optic nerve head biomechanics have demonstrated that the mechanical stress induced
by a given IOP on the optic nerve head is greater in relatively thin peripapillary sclera
(Burgoyne et al., 2005). PPA is hence an important factor which influences optic nerve
head biomechanics. However, very few studies have explored the relationship between
CCT and PPA. Tomais et al. (Tomais et al., 2008) investigated the relationship between
CCT, optic disc area, optic cup area, and peripapillary atrophy in three groups of 30
individuals (patients with glaucoma, ocular hypertension and disease free individuals) in
Athens but found no correlation between central corneal thickness and peripapillary
atrophy, though they did find a negative correlation between PPA and disc area in eyes
with ocular hypertension. The difference between PPA area between the three groups
was not statistically significant. We too found no relationship between the area or extent
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of PPA to central corneal thickness, which is against our expectations of a thinner cornea
being associated with an optic nerve head which may be more vulnerable to IOP induced
stress. Teng et al, (Teng et al., 2010) found a very weak agreement between the presence
of a thin cornea (<525µm) and the presence of beta zone PPA in a study involving 245
patients with open angle glaucoma. To our knowledge there have only been two other
population based studies investigating at peripapillary atrophy in a normal population
but neither investigated the relationship between PPA and central corneal thickness
(Ramrattan et al., 1999, Xu et al., 2007c).
Because of the difficulties of measuring the lamina cribrosa and peripapillary sclera in
vivo, and as the corneoscleral envelope is a continuous structure, some studies have
attempted to find more indirect evidence for an association between CCT and optic
nerve head biomechanics by examining scleral thickness or, as myopia is an independent
risk factor for glaucoma, and as the lamina cribrosa between myopic eyes is thinner than
non-myopic eyes, between CCT and refractive error/axial length (Jonas et al., 2004).
These studies have produced varied results with some supporting a relationship between
CCT and scleral thickness (Albekioni et al., 2003), (Oliveira et al., 2004, Oliveira et al.,
2006) but not others (Cho and Lam, 1999, Oliveira et al., 2004, Shimmyo and Orloff,
2005, Oliveira et al., 2006). Population based studies investigating the relationship
between central corneal thickness and these quantitative traits are also now beginning to
emerge. Meiktila Eye Study from Myanmar (Casson et al., 2008), and the Singapore
Malay Eye Study (Su et al., 2009) report a positive association between CCT and
spherical equivalent refraction and CCT and axial length respectively. The Tajimi Eye
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Study (Suzuki et al., 2005) found a positive relationship between refractive error and
CCT but only in men. In contrast, the Beijing Eye Study did not find an association
between CCT and refractive error (Zhang et al., 2008) which is in keeping with our
findings in the Orcadian population of no statistically significant relationship between
central corneal thickness and refractive error or axial length.
Finally, we found no relationship between CCT, corneal curvature or white-on-white.
Again, some studies have supported a relationship between these traits whilst others
have found no such association. The Tajimi Eye Study (Suzuki et al., 2005) which
investigated a population of Japanese ancestry, Shimmyo et al. in a study of individuals
of self reported Caucasian, Asian, Hispanic and African American ancestry (Shimmyo et
al., 2003), Tong et al in a group of Singaporean school children all reported an
association between corneal thickness and curvature. The Reykjavik Eye Study
(Eysteinsson et al., 2002) as well as a number of smaller studies found no such
association (Chen et al., 2009).
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al., 2009c) 2009 Iranian 14-81 Orbscan II
11.68±0.46
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Even though an understanding of “normal” corneal width is invaluable in
ophthalmology, it has been poorly investigated. Horizontal corneal width is important
for a number of reasons. Various cut offs of corneal width are used for the
definition/diagnosis of ocular conditions such as micro and megalocornea (Meire, 1994);
it is used to diagnose and subsequently monitor congenital glaucoma (Meire, 1994);
Corneal diameter measurements are used in to improve the accuracy of IOL power
calculations in third generation formulas (Holladay et al., 1996), for estimating the size
of the size of ciliary sulcus and anterior chamber width before the implantation of
sulcus-fixated lenses (Price and Parker, 1997). Corneal diameter is also important in the
preoperative evaluation of patients who wish to undergo refractive surgery (Darlington
and Davis, 2008). Corneal diameter is also important in glaucoma - the diameter of the
cornea in relation to glaucoma has been described as far back as the 1800s when Priestly
Smith reported a smaller corneal diameter in eyes with primary glaucoma compared to
normal eyes (Alsbirk, 1975). A number of studies have investigated corneal diameter
and perhaps their methods though novel at the time, compared to current technology,
could be considered to be of limited precision (Rufer et al., 2005). Friede for example,
reported a mean corneal diameter of 11.58 mm after measuring the horizontal and
vertical corneal diameters of nearly 11,000 individuals in 1933 using Wessely’s
keratometer, a device which allowed the measurement of corneal diameter by looking
through a tube with a millimeter rule at one end and a lens at another (Alsbirk, 1975).
Alsbirk used Wessely’s keratometer to investigate corneal diameter in Greenland in the
1970s, and established that there was a difference between corneal diameter between
those of Inuit ancestry compared to Danish ancestry (Alsbirk, 1975). The first
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population based study investigating corneal width in a normal population using current
technology was Rufer et al (Rufer et al., 2005). Using the Orbscan II, a non contact
corneal topography system using a mixture of reflective (placido) and scanning slit
technology (Rufer et al., 2005, Swartz et al., 2007), investigated the horizontal corneal
diameters of 231 male and 140 female white Caucasian volunteers in Hanover,
Germany. Volunteers were aged 10 to 80 years. Average corneal diameters 11.71±0.42
mm, giving a range of 10.87 to 12.55. The mean corneal diameter found in our study
population, 12.3mm for the right eye, and 12.2mm in the left eye, was higher than the
majority of published studies, and certainly higher than all studies that are population
based. If a reference range was calculated using our data, the range defined as mean±2
standard deviations, the upper limit of normal would be 13.2mm in the right eye and 13
mm in the left.
Though accurate data about the possible normal dimensions of the anterior segment,
and their associations with other ocular biometric and demographic variables would be
useful, especially in an era of increasing refractive surgery, the number of studies
investigating the relationship between corneal thickness and corneal diameter in adults
using current technology are limited (see table 6.6). Three population based studies and
a number of other smaller studies, have published normative data on corneal diameter in
adults but few of these studies have explored the relationship between corneal diameter,
demographic variables or other ocular parameters (Alsbirk, 1975, Baumeister et al.,
2004, Rufer et al., 2005, Tananuvat and Pansatiankul, 2005, Kohnen et al., 2006, Pinero
et al., 2008, Hashemi et al., 2009b, Salouti et al., 2009). We investigated the influence of
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a number of demographic and ocular biometric variables on corneal diameter and found
only corneal curvature and anterior chamber depth had a statistically significant
correlation with corneal diameter. Neither gender nor age in adults correlated
significantly with diameter. Rufer et al. in contrast found corneal diameter decreased
slightly with age but there was no difference between genders (Rufer et al., 2005). In a
Tehran-based study, Hashemi et al. found corneal diameter differed significantly
between genders but was not correlated to age (Hashemi et al., 2009b). A small number
of studies, in keeping with our findings, have reported a positive correlation between
corneal diameter and anterior chamber depth (Hosny et al., 2000, Kohnen et al., 2006,
Hashemi et al., 2009b). Hosny et al (Hosny et al., 2000) investigated the relationship
between several ocular biometric parameters in 211 individuals in Alicante and found no
relationship between corneal diameter and CCT or axial length. Corneal diameter did
however, correlate with anterior chamber depth.
Limitations of our study in the context of the corneal parameters of thickness and width,
we share with other published studies in this field. There is evidence to suggest that
corneal thickness, like IOP, shows both diurnal and seasonal variation, so any solitary or
group of measurements taken at a point in time only represents “true” corneal thickness
to a certain extent (Doughty and Zaman, 2000). The problems with study comparison are
similar to those faced in comparing studies on intraocular pressure. The current clinical
gold standard for measuring corneal thickness is ultrasonography - the method used in
our study. Other methods used in the literature, include, scanning slit topography,
specular microcopy and other forms of optical pachymetry. These methods are of
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variable comparability. Scheimpflug anterior segment photography, more commonly
used for the assessment of lens thickness, is a less common method of assessing corneal
thickness (Friedman and He, 2008, Wegener and Laser-Junga, 2009). It is a form of
corneal tomography using a geometrical principle that was first described by an
Austrian Naval Officer Theodor Schiefpflug in the late 1800s. This rule describes the
orientation of the focus plane of an optical system if the image and lens planes are not
parallel to each other. In this situation, a tangent can be drawn from the image, object
and lens planes which allows the calculation of the point of “best focus”. The EAS-
1000 Anterior Eye Segment Analysis System (Nidek Co Ltd, Japan) used in the
Reykjavik Eye Study, is based on this principle (Eysteinsson et al., 2002). It acquires a
single image from which CCT can be calculated (Barkana et al., 2005). More recent
anterior segment imaging systems, such as Pentacam, acquires multiple images of the
anterior segment. Specular microscopy works on the principle of specular reflection –
the phenomenon when objects are observed using light reflected off the different
interfaces of an object formed from material of different refractive indices (such as the
cornea) (Cavanagh et al., 2000, Modis et al., 2001a, Swartz et al., 2007). The Topcon
SP-2000P, a non contact specular microscope (Topcon, Tokyo, Japan), used in the
Tajimi Eye Study, (Suzuki et al., 2005) is also capable of pachymetry by calculating
focal distances (from epithelium to endothelium) which can be used to calculate corneal
thickness (Modis et al., 2001a). Foster et al (Foster et al., 1998) used another form of
optical pachymeter the Depth Measuring Device I; Haag-Streit, Bern, Switzerland,
which is also dependent on specular reflections of corneal interfaces, but instead uses a
measuring device mounted on a slit lamp (Bourne and Alsbirk, 2006). These techniques
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show variable agreement, and the evidence suggests, should not be used interchangeably
(Modis et al., 2001a, Modis et al., 2001b). For example, in a study by Prospero Ponce
and colleagues, ultrasound pachymetry was found to produce readings that are higher
than Scheimpflug measurements of central corneal thickness (Prospero Ponce et al.,
2009). In another study, central corneal thickness was found to be  12-24μm greater 
when measured using scanning slit lamp corneal topography than with non-contact
specular microscopy (Sanchis-Gimeno et al., 2006).
The similar problems of study comparison can be found in studies investigating corneal
diameter – differing methods of procurement, measurement, populations etc. Baumeister
et al compared 2 automated (Orbscan, IOLmaster) and two manual (surgical callipers
and Holladay-Godwin Corneal Gauge) methods of measuring corneal diameter and
found manual methods of measuring corneal diameter were comparatively less precise,
with the Carl Zeiss IOLmaster, the instrument used in our study, being the most reliable
(Cavanagh et al., 2000).
Comparison between studies is difficult due to differences in methodology but overall
our findings demonstrate that though values obtained for corneal parameters in the
Orcadian population may differ from other published reports, they are not dissimilar.
There is a statistically significant association between central corneal thickness, which is
highly relevant clinically but we could not find association between central corneal
thickness and other variables. In particular we could not find a relationship between
central corneal thickness, optic nerve head parameters, refractive error or axial length.
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Corneal diameter was related to corneal curvature and anterior chamber depth but not to




INTRAOCULAR PRESSURE IN THE SCOTTISH POPULATION
ISOLATE OF ORKNEY
7.1 RESULTS
The intraocular pressure of the eye is generated and modulated by the formation of
aqueous humour in the ciliary body, which flows from the posterior to the anterior
chamber of the eye, and exits via the trabecular meshwork and uveoscleral pathways
(Hart, 1992). Figure 7.1 shows the distribution of IOP in our sample, for both right and
left eyes with normal distribution curves superimposed.
Mean IOP for right eyes was 14.8mmHg (95% confidence intervals 14.4mmHg,
15.2mmHg), and for left eyes 15.1mmHg (95% confidence intervals 14.7mmHg,
15.6mmHg). This slight difference in mean IOP between left and right eyes was
statistically significant at the 5% level (paired t-test, p-value = 0.021) but not clinically
significant (mean difference = 0.311 mmHg, 95% confidence interval for mean
difference -0.576mmHg, -0.046mmHg). Mean IOP in men in the right eye was
14.7mmHg, in the left 15.0mmHg. In women mean IOP was 15mmHg in the right eye
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and 15.3mmHg in the left eye. The difference in IOP between men and women was not
significant (p = 0.643).
Bivariate analysis only found a statistically significant association between IOP and
CCT (p=0.004) and IOP and age (p=0.005), but not with any of the other ocular
biometric parameters including axial length or any optic nerve head parameter listed in
table 7.2. On multivariate analysis, age and central corneal thickness were found to be
significantly associated with IOP at the 5% level ( p = 0.032 and p=0.004 respectively).
Table 7.2 summarizes the results of multivariate analysis of IOP as the dependent



























Distribution of Intraocular Pressure
Right Eye Left Eye
Intraocular Pressure in Hgmm
FIGURE 7.1: DISTRIBUTION OF INTRAOCULAR PRESSURE IN THE STUDY POPULATION
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95% Confidence interval for mean 14.4 -15.2 14.7 - 15.6
Standard Deviation 3.4 3.5
Range 7 - 28 8 - 29
Males Mean (95% CI) 14.7 (14.0-15.4) 15.0 (14.3-15.7)
Females Mean (95% CI) 15.0 (14.5-15.5) 15.3 (14.8-15.8)




Age 0.0571 0.02644 0.032
Gender 0.2585 0.5564 0.643
Spherical Equivalent 0.032 0.087 0.714
Central Corneal Thickness 1.2978 0.4479 0.004
Keratometry 228.0 119.6 0.059
Corneal Diameter 1.2113 0.8545 0.159
Anterior Chamber Depth 0.0162 0.0799 0.839
Axial Length 0.874 1.063 0.412
Nerve Fiber Layer Thickness 0.0799 0.0709 0.262
Rim Area -0.0767 0.0836 0.361
Cup Area 0.0965 0.1553 0.535
Maximum Cup Depth -10.99 21.37 0.608
PPA Area -0.1244 0.2243 0.580
PPA peripheral extent 0.0936 0.1946 0.631
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7.2 DISCUSSION
The role of ocular tension, or IOP in the pathogenesis of glaucoma, has been the focus
of research for many centuries (Lascaratos and Marketos, 1988b, Fronimopoulos and
Lascaratos, 1991, Nathan, 2000, Cohen, 2001, Drews, 2006, Tsatsos and Broadway,
2007), (Kronfeld and 2009). Over the last few decades a number of population based
studies have investigated the distribution of IOP in the normal population. Table 7.3
below summarizes some of these main studies.













1964 Finnish 40+ Schiotz 16.0±2.72
De Moine, Iowa
(Armaly, 1965)






1966 Welsh 40-74 GAT and Shiotz 15.9±2.87
Bedford Glaucoma
Survey
(Bankes et al., 1968)




1969 African-Caribbean 35-74 GAT
Male: 16.8± 2.8
Female: 16.5 ± 2.9
Umanak, Greenland
(Alsbirk, 1970) 1970 Inuit-Caucasian 20+ Shiotz 15.7±3.0
Dalby Eye Study
(Bengtsson, 1972)
1972 White Caucasian 8-99 GAT/Schiotz 15.0±5.0
Framingham Eye Study,
USA.




























(Klein et al., 1992a)





(Dielemans et al., 1994)
1994 White Caucasian 55 GAT 14.(NR)
Blue Mountains Eye
Study
(Mitchell et al., 1996)
1996 White Caucasian 49-79 GAT 16.1±2.9
Barbados Eye Study

















(Jacob et al., 1998)
1998 Indian 30-60 GAT 15.48±3.6
Egna-Neumarkt study
(Bonomi et al., 1998)





(Weih et al., 2001)
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2002 South African (Zulu) >40 Tono-Pen XL 13.9±3.4
Tehran Eye Study














2010 African 42.6±16.7 GAT 13.42.8
Since the late 1950’s, these population based studies, have demonstrated that mean IOP,
it’s distribution and it’s relationship to other variables such as age, and gender, can vary
between populations. For example, in the Barbados Eye Study (Leske et al., 1997), a
population based study which was established to investigate the prevalence of open
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angle glaucoma and other ocular conditions in the Antilles, found that IOP was
significantly higher in individuals of self reported African-Caribbean origin (mean
IOP±SD: 18.7±5.2mmHg), compared to those of White Caucasian ancestry (mean
IOP±SD: 16.5±3.0mmHg). Similar findings were reported by the Health and Nutrition
Survey (Klein and Klein, 1981, Hiller et al., 1982) but the Baltimore Eye Study
however, found that IOP was similar in volunteers of African-Caribbean and White
Caucasian ancestry (Sommer et al., 1991).
In the majority of studied populations, intraocular pressure amongst normal individuals
also shows a right skewed distribution. Various theories have arisen to explain this
phenomenon. In the late 1950s, Wolfgang Leydhecker and associates suggested that this
skewness could be explained by the presence of two sub-populations, the amalgamation
of which would form the final right skewed curve (Davanger and Holter, 1965). The
primary “collective” consists of a population with IOPs that follow a normal distribution
curve centered around a mean of 16mmHg. The secondary population consists of a
group with higher IOPs, ranging from 24 to 41mmHg. The distribution of these
pressures are not symmetric about the mean but skewed towards higher pressures. This
secondary collective is believed to be formed by glaucomatous or potentially
glaucomatous eyes. However, we now know that the relationship between IOP and
glaucoma is not that straight forward, and the statistically designated cut-offs between
normal and pathological are too simplistic to distinguish between healthy eyes and ones
with disease potential. Furthermore, IOP, like blood pressure, is a physiological
property, governed by the interaction of different factors. With this idea in mind, Martin
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Davanger and Oivin Holter showed that the skewed distribution for IOP demonstrated
by various population based studies could also be explained by fluid dynamics, and
related the skewed nature of IOP distribution to physical ocular properties such as
effective pore diameter (Davanger and Holter, 1965). Davanger and Holter demonstrated
that if the diameter of outflow pathways within the trabecular meshwork (“effective pore
diameter”), were presumed to have a normal distribution within the population, for both
physiological and more complex mathematical reasons, IOP would be expected to show
a skewed distribution. This explanation supports our increasing understanding of IOP as
a continuum, abrogating the need for Leydecker’s assumption of two separate
populations, one with “normal” IOP mechanisms and another with abnormal IOP
mechanisms.
These findings have not been repeated in all populations. In South East Asian
populations, such of those of the Tajimi (Fukuoka et al., 2008) and Nagoya (Shiose,
1984) the distribution of IOP follows a different course – left skewed with IOP
decreasing with age rather than increasing. Other South East Asian populations have
reported inverse “U” shaped distributions of IOP (Xu et al., 2005, Wong et al., 2009),
Wong, 2009). The Beijing Eye Study (Xu et al., 2005, Xu et al., 2009), for example, a
population based cohort study, measured IOP using non-contact pneumotonometry in a
group of 4439 individuals from Northern China, IOP showed a reversed-U shaped
course, with an increase in IOP from the subgroup 40 to 44 years to 60 to 64 years,
followed by a decrease in IOP from that subgroup  to the sub-group ≥75 years. 
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The distribution of IOP of both eyes in the Orkney population follows those of other
White Caucasian populations. It is unimodal, and skewed to the right, with a mean and
standard deviation, and range comparative to other White Caucasian populations. IOP in
the Orkney sample also shows a statistically significant correlation with age which is in
keeping with other populations such as those of White Caucasian and African-Caribbean
ancestry (Armaly, 1965, Klein et al., 1992a, Leske et al., 1997, Bonomi et al., 1998) but
not of South East Asian ancestry. (Shiose, 1984, Fukuoka et al., 2008), (Xu et al., 2005,
Wong et al., 2009) In some studies of White Caucasian populations, this association is
not significant (Kahn et al., 1977a). Aging is associated with a number of changes in
both ocular and non ocular tissue. Age related changes have been described in the
trabecular meshwork which increase the resistance of the meshwork to aqueous outflow
(Tamm and Fuchshofer, 2007). These changes may explain part of the age related
increase in IOP observed in these studies. Changes in the cornea such as increased cross
linking between collagen fibrils have also been observed with age and these changes
may contribute to some of the biomechanical changes of the cornea associated with age
(Kotecha, 2007). In addition to corneal thickness, other biomechanical parameters may
also influence the measurement of IOP. The increased corneal rigidity associated with
age may hence induce further measurement errors and contribute to this association
(Kotecha et al., 2005).
We did not find a significant relationship between gender and IOP though there is
evidence that oestrogen receptors can be found in the ciliary body and outflow tract and
it is possible these could influence glaucoma via aqueous formation (Ogueta et al., 1999,
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Lee et al., 2003). There is also some evidence that female sex hormones influence
intraocular pressure (Altintas et al., 2004, Sator et al., 1997). Our findings are supported
by some population based studies (Klein et al., 1992a, Giuffre et al., 1995) but not others
(Armaly, 1965, Hollows and Graham, 1966, Leske et al., 1997, Wallace and Lovell,
1969).
The only ocular factor found to be associated with IOP in our study was CCT. This
finding has been reported in many others, in both population based as well as smaller
studies (Wolfs et al., 1997, Dohadwala et al., 1998, Foster et al., 1998, Bhan et al., 2002,
Eysteinsson et al., 2002, Ko et al., 2005, Li et al., 2002, Lleo et al., 2003, Foster et al.,
2003), (Suzuki et al., 2005, Doughty and Jonuscheit, 2007, Zhang et al., 2008, Su et al.,
2009, Gelaw et al.), though not all populations have reported this association (Nemesure
et al., 2003). Perusing the IOP-CCT relationship has been a means of assessing the effect
of CCT on IOP (Doughty and Zaman, 2000, Bhan et al., 2002, Doughty et al., 2002)
(Doughty and Jonuscheit, 2007). This relationship we discussed at some length in
Chapter 1, then revisited in chapter 6. In brief, the measurement of intraocular pressure
by some forms of tonometry, especially Goldman applanation tonometry is influenced
by the corneal thickness (Bhan et al., 2002, Kniestedt et al., 2008). In Goldman
Applanation Tonometry, a force is used to applanate a known area and then used to
calculate pressure as pressure is equivalent to force divided by area. The “known area”
was calculated by Goldman and Schmidt as one where the effects of surface tension
created by the tear meniscus would abrogate or reduce the effects of the rigidity of the
cornea. Unfortunately in this calculation, Goldman and Schmidt assumed a central
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corneal thickness of 500µm and further assumed that there would be little inter or intra-
population variability in this parameter. (Hart, 1992, Whitacre and Stein, 1993, Chihara,
2008). A number of studies where manometry and tonometry have been performed
concurrently have demonstrated that central corneal thickness has an impact on
tonometry, and overall, thick corneas overestimate IOP and thinner than “average”
corneas underestimate IOP (Ehlers et al., 1975, Whitacre et al., 1993, Doughty and
Zaman, 2000), (Feltgen et al., 2001, Kohlhaas et al., 2006). This relationship does not
hold true for all populations. For example, in the Barbados Eye Study, the relationship
between IOP and CCT in volunteers of African Caribbean or “mixed” ancestry was not
statistically significant, though the relationship was statistically significant for those of
White Caucasian ancestry (Nemesure et al., 2003).
A number of studies have identified myopia as a risk factor for open angle glaucoma
(Daubs and Crick, 1981, Ponte et al., 1994, Mitchell et al., 1999, Grodum et al., 2001,
Yoshida et al., 2001, Ramakrishnan et al., 2003, Wong et al., 2003, Xu et al., 2007b).
Furthermore, ocular tension has been postulated as a possible mechanism for myopia
and axial elongation (Pruett, 1988, Nomura et al., 2004, McMonnies, 2008). A number
of studies, most not taking CCT into account, have shown a correlation between
intraocular pressure and myopia (Abdalla and Hamdi, 1970, David et al., 1985) (Quinn
et al., 1995, Mitchell et al., 1999, Wong et al., 2003, Nomura et al., 2004) However,
Edwards and Brown (Edwards and Brown, 1996) found that myopia preceded a higher
IOP rather proceeded it, suggesting that IOP may not be a cause of axial elongation but a
result of it. This finding has not been universal (Goss and Caffey, 1999). In theory, if a
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cornea is steeper, a greater force needs to be applied in order to obtain the required
applanation area. Some studies have supported this theory (Liu and Roberts, 2005,
Harada et al., 2008) whereas others have not found such a relationship (Francis et al.,
2007, Saleh et al., 2006).We did not find any relationship between IOP and refractive
error, axial length or corneal curvature which is keeping with a number of other
published studies (Lee et al., 2004b, Manny et al., 2008, Francis et al., 2007, Saleh et al.,
2006). The reasons for these possible differences are discussed below and in chapter 9.
Since the 10th century, and the first documented putative relationship between glaucoma
and intraocular pressure was described by the Arabian surgeon Al-Tabari (Cohen, 2001),
raised intraocular pressure has been intimately associated with the pathogenesis of
glaucoma (Halpern and Grosskreutz, 2002, Flammer and Mozaffarieh, 2007). Population
based studies have demonstrated that increased IOP is related to an increased prevalence
of open angle glaucoma in a dose dependent manner (Sommer et al., 1991, Klein et al.,
1992a, Klein et al., 1992b, Mitchell et al., 1996, Foster et al., 2003, Iwase et al., 2004,
Vijaya et al., 2005). A number of large multi-centered randomized controlled trials have
demonstrated that the onset/progression of glaucomatous optic neuropathy can be
reduced by lowering IOP (2000, Feiner and Piltz-Seymour, 2003, Heijl et al., 2002,
Burr et al., 2005, Maier et al., 2005, Vass et al., 2007). A number of animal models for
the disease have corroborated and provided further means of investigating the
pathogenesis of glaucoma in vivo. (Lindsey and Weinreb, 2005, Morrison, 2005,
Rasmussen and Kaufman, 2005, Weinreb and Lindsey, 2005). Overall, raised IOP
induces a series of events which culminates in the death of retinal ganglion cells by
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apoptosis. (Guo et al., 2005). The association between raised IOP and optic nerve head
parameters in eyes with open angle glaucoma is well established (Sommer et al., 1991,
Leske et al., 1997, Halpern and Grosskreutz, 2002, Flammer and Mozaffarieh, 2007).
Even in glaucoma free eyes, a number of population based studies have found
correlations between IOP and certain optic nerve parameters (Varma et al., 1995, Leske
et al., 1997, Leibowitz et al., 1980, Abe et al., 2009). For example, in the Baltimore Eye
Study, higher IOP was correlated with a smaller neural retinal rim area (Varma et al.,
1995). In the Tajimi Eye Study, IOP was found to be positively correlated to cup area
and cup to disc area ratio and negatively correlated to rim area, rim volume and retinal
nerve fiber layer thickness (Abe et al., 2009). This has not been the case in all population
based studies however (Klein et al., 1989, Varma et al., 1995, Ruangvaravate and
Neungton, 2008). We too found no relationship between IOP and optic nerve head
parameters including peripapillary atrophy in our population, supporting the latter rather
than the former reports. There are many possible reasons for these differences. These are
discussed below and in chapter 9.
One of the greatest problems in this area of research is that these studies are difficult to
compare. Comparison is hampered by the same problems that hinder the comparison of
other studies looking at ocular QTs– such as lack of homogeneity of method and that
many are not population based. The clinical gold standard for measuring IOP is
Goldman Applanation tonometry (GAT), which we used in our study. Older population
based studies looking at population distributions of IOP have used Schiotz tonometry or
a mixture of Schiotz and GAT (table 7.3). More recent studies, have used
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pneumotonometry or the tonopen. Schiotz tonometry is a form of indentation tonometry
(as opposed to applanation tonometry used by Goldman) (Kniestedt et al., 2008). The
basic principle that governs indentation tonometry is quite simple – if the internal
pressure of a fluid or gas filled object is low, then a given force will cause greater
indentation than if this pressure was high. The Schiotz tonometer, first developed in
1905, was gradually replaced the Malakoff tonometer. The Schiotz tonometer is used
with the volunteer or patient supine. Gravity provides the “known force” for a weighted
metal plunger attached to a scale. The lower the IOP, the deeper the plunger descends
into the anterior segment. For the pointer on the scale to move 1 unit, the plunger must
descend 0.05mm. Despite these simple principles, its use is complex. The scale readings
are related in a logarithmic rather than in simple a linear manner to IOP; Nomograms,
developed using cadaver eyes (Friedenwald, 1957, McBain, 1957), must be used to
convert scale readings into pressure readings; Additional weights must be added to the
plunger to read higher pressures (above the scale reading 3, which gives a pressure of
24.4 with 5.5g using the Friedenwald nomogram). Shiotz also assumed that ocular
rigidity was a constant when designing his tonometer. Scleral rigidity is not the same in
all eyes. Myopes for example have lower scleral rigidity than hyperopes and
emmetropes – IOP hence tends to be underestimated (Mc, 1958). Pressure readings
obtained via Shiotz tonometry also show a poor correlation to the current gold standard,
Goldman Applanation Tonometry (Krieglstein and Waller, 1975).
The gold standard for measuring IOP in the laboratory is manometry (Kniestedt et al.,
2008). Manometric studies have demonstrated that GAT is more accurate than the Tono-
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pen in measuring IOP (Eisenberg et al., 1998). Studies have shown that
pneumotonometry tends to overestimate IOP at lower pressures and under estimate IOP
at higher pressures. IOP values obtained via pneumotonometry were also consistently
higher than that by GAT (Sanchez-Tocino et al., 2005). Clinical studies have shown that
the reliability of the tonopen is also less than that of GAT (Boothe et al., 1988), with
variable results for pneumotonometry (Zadok et al., 1999, Tonnu et al., 2005, Regine et
al., 2006). The accuracy of even the gold standard GAT is influenced by a variety of
factors (Whitacre and Stein, 1993). GAT overestimates IOP in non-oedmatous thick
corneas and under estimates IOP in oedemetaous and thinner corneas (Ehlers et al.,
1975). Nomograms are available for correcting IOP according to CCT but their
acceptance and use is far from universal (Chihara, 2008, Doughty et al., 2002, Gunvant
et al., 2005). None of the population based studies on IOP have taken CCT of their
volunteers into account. For this reason, to allow comparison between studies, and also
because there is still no method of accounting for CCT which is universally accepted, in
our study we have not accounted for CCT in our IOP measurements.
In addition to the problems associated with tonometry, short and long term IOP
fluctuations are now well described (Shiose, 1990). There is evidence to suggest that
IOP shows not only diurnal variation but seasonal variation as well. It is impractical in a
large cohort to limit measurements of IOP to the same time each day or the same period
each year. Even if this was done, inter-individual variation would probably be such that
we would be unsure at exactly which time of the day that each individual’s IOP “peak”
and “trough” occurred. 24 hour IOP measurements could be considered the gold
252
standard, but in a large cohort, this is simply impractical. Hence, any mean IOP
measurement for a population, even using GAT, will be an estimate at best.
These findings highlight that intraocular pressure in our sample of the Orcadian
population, is not dissimilar to other published White Caucasian populations. IOP in this
sample was correlated to both age and central corneal thickness. Clinically, this is a very
important finding as these relationships do not hold in all populations (Nemesure et al.,
2003, Shiose, 1984, Fukuoka et al., 2008, Xu et al., 2005, Wong et al., 2009). Though no
longer considered the sole causative factor, IOP remains an important risk factor for
primary open angle glaucoma and remains the only treatable component of the disease.
So in the evaluation of subjects for glaucoma and other ocular conditions in the
Orcadian population when the assessment of IOP is required, it is important to make the




OPTIC NERVE PARAMETERS IN THE SCOTTISH POPULATION
ISOLATE OF ORKNEY
8.1 RESULTS
The distribution of optic nerve head parameters and nerve fibre layer thickness are
shown in the diagrams below and summary statistics in table 8.1. Mean values for these
main parameters with their 95% confidence interval in brackets are as follow: optic disc
area was 2.10mm² (2.03-2.16mm²) in the right eye, 2,04mm² (1.97-2.11mm²) in the left
eye; mean optic rim area was 1.53mm² (1.48-1.58mm²) in the right eye, 1.48mm² (1.43-
1.53mm²) in the left eye; mean cup area was 0.57mm² (0.52-0.62mm²) in the right eye,
0.56mm² (0.51-0.61mm²) in the left eye; mean vertical cup to disc ratio in both eyes 0.39
(0.36-0.42); mean nerve fibre layer thickness in both eyes 0.23mm (0.22-0.24mm). The
overall prevalence of peripapillary atrophy was 25.0% in right eyes and 25.3% in left
eye. 9.6% of effected right eyes, and 9.5% of effected left eyes were unilateral. Mean
peripapillary atrophy area in the right eye 0.24mm² (0.14-0.33mm²), left eye 0.28mm²
(0.17-0.39mm²). The difference between right and left eyes was only statistically
significant at the 5% level for optic disc area in female eyes (p=0.019, paired t-test). For
all other parameters, the difference between right and left eyes were not statistically
significant at the 5% (p values all > 0.05).
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TABLE 8.1: SUMMARY STATISTICS FOR MAIN OPTIC NERVE HEAD PARAMETERS
Right Eye Left Eye
Optic Disc Area (mm2)
Mean




95% Confidence interval for mode
Males (Mean , 95% CI)

















Optic Rim Area (mm2)
Mean




95% Confidence interval for median
Males (Mean , 95% CI)

















Optic Cup Area (mm2)
Mean




95% Confidence interval for mode
Males (Mean , 95% CI)


















TABLE 8.1 (CONTINUED): SUMMARY STATISTICS FOR MAIN OPTIC NERVE HEAD
PARAMETERS
Right Eye Left Eye
Vertical Cup to Disc Ratio
Mean




95% Confidence interval for mode
Males (Mean , 95% CI)

















Nerve Fiber Layer Thickness (mm)
Mean




95% Confidence interval for mode
Males (Mean , 95% CI)























95% Confidence interval for median
Peripheral Extent (Mean , 95% CI)
Males (Mean , 95% CI)
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Distribution of Optic Disc Area


























Distribution of Rim Area
Right Eyes Left Eyes
FIGURE 8.2: DISTRIBUTION OF OPTIC RIM AREA
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Right Eyes Left Eyes
Distribution of Retinal Nerve Fibre Layer (RNFL) Thickness



























Distribution of Cup Area
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Distribution of Peripapillary Atrophy (PPA) Area
PPA Area (mm2)
Right Eyes Left Eyes
FIGURE 8.5: DISTRIBUTION OF PERIPAPILLARY ATROPHY AREA
Distributions of the above parameters were unimodal (figures 8.1 to 8.5). No statistically
significant association was found between age and the optic nerve head parameters of
disc area, rim area, cup area, maximum cup depth, nerve fibre layer thickness or
peripapillary atrophy. A multivariate model confirmed statistically significant
associations between global disc area, rim area and cup area (all p values = 0.000). Total
disc area, cup area and nerve fibre layer thickness were also related to maximum cup
depth (p = 0.18, p = 0.000, p = 0.000 respectively). Nerve fibre layer thickness is related
to cup area, rim area and maximum cup depth (p=0.044, p=0.029, p=0.000 respectively).
The area of peripapillary atrophy is related significantly to the radial extent of the
atrophy (p=0.000). No statistically significant relationships were noted between total
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disc area, rim area, cup area, nerve fiber layer thickness and the ocular biometric
parameters of intra-ocular pressure, refractive error, axial length, central corneal
thickness, anterior chamber depth or corneal curvature (all p values greater than 0.05).
8.2 DISCUSSION
Examination of the optic nerve head and its parameters plays a central role in the
diagnosis of ocular disease. This is not just in the case of primary open angle glaucoma,
where structural damage to the nerve is believed to precede functional problems, but is
central in the evaluation of a wide range of ocular conditions (Sommer et al., 1979,
Quigley et al., 1989, Harwerth et al., 1999, Kerrigan-Baumrind et al., 2000, Wollstein
and Schuman, 2008). Hence understanding the appearance of the optic nerve in a disease
free population is a vital part of clinical ophthalmology. Early attempts were made by
Bengtsson to quantify optic nerve head parameters using an early form of planimetry in
a population based survey (Bengtsson, 1976). Since then a number of population based
studies have emerged documenting optic disc parameters in different populations (table
8.2). These have shown that optic disc morphology and dimensions can show inter-
population, intra-population and intra-individual variation. Comparison of these studies
are plagued by the same problems of comparing other eye studies, that of lack of
homogeneity of methods. The early days of optic disc evaluation consisted of visual
inspection (Reeves and Taylor, 2004). The introduction of ophthalmoscope by Helmotz
in 1851 made the evaluation of the optic nerve head in vivo possible. However, even
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with the use of more sophisticated optical equipment, reproducibility of various forms of
subjective analysis of the optic nerve head shows high inter and intra-observer
variability (Varma et al., 1992). More objective methods of documenting the optic nerve
head have arisen (Kwartz et al., 2005, Zangwill and Bowd, 2006). Stereoscopic
photographs of the optic nerve head are common a method of documenting the
appearance of the optic disc but is subjective and dependent on the operators’ experience
and skill (Tielsch et al., 1988). Methods of planimetry have been used to quantify disc
and cup area in optic nerve photographs (Spencer et al., 1995, Bourne et al., 2008a,
Bourne et al., 2008b). The observer manually delineates the margins of the optic disc
and cup. Computer software digitizes the image and calculates the required parameters.
Optic nerve head analyzers (ONHA) such as the device produced by Rodenstock, use a
video camera which takes multiple images of the fundus (Gramer and Siebert, 1989). By
taking images of the optic nerve head from different angles and using a pattern of stripes
projected onto the optic nerve, the ONHA is able to develop a topographic image of the
optic nerve head. Even more sophisticated imaging devices are now available such as
optical coherence tomograhy (OCT), which uses a reflectance technique similar to the
method used in the Carl Zeiss IOLmaster and scanning laser polarimetry which uses the
phase shift or retardation of polarized light as it passes through the peripapillary retinal
nerve fiber layer to estimate it’s thickness (Burgoyne, 2004). These methods have their
own advantages and disadvantages (Gramer and Siebert, 1989, Burgoyne, 2004, Meyer
and Howland, 2001). It is important to note, that with all these techniques, the values
given for optic disc parameters (the “true retinal size”) are computed by taking into
account various magnification factors of the eye and optical system of the machine
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(Rudnicka et al., 1998). A number of studies have observed that the size of optic nerve
parameters can show systematic variation depending on the measurement technique
(Spencer et al., 1995, Rudnicka et al., 1998, Meyer and Howland, 2001). Optic nerve
measurements obtained by using the Heidelberg Retinal Tomograph, for example, have
been observed to be smaller than those using photography techniques (Spencer et al.,
1995, Meyer and Howland, 2001). Hence comparison of values between these studies is
even problematic.
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TABLE 8.2: SELECTED STUDIES INVESTIGATING OPTIC NERVE HEAD PARAMETERS
(ODA: OPTIC DISC AREA; ORA: OPTIC RIM AREA; OCA: OPTIC CUP AREA; VCDR: VERTICAL CUP TO DISC RATIO; NFLT: NERVE FIBER LAYER THICKNESS; PPA: PERIPAPILLARY ATROPHY)
OPTIC NERVE PARAMETERS

















































































1999 Planimetry 55+ White Caucasian 2.42±0.47 1.85±0.39 0.57±0.34 0.49±0.14
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TABLE 8.2 (CONTINUED): SELECTED STUDIES INVESTIGATING OPTIC NERVE HEAD PARAMETERS
(ODA: OPTIC DISC AREA; ORA: OPTIC RIM AREA; OCA: OPTIC CUP AREA; VCDR: VERTICAL CUP TO DISC RATIO; NFLT: NERVE FIBER LAYER THICKNESS; PPA: PERIPAPILLARY ATROPHY)
OPTIC NERVE PARAMETERS





































11-77 Turkish 1.98±0.42 1.41±0.35 0.57±035 0.35±0.21
(Durukan et
al., 2004)













































2005 HRT II 65-89 White Caucasian 1.98±0.36 1.52±0.31 0.45±0.35 0.23±0.07
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TABLE 8.2 (CONTINUED): SELECTED STUDIES INVESTIGATING OPTIC NERVE HEAD PARAMETERS
(ODA: OPTIC DISC AREA; ORA: OPTIC RIM AREA; OCA: OPTIC CUP AREA; VCDR: VERTICAL CUP TO DISC RATIO; NFLT: NERVE FIBER LAYER THICKNESS; PPA: PERIPAPILLARY ATROPHY)
OPTIC NERVE PARAMETERS


















































2008 HRT II 30-80 Thai 2.67 2.09 0.55 0.26
(Abe et al.,
2009)
2009 HRT II 40+ Japanese subjects 2.06±0.41 1.55±0.29 0.51±0.35 0.25±0.07
265
Summary statistics for optic nerve head parameters in our study are reported in table 8.2.
For the reasons stated above, it difficult to compare the values we obtained in our study
for optic nerve head parameters with others published in the field for any definitive
conclusions. If we compare disc area in the Orcadian population to other published
studies involving white Caucasian populations using the HRT to measure optic nerve
parameters, our results are not dissimilar. However, if compared to studies using
techniques such as the optic nerve head analyzer, mean Orcadian parameters appear
smaller – an observation which is probably due to the difference in method and has also
been noted elsewhere (Spencer et al., 1995, Meyer and Howland, 2001). The term
macrodisc and microdisc are used clinically to describe optic discs that are considered
relatively large or small. Defined as being either two standard deviations above mean
disc area, for macrodiscs, or two standard deviations below the mean disc area for
microdiscs, clinically this diagnosis can be of importance as these discs can be
associated with other ocular abnormalities. Macrodiscs in our study sample would be
above approximately 3.13mm² and microdiscs below approximately 1.01mm².
The only statistically significant associations we found between the parameters was
between global disc area, rim area and cup area, between disc area, cup area, nerve fibre
layer thickness and maximum cup depth and between nerve fibre layer thickness and cup
area and rim area. There was no statistically significant association found between these
optic nerve head parameters and age, gender or other ocular biometric parameters. Some
of these findings are supported by populations based studies but not others. The
Rotterdam Study, a population based cross sectional study, for example, found that age
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was not associated with any optic disc parameters but disc area and rim area was
marginally smaller in women compared to men (Ramrattan et al., 1999). Disc and rim
area were also found to be weakly associated to refractive error. In study carried out in
Antalya however, refractive error was not associated with optic nerve parameters but age
was a significant factor (Durukan et al., 2004). The reasons for these differences are
probably multifactorial and will be discussed in greater depth in the final chapter of this
thesis.
Our positive findings described above – a relationship between certain optic head
parameters with each other, are not surprising if one considers the anatomy and
development of the optic nerve. Embryologically, the optic pits, the primordia of the
globe, appear bilaterally at around 22 days of gestation from neuroectoderm (Edward
and Kaufman, 2003). These develop into the optic vesicles which are affixed to the
telencephalon via an elongation of the neuroectoderm known as the optic stalks – the
primordium of the optic nerve. At around 6 weeks of gestation, axons of the retinal
ganglion cells penetrate the optic stalk. The nerve fibre layer of the eye is eventually
formed by axons of the retinal ganglion cells, the optic disc rim is formed from the
axons as they exit the globe, and the disc area is the sum of the primordial stalk coupled
with the axons. Ocular development is a highly coordinated process and a number of
genes and other factors have already been identified (reviewed by Harada et al (Harada
et al., 2007)). Considering their anatomical and embryological relationship, it is
unsurprising that these parameters are related.
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Para or peri papillary (PPA) represents chorioretinal atrophy adjacent the optic nerve
head (Jonas, 2005). Commonly, PPA is divided into two zones, a zone alpha and a zone
beta. Zone beta lies adjacent to the optic disc or the peripapillary scleral ring, and is
characterized ophthalmoscopically by discernible sclera and large choroidal vessels.
Sandwiched between zone beta or the peripapillary scleral ring (of Elschnig) and the
retina lies zone alpha, a region characterized by varying degrees of hyper and
hypopigmentation and areas of chorio-retinal atrophy. Histologically, the beta zone
corresponds to an area characterized by a reduction in the numbers of photoreceptors
and loss of retinal epithelial cells (Fantes and Anderson, 1989, Kubota et al., 1993,
Curcio et al., 2000). Since the 1970s, the evidence supporting a relationship between
PPA and glaucomatous optic neuropathy has been accumulating (Primrose, 1970,
Wilensky and Kolker, 1976, Nevarez et al., 1988, Buus and Anderson, 1989, Jonas et al.,
1992, Jonas and Xu, 1993, Jonas et al., 1989, Jonas and Naumann, 1989, Araie et al.,
1994, Park et al., 1996, Park et al., 2001, Lee et al., 2002). Both alpha and beta zones
have been found to be greater in eyes with glaucoma compared to normal eyes (Jonas et
al., 1989, Jonas, 2005). Alpha and beta zones have been found to tally with relative and
absolute scotomas respectively in visual field analysis (Jonas et al., 1991). Very
recently, beta zone PPA has been identified as a risk factor for glaucoma progression as
well (Teng et al., 2010). The mechanism by which PPA contributes to glaucomatous
optic neuropathy is unclear but engineering models of optic nerve head biomechanics
have demonstrated that the susceptibility of the optic nerve head to IOP induced stress
can be influenced by the thinness of peripapillary sclera as well as the dimensions and
geometry of the optic canal (Burgoyne et al., 2005). Mechanical stress induced by IOP is
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greater for a smaller radius of curvature and thinner peripapillary sclera. Based on this
evidence we had postulated that the extent of PPA would be related to corneal thickness
- greater levels of PPA associated with thinner corneas, as well as longer axial lengths.
Furthermore, despite this clinical interest in PPA as a risk factor glaucoma, there have
been few population based studies investigating the distribution of PPA in a normal
population.
We found the mean area of peripapillary atrophy in the right eye to be 0.24mm² (0.14-
0.33mm²) and the left eye 0.28mm² (0.17-0.39mm²). The overall prevalence of
peripapillary atrophy was 25.0% in right eyes and 25.3% in left eye. 9.6% of effected
right eyes, and 9.5% of effected left eyes were unilateral. The only association we
between the total area of peripapillary atrophy and other ocular biometric parameters
was between the total area and the radial extent of PPA. Jonas et al published one of the
first major studies investigating PPA in a non-glaucoma population recruited from a
hospital in Erlangen, Germany (Jonas et al., 1989, Jonas and Naumann, 1989). Mean age
was approximately 44 years with a range of 3-81 year. Using planimetric methods, they
reported a prevalence of 15.2% beta zone atrophy in normal eyes. Mean beta zone PPA
was found to 0.13mm. The Rotterdam Study is one of the few population based studied
which have investigated PPA (Ramrattan et al., 1999). Using a form of planimetry to
quantitate stereo-photographs, the study found 55% of their study cohort had at least
one eye affected by PPA, with 13% having at least one eye affected by beta zone PPA.
The prevalence of zone beta was found to increase with refractive error but no
association was found with age or gender like in our study. The other population based
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study to investigate PPA in the Beijing Eye Study, a cohort study in northern China
(Wang et al., 2008). Beta zone PPA was found in 19.9% of volunteers in this study with
a mean value of 0.46mm². Like the findings of our study, PPA did not vary significantly
between genders. However, the Beijing Study did find an association between PPA and
age and myopic refractive error. As before, because of the difference in methods used,
sample profiles study comparison is problematic. As discussed above, “true size” of
PPA is calculated by the different imaging systems using different criteria which are not
necessarily comparable (Rudnicka et al., 1998, Meyer and Howland, 2001). It is
however worth noting that our sample had a considerably higher overall PPA compared




In the early days of ophthalmology, our knowledge of the eye was initially based on
visual inspection of individual cases and examination of cadaveric specimens. With the
advancement of technology and research methods, further knowledge about the eye was
accrued from studies. Initially these were small scale and on predominantly White
Caucasian populations. These conclusions were then extrapolated to manage ocular
diseases of other more varied populations. Over the past decade, but especially over the
last 3 years, there has been an increasing number of population based studies looking at
the prevalence of glaucoma and various QTs associated with it. The Orcades Eye Study
is the first population based study investigating quantitative traits related to primary
open angle glaucoma in a Scottish population. Our study has demonstrated that the
average values, distribution and relationships between the primary open angle glaucoma
related quantitative traits of intraocular pressure, central corneal thickness and a number
of optic nerve head parameters is not dissimilar to other populations of White Caucasian
descent (tables 6.1,7.1 and 8.1; figures 6.1, 7.1, 8.1 to 8.4;). In brief, we found mean IOP
for right eyes to be 14.8mmHg (95% confidence intervals 14.4mmHg, 15.2mmHg), and
for left eyes 15.1mmHg (95% confidence intervals 14.7mmHg, 15.6mmHg). Mean CCT
in both eyes was found to be 540µm (95% confidence interval 536µm, 544µm). Mean
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values for the main optic nerve head parameters with their 95% confidence intervals in
brackets are as follows: optic disc area was 2.10mm² (2.03-2.16mm²) in right eyes and
2.04mm² (1.97-2.11mm²) in left eyes; mean optic rim area was 1.53mm² (1.48-1.58mm²)
in right eyes and 1.48mm² (1.43-1.53mm²) in left eyes; mean cup area was 0.57mm²
(0.52-0.62mm²) in right eyes and 0.56mm² (0.51-0.61mm²) in left eyes; mean vertical
cup to disc ratio in both eyes was 0.39 (0.36-0.42); mean nerve fibre layer thickness in
both eyes was 0.23mm² (0.22-0.24mm²). The overall prevalence of peripapillary atrophy
was 25.0% in right eyes and 25.3% in left eyes. 9.6% of effected right eyes, and 9.5% of
effected left eyes were unilateral. Mean peripapillary atrophy area in right eyes was
0.24mm² (0.14-0.33mm²) and in left eyes 0.28mm² (0.17-0.39mm²). The difference
between left and right eyes and between genders was not statistically significant except
in the case of IOP. Though the difference between left and right eyes was statistically
significant for IOP at the 5% level (paired t-test, p-value = 0.021) it was not clinically
significant (mean difference = 0.311 mmHg, 95% confidence interval for mean
difference -0.576,-0.046mmHg). Bivariate analysis only found a statistically significant
association between IOP and CCT (p=0.004) and IOP and age (p=0.005), but not with
any of the other ocular biometric parameters including axial length or any optic nerve
head parameter. On multivariate analysis, age and central corneal thickness were found
to be associated with IOP at the 5% level ( P = 0.032 and P=0.004 respectively).
Comparison of these studies is hindered by the differences of methodology used to
recruit volunteers, measure QT’s and define disease. Many of the techniques used to
measure QTs are not comparable and have been discussed in greater detail in previous
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chapters. Another problem with a number of these studies which was mentioned briefly
in chapter 1, is that of self reported race. Though this remains a concept which is often
disputed, race/ethnicity/population are useful constructs and indicators of ancestry for
exploring hypotheses about genetic and environmental risk factors in health and disease
(Burchard et al., 2003, Bamshad et al., 2004). Individuals within the same “race” tend to
share a greater proportion of their genetic background as they have a more recent
common ancestry than individuals from more distant populations. Recent studies
investigating ancestry with more recent genetic markers have demonstrated that it is
possible to assign individuals into geographic regions using certain markers (Bamshad et
al., 2004). Further more, the demarcation between quantitative traits, which may have
been influenced by natural selection may be greater than the difference between more
neutral markers. However, for any conclusions to be valid, a study participant’s
population of origin must be identified as accurately as possible. The majority of studies
done in ophthalmology, have relied on self reported. Unfortunately, there can be a high
level of disparity between the physical appearance of a subject and any genetic measure
of ancestral population (Klimentidis and Shriver, 2009). This is especially problematic
in studies done in the United States where classification systems are sometimes broad
and involve populations with potentially high levels of admixture. For example, the
term “Asian” is used as a “racial” or “ethnic” category. However, this term encompasses
South Asians, East Asians and South East Asians who are genetically and culturally a
heterogeneous group. The term “Hispanic” as a “racial” or “ethnic” categorization is
equally meaningless. The term is often used to described descendents from Latin
American countries or descendents from Spanish cultures (Bertoni et al., 2003).
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However, Hispanics are also culturally diverse and genetically heterogeneous, and can
have genetic contributions from European, African and Native American populations
(Sans, 2000). The contribution from each population can vary and Hispanic populations
can exhibit different ancestral structures from a di- (contributions from Europe + Native
American or African) to trihybrid structure (contributions from all three continents)
(Bertoni et al., 2003). Admixture is also present amongst self reported White Caucasians
(Halder et al., 2009). Admixed populations can also incorrectly estimate the contribution
of ancestral populations to their final genetic composition (Klimentidis et al., 2009). In
newer studies carried out in cohorts composed of (what we could possibly presume) to
be more genetically homogenous individuals, such as populations in rural India or
Mongolia, self reported race is probably less problematic.
Despite the limitations of these studies, they are important for a number of reasons. They
have highlighted that primary open angle glaucoma is a heterogeneous disease, with a
prevalence that varies between populations. For example, the prevalence of POAG in
certain populations of African-Caribbean descent has been found to be much higher than
many populations of White Caucasian descent (Rudnicka et al., 2006). The responses to
treatment, course of the disease can also differ between populations. In certain African-
Caribbean populations for example, the course of POAG tends to be more aggressive
and less amenable to treatment than White Caucasian populations (Rudnicka et al.,
2006). The type of glaucoma also varies between populations. Primary angle closure
glaucoma, for example, is more common in populations of South East Asian descent that
White Caucasian populations (Rudnicka et al., 2006). In addition, individual QTs and
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their association with other physiological variables can also differ between some
populations. Intraocular pressure for example, tends to be higher, and optic discs larger
in certain populations of African Caribbean descent compared to White Caucasian
populations (Racette et al., 2003). A number of studies have demonstrated a relationship
between intraocular pressure and central corneal thickness (Ehlers et al., 1975, Whitacre
et al., 1993, Doughty and Zaman, 2000), (Feltgen et al., 2001, Kohlhaas et al., 2006).
However, this relationship does not hold true for all populations. In the Barbados Eye
Study for example, a population based study in the Lesser Antilles, the relationship
between IOP and CCT in volunteers of African Caribbean or “mixed” ancestry was not
statistically significant, though the relationship was statistically significant for those of
White Caucasian ancestry (Nemesure et al., 2003). IOP in most populations tends to
increase with age. However, in Japanese populations, IOP decreases with age (Shiose,
1984). This phenomenon is not even observed in populations in mainland China (Xu et
al., 2005). The Liwan Eye Study found that mean anterior chamber depth differed
significantly in Chinese populations living in Guangzhou, Mongolia and Singapore (He
et al., 2008a). Hence, populations which could be considered geographically, and
possibly genetically neighboring each other, can not only have different “normal” values
but QTs can have different physiological associations with other factors.
The understanding of what is “normal” or healthy is the first step in understanding what
is abnormal, or diseased. What these studies, even with their limitations have
demonstrated is that is “normal” differs between populations. The Orcades Eye Study is
the first population based study investigating quantitative traits related to primary open
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angle glaucoma in a Scottish population. Our study has demonstrated that the average
values, distribution and relationships between the primary open angle glaucoma related
quantitative traits of intraocular pressure, central corneal thickness and a number of optic
nerve head parameters is not dissimilar to other populations of White Caucasian descent.
Knowledge of such parameters in a normal population is invaluable in a clinical setting,
as reference ranges are often used to triage patients and sometimes even define disease.
The obvious example is of course intraocular pressure, values of which in the past have
been the axis around which glaucoma management revolved. Intraocular pressure was
initially assumed to take a Gaussian distribution. Mean IOP in White Caucasian adult
populations, whether investigated by Schiotz tonometry or Goldman Applanation
Tonometry, was fairly consistently estimated to being between approximately 15 to 16
mmHg, with a standard deviation of 2.5-2.8mmHg. (Armaly, 1965, Wallace and Lovell,
1969, Burr et al., 2007). “ Normal IOP” was based on mean IOP ±2 standard deviations
and 21-22mmHg was generally accepted as the upper limit of normal. So for many
years an IOP greater than 21-22mmHg was considered abnormal. We now recognize
that the concept of “normal IOP” is not that simple. For example, a subpopulation of
patients exist, who develop glaucomatous optic neuropathy but never have IOPs
recorded above 21mmHg and another population exists whose IOP remains above
21mmHg but do not always develop glaucomatous optic neuropathy. So though it is
now recognize no absolute “safe” or “dangerous” value of IOP can be defined, and IOP
goals for glaucoma must be individualized, IOP remains the only treatable risk factor for
glaucoma and, a populations’ IOP must be understood before targets can be set for an
individual’s IOP. A less obvious example is corneal width, which can be used to define
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micro or megalocornea and define and subsequently monitor congenital glaucoma, as
discussed in chapter 6. Corneal diameter measurements have also been used in to
improve the accuracy of IOL power calculations in third generation formulas (Holladay
et al., 1996), for estimating the size of the size of ciliary sulcus and anterior chamber
width before the implantation of sulcus-fixated lenses (Price and Parker, 1997). Hence
and understanding of the mean and distribution of corneal width in a population is
invaluable.
Understanding the relationship between these quantitative traits also aids the clinical
decision making process. Perhaps one of the most important of our findings is that
intraocular pressure in our sample is correlated to both age and central corneal thickness.
These findings are not universal (Nemesure et al., 2003, Shiose, 1984, Fukuoka et al.,
2008, Xu et al., 2005, Wong et al., 2009). Though the management of primary open
angle glaucoma no longer whirls around intraocular pressure alone, IOP remains an
important risk factor and the only treatable component of the disease. So in the
evaluation of subjects for glaucoma and other ocular conditions in the Orcadian
population when the assessment of IOP is required, it is important to make appropriate
allowances for age and corneal thickness. Though the measurement of central corneal
thickness is considered good practice in the assessment of primary open angle glaucoma,
taking such measurements when assessing glaucoma suspects is not universal
(American_Academy_of_Ophthalmology, 2008). Important negatives in our sample
include central corneal thickness and optic disc parameters do not vary with age, or with
each other.
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The differences between summary statistics and distributions between some populations
could be attributed to differences in methodology. We believe that some of these
differences in quantitative trait values can also be attributed to human genetic variation
between populations as well as differences in environmental factors influencing these
traits, not just at an individual level in the form of developmental plasticity, but at a
population level.
Many of the limitations of our study we share with other published studies in the field.
For example, in common with many other population based studies, though we have
taken an average of several measurements, we have only measured each quantitative
trait in one sitting. There is evidence that intraocular pressure and central corneal
thickness can show diurnal as well as seasonal variation (Shiose, 1990, Doughty and
Zaman, 2000). It is impractical in a large cohort to limit measurements of quantitative
traits to the same time of day or season or the year. Furthermore, inter-individual
variation would probably be such that individual peaks and troughs are likely to occur at
slightly different times of the day, and 24 hour measurements of quantitative traits
would be impractical and probably unpopular amongst the study cohort.
This initial analysis of data has primarily an epidemiological one and hence the
ascertainment strategy of our study may be considered to be a limitation. As our results
have shown, the age and gender distribution of our study does not completely mirror the
age distribution of the Orcadian population (table 5.1). The long term goal of the
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Orcades Eye Study is not epidemiological research but to investigate the inheritance of
quantitative traits related to primary open angle glaucoma in the population isolate of
Orkney. To establish this project, we utilized the resources and volunteers of the cross
sectional family based genetics study, the Orkney Cardiovascular Disease Study. Hence
our recruitment strategy needed to be in agreement with the strategy of the overall
Orcades Project. Volunteers who had been the first to participate in other arms of the
study were the first to be invited to take part in the Orcades Eye Project. There were two
main reasons for employing this strategy. The first was to avoid volunteer fatigue as
these individuals would have been exposed to a long succession of investigations in the
other arms of the project, and we hoped to leave as much time as possible between
visits. These volunteers were also the most likely to have genome-wide scans completed
in the time frame of the PhD.
The second limitation of our study is the sample size of the study. In accordance with
our initial power calculation, we had aimed to collect data on quantitative traits related
to primary open angle glaucoma from a minimum of 1000 volunteers. Unfortunately a
number of practical and logistic problems we did not anticipate forced us to defer the
start date of the project and other issues impeded its progress. These were discussed in
detail in chapter 5. In brief, protracted negotiations with the vendor, delayed renovations
due to a shortage of appropriate manpower and inclement weather all delayed the start of
the project. The progress of the project was impeded by equipment related issues,
volunteer and staffing problems. Finally, it was not possible to use all the volunteer data
which was gathered as only a limited number had genome-wide scans completed in time
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for analysis. With hindsight, our original aims – to secure funding, find and renovate
premises, source appropriate equipment, train in the use of that equipment, establish and
refine standard operating procedures, set up, refine and verify databases, recruit
volunteers, then gather both quantitative and qualitative data from 1000 volunteers, enter
and analyze this data within the time frame of a PhD, was unrealistic. Though we have
not procured the quantity of data we had initially planned, the quality of data is
excellent, and the procedures and protocols which were established for data collection,
entry and management, once initial faults had been resolved, have worked extremely
well.
We had also hoped to calculate heritabilities for these parameters. Genetic data for the
Orcades project was only accessible to a small number of individuals, so we were
dependent on other members of the team to execute this analysis. A partial preliminary
analysis has been performed but due to time and manpower pressures this is not
complete, and now must be considered future work. Within this current data set we also
have data on refractive error, axial length, corneal power and anterior chamber depth. A
number of population based studies have investigated the prevalence and distribution of
refractive error, a common cause of reversible visual impairment (Hyams et al., 1977,
Taylor, 1981, Hashemi et al., 2004, Xu et al., 2007a, Rein et al., 2006, Resnikoff et al.,
2008, Warrier et al., 2008, Casson et al., 2007, Wong et al., 2000, Wensor et al., 1999,
Tielsch et al., 1995a, Kempen et al., 2004, Olsen et al., 2007, Xu et al., 2009, Wu et al.,
1999, Aine, 1984, Sawada et al., 2008, Attebo et al., 1999, Wong et al., 2003). Anterior
depth is an important quantitative trait related to glaucoma and has been investigated by
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a number of population based studies (Aung et al., 2005, He et al., 2008a, Foster et al.,
1997, Tananuvat and Pansatiankul, 2005, Hashemi et al., 2009a, Bonomi et al., 2000a,
He et al., 2008b) Other future work with this current data would involve investigating
the distribution and relationships of these traits in the Scottish Population Isolate of
Orkney. Despite the limitations of this study, to date, the only other population based
study which has collected such a wide range of POAG associated quantitative traits
including peripapillary atrophy and central corneal thickness is the Beijing Eye Study




Though my part in data collection is now complete, there are plans for further collection
of POAG associated quantitative trait data. With increased numbers, future work
includes a meaningful analysis of the heritability of these quantitative traits, the use of
association and linkage methods to explore the inheritance of quantitative traits related
to primary open angle glaucoma. Furthermore, since this project was established, our
understanding of complex disease and of the challenges of genome-wide studies and
the technology to support such studies has grown. Though genome wide association
studies have successfully identified a number of disease susceptibility loci, these loci
only explain a small proportion of possible phenotypic variability (Manolio et al.,
2009). Height for example, has an estimated heritability of 80-90% and despite a
number of large scale studies identifying over 40 height associated genetic variants,
these variants account for only around 5% of variation (Gudbjartsson et al, 2008,
Lettre et al, 2008, Maher, 2008, Weedon et al, 2008) . Findings from other quantitative
traits and complex diseases, despite high estimated heritabilities have been equally
disappointing (Maher B, 2008). Several suggestions have been made to explain the
limited success of current genome-wide association studies (de los Campos et al., 2010,
Manolio et al., 2009). Previously utilized chips may not have captured sufficient genetic
diversity, both in quantitiy and quality. Poor modeling, current additive models of
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quantitative traits or complex disease not accounting for certain effects such as epistasis,
or the role of copy number variations or rare variants in complex disease and
quantitative trait aetiology, and inadequate sample size are other factors which may
contribute to lack of GWAS success.
In the light of this knowledge, other future work and improvements to the project would
include: (1). Improving genome wide coverage by using more recent methods of
genotyping. Commercially available chips now not only show increased converage, they
also have the ability to detect copy number varation. The Illumina HumanOmni5 Bead
chip for example, has over 4,300,000 makers and CNV capability (Illumina, 2011). This
is compared to 317,000 tag SNPs of the the Illumina HumaHap300 (Illumina, 2006)
used in this study; (2) Increasing sample size. This could be accomplished in absolute
terms by recruiting more Orcadians into the study , but considering the total population
of Orkney is limited to around 20,000 individuals and even a study of 30,000 was able to
identify only a very small minority (less than 5%) of variants responsible for human
height (Gudjartsson et al., 2008, Maher 2008), a more pragmatic approach would be to
collaborate with other research groups. Pooling and meta-analyses of genetic data by
international consortia have already successfully identified new susceptibility alleles
(Park et al, 2010, Schunkert et al., 2011). Collaborations between the Orcades study and
a number of other population based studies has already being established (Vitart et al,
2010); (3) Analyzing other models and exploring the contribution of other factors such
as the role of epigenetic variation to complex disease aetiology. Hence future work
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would also include exploring the contribution of epigenetics to ocular quantitative traits
(Rakyan et al., 2011).
Since this study was established, a number of studies in other populations have
published heritability estimates, identified regions of the genome and putative genes for
glaucoma associated quantitative traits including central corneal thickness, intraocular
pressure and optic nerve head parameters including peripapilllary atrophy (Macgregor et
al., 2010, Charlesworth et al., 2010, Zheng et al., 2008, Zheng et al., 2009, He et al.,
2008d, He et al., 2008c, Healey et al., 2008, Healey et al., 2007, van Koolwijk et al.,
2007, Carbonaro et al., 2008, Duggal et al., 2007, Tsai et al., 2009, Klein et al., 2009).
These results support the use of a quantitative trait approach to locating genes and
regions of the genome associated with primary open angle glaucoma susceptibility. Data
from the Orcades Eye Study has recently helped identify novel loci associated with
corneal thickness (Vitart et. Al., 2010). Hopefully, with further analysis and
collaboration, the Orcades Eye Study will identify other genes and regions of the
genome associated with a susceptibility to primary open angle glaucoma, findings which
may eventually lead to the development of more effective methods of treatment for this
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